Banque;athway name;GO accession;SIZE;NES;NOM p-val;FDR q-val
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM;GO:0072599;105;3.601121;0;0
GO BP;COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE;GO:0006613;92;3.540488;0;0
GO BP;MITOCHONDRIAL TRANSLATIONAL TERMINATION;GO:0070126;85;3.17177;0;0
GO BP;PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM;GO:0070972;124;3.1521564;0;0
GO BP;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY;GO:0033108;89;3.1233432;0;0
GO BP;MITOCHONDRIAL TRANSLATION;GO:0032543;130;3.0968034;0;0
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY;GO:0000184;111;3.0922995;0;0
GO BP;TRANSLATIONAL TERMINATION;GO:0006415;100;3.056448;0;0
GO BP;MITOCHONDRIAL GENE EXPRESSION;#N/A;157;3.0535364;0;0
GO BP;ATP SYNTHESIS COUPLED ELECTRON TRANSPORT;GO:0042773;85;3.0301664;0;0
GO BP;TRANSLATIONAL INITIATION;GO:0006413;168;3.0265896;0;0
GO BP;RESPIRATORY ELECTRON TRANSPORT CHAIN;GO:0022904;101;2.9793448;0;0
GO BP;OXIDATIVE PHOSPHORYLATION;GO:0006119;126;2.9411042;0;0
GO BP;TRANSLATIONAL ELONGATION;GO:0006414;123;2.929721;0;0
GO BP;PROTEIN TARGETING TO MEMBRANE;GO:0006612;163;2.908181;0;0
GO BP;NADH DEHYDROGENASE COMPLEX ASSEMBLY;GO:0010257;60;2.8156576;0;0
GO BP;VIRAL GENE EXPRESSION;#N/A;177;2.725202;0;0
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS;GO:0000956;187;2.6962905;0;0
GO BP;MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE;GO:0006120;49;2.6249664;0;0
GO BP;RIBOSOME ASSEMBLY;GO:0042255;54;2.5918195;0;0
GO BP;ELECTRON TRANSPORT CHAIN;GO:0022900;154;2.5913975;0;0
GO BP;CYTOPLASMIC TRANSLATION;GO:0002181;88;2.5429926;0;0
GO BP;REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS;GO:0006521;48;2.5345438;0;0
GO BP;RIBOSOMAL LARGE SUBUNIT BIOGENESIS;GO:0042273;65;2.5050576;0;0
GO BP;CYTOCHROME COMPLEX ASSEMBLY;GO:0017004;34;2.5005107;0;0
GO BP;CELLULAR RESPIRATION;GO:0045333;162;2.4706337;0;0
GO BP;ATP SYNTHESIS COUPLED PROTON TRANSPORT;GO:0015986;22;2.4490252;0;0
GO BP;PROTEIN TARGETING;GO:0006605;368;2.432565;0;0
GO BP;REGULATION OF CELLULAR AMINE METABOLIC PROCESS;#N/A;58;2.4234345;0;0
KEGG;RIBOSOME;;80;3.6850057;0;0
KEGG;OXIDATIVE PHOSPHORYLATION;;112;3.0963411;0;0
KEGG;PARKINSONS DISEASE;;108;2.980065;0;0
KEGG;HUNTINGTONS DISEASE;;147;2.6023223;0;0
KEGG;ALZHEIMERS DISEASE;;132;2.461674;0;0
KEGG;PROTEASOME;;36;2.3218188;0;0
GO BP;INNER MITOCHONDRIAL MEMBRANE ORGANIZATION;GO:0007007;44;2.37917;0;1.52E-05
GO BP;RESPIRATORY CHAIN COMPLEX IV ASSEMBLY;GO:0008535;24;2.3846724;0;1.57E-05
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE;GO:0090150;274;2.4126348;0;1.62E-05
GO BP;AEROBIC ELECTRON TRANSPORT CHAIN;GO:0019646;17;2.3148603;0;5.92E-05
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE;#N/A;16;2.2939699;0;8.62E-05
GO BP;RIBOSOMAL SMALL SUBUNIT ASSEMBLY;GO:0000028;15;2.2718565;0;1.20E-04
GO BP;MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX IV ASSEMBLY;#N/A;20;2.2812595;0;1.24E-04
GO BP;RIBOSOME BIOGENESIS;GO:0042254;274;2.260574;0;1.43E-04
GO BP;PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS;GO:0010499;18;2.2527218;0;1.52E-04
GO BP;RIBOSOMAL SMALL SUBUNIT BIOGENESIS;GO:0042274;64;2.2048466;0;3.43E-04
GO BP;RIBOSOMAL LARGE SUBUNIT ASSEMBLY;GO:0000027;26;2.1848977;0;4.67E-04
GO BP;ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS;GO:0031145;73;2.1836746;0;4.67E-04
GO BP;CRISTAE FORMATION;GO:0042407;32;2.142168;0;7.19E-04
GO BP;AMINE METABOLIC PROCESS;GO:0009308;86;2.114593;0;0.001003958
KEGG;CARDIAC MUSCLE CONTRACTION;;47;2.0544746;0;0.001048062
GO BP;RNA CATABOLIC PROCESS;GO:0006401;345;2.085908;0;0.001489606
GO BP;RIBONUCLEOPROTEIN COMPLEX BIOGENESIS;#N/A;391;2.056497;0;0.002072148
GO BP;RRNA METABOLIC PROCESS;GO:0016072;207;2.0408561;0;0.002548853
GO BP;INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY;GO:0070498;79;2.0385945;0;0.002626831
GO BP;NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031111;31;-2.2489927;0;0.003736457
GO BP;ENDOTHELIAL CELL DEVELOPMENT;GO:0001885;43;-2.2102027;0;0.00375344
GO BP;PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX;GO:0030150;16;1.9986708;0;0.004062691
KEGG;PROTEIN EXPORT;;22;1.9290744;0;0.00417297
GO BP;CELL FATE COMMITMENT;GO:0045165;121;-2.1632059;0;0.004585505
GO BP;REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY;GO:1904666;19;1.9752406;0;0.005110324
KEGG;FOCAL ADHESION;;145;-2.0132914;0;0.005120426
GO BP;ESTABLISHMENT OF ENDOTHELIAL BARRIER;GO:0061028;33;-2.1492567;0;0.005315911
GO BP;RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION;#N/A;173;1.9377202;0;0.006951243
GO BP;AEROBIC RESPIRATION;GO:0009060;79;1.9382656;0;0.007047254
GO BP;HISTONE METHYLATION;GO:0016571;111;-2.1048696;0;0.007129994
GO BP;ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS;#N/A;227;1.939775;0;0.00716587
GO BP;MITOCHONDRIAL MEMBRANE ORGANIZATION;GO:0007006;113;1.9383833;0;0.007166666
GO BP;MITOCHONDRION ORGANIZATION;GO:0007005;449;1.9320722;0;0.007300216
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE;GO:0072594;475;1.9295963;0;0.007367379
GO BP;BODY MORPHOGENESIS;GO:0010171;40;-2.109278;0;0.007492248
GO BP;REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;GO:0031110;64;-2.0941408;0;0.007651622
GO BP;HISTONE H3 K4 TRIMETHYLATION;GO:0080182;16;-2.1135674;0;0.007749867
KEGG;REGULATION OF ACTIN CYTOSKELETON;;156;-1.9018935;0;0.008406317
KEGG;BASAL CELL CARCINOMA;;33;-1.9101368;0.001582279;0.009198043
GO BP;REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS;#N/A;25;-2.0719407;0;0.009862464
GO BP;PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE;#N/A;30;1.8982087;0;0.010071578
KEGG;ACUTE MYELOID LEUKEMIA;;51;-2.018866;0;0.010240853
GO BP;SPINAL CORD DEVELOPMENT;GO:0021510;54;-2.053305;0;0.010335261
GO BP;REGULATION OF MITOCHONDRIAL GENE EXPRESSION;#N/A;28;1.8917458;0;0.01067456
GO BP;MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;#N/A;92;-2.0245004;0;0.010693592
GO BP;ENDOTHELIUM DEVELOPMENT;GO:0003158;83;-2.0633492;0;0.010745695
GO BP;PEPTIDYL LYSINE TRIMETHYLATION;GO:0018023;40;-2.029227;0;0.011074755
KEGG;CELL ADHESION MOLECULES CAMS;;57;-1.9111198;0;0.011201162
KEGG;LEUKOCYTE TRANSENDOTHELIAL MIGRATION;;75;-1.9293101;0;0.011406479
GO BP;ARTERY DEVELOPMENT;GO:0060840;61;-2.016167;0;0.01153562
GO BP;VENTRAL SPINAL CORD DEVELOPMENT;GO:0021517;21;-2.0423172;0;0.011663002
GO BP;EMBRYONIC CRANIAL SKELETON MORPHOGENESIS;GO:0048701;28;-2.0305662;0;0.011775481
GO BP;SNRNA 3 END PROCESSING;#N/A;18;1.8797369;0.007712083;0.012007087
GO BP;COLLAGEN METABOLIC PROCESS;GO:0032963;64;-2.0333192;0;0.012012685
GO BP;GLUTAMATE RECEPTOR SIGNALING PATHWAY;GO:0007215;42;-2.0045485;0;0.013187658
GO BP;HISTONE H3 K9 METHYLATION;GO:0051567;29;-1.9969009;0;0.014270157
GO BP;NEURAL PRECURSOR CELL PROLIFERATION;GO:0061351;97;-1.9783342;0;0.014775744
GO BP;ATP METABOLIC PROCESS;GO:0046034;248;1.853272;0;0.015088161
GO BP;HISTONE H3 K4 METHYLATION;GO:0051568;46;-1.9694844;0;0.015158876
GO BP;COLLAGEN FIBRIL ORGANIZATION;GO:0030199;33;-1.9710865;0;0.015166868
GO BP;FOREBRAIN DEVELOPMENT;GO:0030900;233;-1.9843711;0;0.015286598
GO BP;COLLATERAL SPROUTING;GO:0048668;21;-1.9882957;0;0.015304039
GO BP;CARDIOVASCULAR SYSTEM DEVELOPMENT;#N/A;464;-1.978574;0;0.015364029
GO BP;MORPHOGENESIS OF AN EPITHELIAL SHEET;GO:0002011;46;-1.9716058;0;0.015607298
GO BP;HISTONE H3 K9 MODIFICATION;GO:0061647;38;-1.9654859;0.003174603;0.015626729
GO BP;EMBRYONIC ORGAN MORPHOGENESIS;GO:0048562;169;-1.9799886;0;0.015666306
GO BP;PROTEOGLYCAN METABOLIC PROCESS;GO:0006029;57;-1.9733158;0;0.01568581
GO BP;HEAD MORPHOGENESIS;GO:0060323;29;-1.9628656;0;0.015978552
GO BP;REGULATION OF NUCLEOTIDE METABOLIC PROCESS;#N/A;84;-1.9499741;0;0.016334899
GO BP;SENSORY SYSTEM DEVELOPMENT;GO:0048880;228;-1.9521358;0;0.016373808
GO BP;REGULATION OF HISTONE H3 K9 METHYLATION;GO:0051570;18;-1.9561709;0;0.016458912
GO BP;ADIPOSE TISSUE DEVELOPMENT;GO:0060612;31;-1.9474331;0;0.016577058
GO BP;REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY;GO:1900449;28;-1.9527602;0;0.016717015
GO BP;CELLULAR PROTEIN COMPLEX DISASSEMBLY;#N/A;187;1.8395833;0;0.016732179
GO BP;SUPRAMOLECULAR FIBER ORGANIZATION;GO:0097435;483;-1.9568024;0;0.016787464
GO BP;GLIAL CELL MIGRATION;GO:0008347;34;-1.9426992;0;0.017039306
GO BP;SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0031146;83;1.8354986;0;0.017067697
GO BP;REGULATION OF HISTONE METHYLATION;GO:0031060;54;-1.9354553;0;0.018395742
GO BP;POSITIVE REGULATION OF HISTONE METHYLATION;GO:0031062;33;-1.9317223;0;0.01872514
GO BP;PEPTIDYL LYSINE METHYLATION;GO:0018022;106;-1.9275944;0;0.019222807
GO BP;CELL JUNCTION ASSEMBLY;GO:0034329;179;-1.9187877;0;0.02142203
GO BP;NUCLEUS LOCALIZATION;GO:0051647;22;-1.9166347;0;0.021565193
GO BP;REGULATION OF CHROMATIN ORGANIZATION;GO:1902275;149;-1.9119298;0;0.021571405
GO BP;REGULATION OF ORGANELLE ASSEMBLY;GO:1902115;163;-1.9085379;0;0.021607999
GO BP;NEURON MIGRATION;GO:0001764;96;-1.9132621;0;0.021608582
GO BP;NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;GO:1902904;101;-1.9138954;0;0.021936813
GO BP;EPITHELIAL CELL DEVELOPMENT;GO:0002064;141;-1.9086738;0;0.022024088
GO BP;PEPTIDYL ASPARAGINE MODIFICATION;#N/A;32;1.8061959;0.008450705;0.022198664
GO BP;REGULATION OF MICROTUBULE DEPOLYMERIZATION;GO:0031114;26;-1.904633;0;0.022403123
GO BP;UROGENITAL SYSTEM DEVELOPMENT;GO:0001655;215;-1.8859808;0;0.022783654
GO BP;SENSORY ORGAN DEVELOPMENT;GO:0007423;322;-1.8886648;0;0.023040306
GO BP;POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061098;33;-1.8915194;0.001547988;0.023103297
GO BP;NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY;GO:0045746;31;-1.8597339;0;0.023116508
GO BP;ACTIN FILAMENT BASED MOVEMENT;GO:0030048;91;-1.8872089;0;0.023133963
GO BP;CONNECTIVE TISSUE DEVELOPMENT;GO:0061448;155;-1.8859891;0;0.02316338
GO BP;EPIBOLY;#N/A;27;-1.889287;0.003154574;0.023180952
GO BP;POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;#N/A;16;-1.859904;0.001680672;0.023337644
GO BP;REGULATION OF CELL MATRIX ADHESION;GO:0001952;81;-1.8660312;0;0.023373244
GO BP;EXTRACELLULAR STRUCTURE ORGANIZATION;#N/A;229;-1.894655;0;0.023378724
GO BP;CARDIAC MYOFIBRIL ASSEMBLY;GO:0055003;16;-1.866955;0;0.023418179
GO BP;THIOESTER BIOSYNTHETIC PROCESS;#N/A;49;-1.8917593;0;0.023455927
GO BP;REGULATION OF MICROTUBULE POLYMERIZATION;GO:0031113;41;-1.8958055;0;0.023493648
GO BP;NEGATIVE REGULATION OF CELL DEVELOPMENT;GO:0010721;207;-1.8604128;0;0.02350201
GO BP;RENAL SYSTEM DEVELOPMENT;#N/A;189;-1.8824409;0;0.023502983
GO BP;REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;#N/A;256;-1.8926494;0;0.023520883
GO BP;CELL JUNCTION ORGANIZATION;#N/A;214;-1.86125;0;0.023545835
GO BP;POSITIVE REGULATION OF CELL KILLING;#N/A;21;-1.8556527;0.001709402;0.02355914
GO BP;T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE;GO:0002292;33;-1.8674339;0;0.023566682
GO BP;NEUROBLAST PROLIFERATION;GO:0007405;37;-1.8564235;0;0.023586374
GO BP;EYE MORPHOGENESIS;GO:0048592;91;-1.8527515;0;0.02359243
GO BP;PYRUVATE METABOLIC PROCESS;GO:0006090;119;-1.8568729;0;0.023615267
GO BP;POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0045923;22;-1.8631262;0.004854369;0.023621412
GO BP;CEREBRAL CORTEX DEVELOPMENT;GO:0021987;84;-1.868201;0;0.023684138
GO BP;TELENCEPHALON DEVELOPMENT;GO:0021537;159;-1.8618581;0;0.023685649
GO BP;CRANIAL SKELETAL SYSTEM DEVELOPMENT;GO:1904888;42;-1.8969235;0;0.023710072
GO BP;COVALENT CHROMATIN MODIFICATION;GO:0016569;377;-1.8691765;0;0.023736356
GO BP;VASCULOGENESIS;GO:0001570;52;-1.8638;0;0.023798198
GO BP;SENSORY ORGAN MORPHOGENESIS;#N/A;145;-1.8527541;0;0.023860525
GO BP;PALLIUM DEVELOPMENT;GO:0021543;115;-1.8486145;0;0.023934785
GO BP;POST EMBRYONIC DEVELOPMENT;GO:0009791;71;-1.8493006;0;0.023949135
GO BP;ARTERY MORPHOGENESIS;GO:0048844;42;-1.8973417;0.001540832;0.023957996
GO BP;HISTONE H3 DEACETYLATION;GO:0070932;18;-1.8501731;0;0.024006443
GO BP;NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043242;58;-1.8993694;0;0.024012018
GO BP;CELL FATE SPECIFICATION;GO:0001708;39;-1.8530052;0;0.02403406
GO BP;EMBRYONIC SKELETAL SYSTEM DEVELOPMENT;GO:0048706;68;-1.869463;0;0.024036257
GO BP;EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS;GO:0048704;47;-1.8708616;0;0.024041353
GO BP;FACE DEVELOPMENT;GO:0060324;38;-1.8714621;0.003034901;0.024154184
GO BP;POSITIVE REGULATION OF CHROMATIN ORGANIZATION;#N/A;86;-1.8466219;0;0.024196327
GO BP;EMBRYONIC ORGAN DEVELOPMENT;GO:0048568;269;-1.8501896;0;0.024273181
GO BP;HINDBRAIN MORPHOGENESIS;GO:0021575;30;-1.8721057;0;0.024308268
GO BP;REGULATION OF CELL MORPHOGENESIS;GO:0022604;355;-1.8769498;0;0.024327103
GO BP;EPITHELIAL CELL DIFFERENTIATION;GO:0030855;390;-1.8728132;0;0.024391748
GO BP;PROTON TRANSMEMBRANE TRANSPORT;GO:1902600;118;1.7920809;0;0.024393955
GO BP;MICROTUBULE DEPOLYMERIZATION;GO:0007019;35;-1.8776968;0.001564945;0.024435606
GO BP;MITOCHONDRIAL TRANSMEMBRANE TRANSPORT;GO:1990542;82;1.7928298;0;0.024568947
GO BP;HEART MORPHOGENESIS;GO:0003007;177;-1.8728199;0;0.024761321
GO BP;REGULATION OF AMYLOID BETA FORMATION;GO:1902003;22;-1.8736097;0.00331675;0.024814868
GO BP;NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION;#N/A;109;-1.8424371;0;0.025225723
GO BP;REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY;GO:0048169;16;-1.8389933;0.001672241;0.025226574
GO BP;POSITIVE REGULATION OF CELL DEVELOPMENT;GO:0010720;352;-1.8379942;0;0.025297731
GO BP;MICROTUBULE POLYMERIZATION;GO:0046785;64;-1.8371725;0.001470588;0.025342938
GO BP;BLOOD VESSEL MORPHOGENESIS;GO:0048514;370;-1.8393171;0;0.025382051
GO BP;POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033138;63;-1.8401698;0.001468429;0.025412627
GO BP;HINDBRAIN DEVELOPMENT;GO:0030902;90;-1.8405433;0;0.025573859
GO BP;POSITIVE REGULATION OF MRNA CATABOLIC PROCESS;GO:0061014;40;-1.8337895;0;0.026534768
GO BP;SKELETAL SYSTEM MORPHOGENESIS;GO:0048705;138;-1.8323495;0;0.026537485
GO BP;DENDRITE DEVELOPMENT;GO:0016358;177;-1.8296463;0;0.026575038
GO BP;ROOF OF MOUTH DEVELOPMENT;GO:0060021;60;-1.8303037;0;0.026661422
GO BP;CORONARY VASCULATURE DEVELOPMENT;GO:0060976;36;-1.8324938;0;0.026783
GO BP;BASEMENT MEMBRANE ORGANIZATION;GO:0071711;23;-1.8308119;0.00166113;0.02678397
GO BP;CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS;#N/A;26;-1.8231318;0;0.02768394
GO BP;ACETYL COA BIOSYNTHETIC PROCESS;GO:0006085;22;-1.8222253;0.004862237;0.0277595
GO BP;REGULATION OF T HELPER CELL DIFFERENTIATION;#N/A;16;-1.8188865;0.004792332;0.02785771
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION;GO:0010573;23;-1.8240156;0.003159558;0.02785985
GO BP;REGULATION OF NMDA RECEPTOR ACTIVITY;GO:2000310;17;-1.8249949;0.001692047;0.027875373
GO BP;HISTONE H3 ACETYLATION;GO:0043966;50;-1.8209479;0;0.027911378
GO BP;AORTA DEVELOPMENT;GO:0035904;40;-1.8231709;0;0.027913263
GO BP;ACETYL COA METABOLIC PROCESS;GO:0006084;34;-1.8191375;0.001497006;0.028023874
GO BP;REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION;GO:0043370;24;-1.8104564;0.003174603;0.028033195
GO BP;CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION;GO:0021953;94;-1.8109393;0;0.028037291
GO BP;PROTEIN K63 LINKED DEUBIQUITINATION;GO:0070536;28;-1.8117527;0.001574803;0.028052757
GO BP;CARDIAC CHAMBER DEVELOPMENT;#N/A;125;-1.807541;0;0.028080748
GO BP;CELL DIFFERENTIATION IN SPINAL CORD;GO:0021515;19;-1.8195692;0.001574803;0.02815964
GO BP;AXON DEVELOPMENT;GO:0061564;337;-1.816532;0;0.02819844
GO BP;EMBRYONIC MORPHOGENESIS;GO:0048598;383;-1.8170396;0;0.028216586
GO BP;RESPONSE TO ZINC ION;GO:0010043;23;-1.8118424;0.00330033;0.028237037
GO BP;NEGATIVE REGULATION OF CELL DIFFERENTIATION;GO:0045596;426;-1.8080932;0;0.02826437
GO BP;POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION;#N/A;32;-1.8075451;0;0.028285716
GO BP;POSITIVE REGULATION OF NEURON DIFFERENTIATION;GO:0045666;246;-1.8085974;0;0.028319493
GO BP;REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:1902991;28;-1.8120679;0.001550388;0.028363965
GO BP;EMBRYONIC APPENDAGE MORPHOGENESIS;#N/A;84;-1.8145546;0;0.028467804
GO BP;CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION;GO:0043367;36;-1.8125589;0.001494768;0.028493367
GO BP;PROTEIN TARGETING TO MITOCHONDRION;GO:0006626;88;1.773235;0;0.028581867
GO BP;MULTICELLULAR ORGANISM GROWTH;GO:0035264;112;-1.8147379;0;0.028601602
GO BP;NEURON PROJECTION GUIDANCE;GO:0097485;166;-1.8128741;0;0.028604588
GO BP;POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL;GO:2000463;15;-1.8043762;0;0.028711373
GO BP;REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051493;409;-1.8050412;0;0.028758729
GO BP;NEURON PROJECTION ORGANIZATION;#N/A;67;-1.8129939;0;0.028809894
GO BP;ACTIN MEDIATED CELL CONTRACTION;GO:0070252;71;-1.8021678;0;0.029245108
GO BP;HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS;GO:0030201;23;-1.8004677;0.004926108;0.02945628
GO BP;CIRCADIAN REGULATION OF GENE EXPRESSION;GO:0032922;49;-1.8000708;0.001485884;0.029476907
GO BP;POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT;#N/A;331;-1.7992599;0;0.029524451
GO BP;EPITHELIAL TUBE MORPHOGENESIS;GO:0060562;222;-1.7964655;0;0.02955461
GO BP;LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS;GO:0035338;15;-1.7972353;0.005119454;0.029578596
GO BP;REGULATION OF CILIUM ASSEMBLY;GO:1902017;46;-1.8008007;0;0.029599158
GO BP;MUSCLE FILAMENT SLIDING;GO:0030049;23;-1.7982999;0.001644737;0.029617477
GO BP;TIGHT JUNCTION ORGANIZATION;GO:0120193;50;-1.7801225;0.002962963;0.029674802
GO BP;REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL;#N/A;22;-1.7974113;0.005042017;0.029717337
GO BP;PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE;#N/A;39;1.7675945;0;0.029745443
GO BP;POSITIVE REGULATION OF SYNAPTIC TRANSMISSION;GO:0050806;82;-1.7804624;0;0.02975326
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048010;71;-1.780661;0;0.029862162
GO BP;DEVELOPMENTAL GROWTH;GO:0048589;436;-1.7880808;0;0.029893002
GO BP;ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE;GO:0006086;16;-1.7935019;0.001733102;0.029921193
GO BP;NEUTRAL LIPID BIOSYNTHETIC PROCESS;#N/A;29;-1.79165;0.003164557;0.02995527
GO BP;HISTONE DEACETYLATION;GO:0016575;64;-1.7920369;0;0.030006085
GO BP;REGULATION OF MICROTUBULE BASED PROCESS;GO:0032886;183;-1.7895237;0;0.030022461
GO BP;TISSUE MIGRATION;#N/A;205;-1.7806761;0;0.030038862
GO BP;COLLAGEN BIOSYNTHETIC PROCESS;GO:0032964;31;-1.7882094;0.003120125;0.03005471
GO BP;MICROVILLUS ORGANIZATION;GO:0032528;19;-1.7905854;0.008064516;0.03008063
GO BP;TOOTH MINERALIZATION;GO:0034505;15;-1.793604;0.001655629;0.030093174
GO BP;REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0019217;65;-1.7920953;0.001412429;0.030184928
GO BP;REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL;GO:0060078;59;-1.7939671;0;0.030189691
GO BP;POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;#N/A;117;-1.7896065;0;0.03019643
GO BP;POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS;GO:0045723;15;-1.788324;0.003246753;0.030202463
GO BP;NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT;#N/A;193;-1.7807342;0;0.030217666
GO BP;ACTIN FILAMENT BUNDLE ORGANIZATION;GO:0061572;119;-1.777577;0;0.03029011
GO BP;TUBE FORMATION;GO:0035148;111;-1.7809043;0;0.030331546
GO BP;CEREBELLAR CORTEX FORMATION;GO:0021697;16;-1.7809373;0.005025126;0.030499408
GO BP;POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION;GO:0010575;18;-1.7820373;0.001647446;0.030528683
GO BP;POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:1902993;15;-1.7813113;0.00681431;0.030600933
GO BP;DENDRITIC SPINE MORPHOGENESIS;GO:0060997;44;-1.7845037;0;0.030602058
GO BP;NEUROMUSCULAR PROCESS CONTROLLING BALANCE;GO:0050885;30;-1.7832516;0.006349206;0.03066331
GO BP;ASTROCYTE DIFFERENTIATION;GO:0048708;40;-1.782102;0.001512859;0.030700753
GO BP;REGULATION OF CELL SHAPE;GO:0008360;117;-1.7848054;0;0.030747864
GO BP;HEART DEVELOPMENT;GO:0007507;399;-1.7822301;0;0.03082818
GO BP;CELL CELL JUNCTION ASSEMBLY;GO:0007043;89;-1.784989;0;0.030848304
GO BP;CARDIAC SEPTUM DEVELOPMENT;GO:0003279;85;-1.783262;0;0.030854957
GO BP;REGULATION OF NEURONAL SYNAPTIC PLASTICITY;GO:0048168;29;-1.7851826;0.001628664;0.030965704
GO BP;NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;63;-1.7671571;0;0.031104084
GO BP;CARDIAC VENTRICLE MORPHOGENESIS;GO:0003208;49;-1.7673849;0.00154321;0.031189853
GO BP;NEURON PROJECTION ARBORIZATION;GO:0140058;19;-1.7743282;0.001587302;0.03129193
GO BP;REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;#N/A;37;-1.7736092;0.002994012;0.031349014
GO BP;CENTRIOLE ASSEMBLY;GO:0098534;35;-1.7673922;0;0.031355757
GO BP;REGULATION OF PROTEIN DEPOLYMERIZATION;GO:1901879;62;-1.7714691;0.001451379;0.03138591
GO BP;REGULATION OF CELL JUNCTION ASSEMBLY;GO:1901888;67;-1.7728039;0;0.03142579
GO BP;REGULATION OF ALPHA BETA T CELL ACTIVATION;#N/A;51;-1.7641147;0.001494768;0.03144742
GO BP;POSITIVE REGULATION OF DENDRITE DEVELOPMENT;GO:1900006;61;-1.767533;0;0.03148297
GO BP;AMYLOID BETA FORMATION;GO:0034205;28;-1.7653859;0.001612903;0.03149671
GO BP;APICAL JUNCTION ASSEMBLY;GO:0043297;54;-1.7716421;0;0.031499695
GO BP;BARBED END ACTIN FILAMENT CAPPING;GO:0051016;17;-1.7643316;0.003454231;0.031526387
GO BP;CARDIAC VENTRICLE DEVELOPMENT;GO:0003231;92;-1.7676384;0;0.031618394
GO BP;INNER EAR MORPHOGENESIS;GO:0042472;51;-1.7643819;0.002998501;0.031658195
GO BP;CELLULAR EXTRAVASATION;GO:0045123;31;-1.7716569;0.009646302;0.03167766
GO BP;REGULATION OF HISTONE MODIFICATION;GO:0031056;113;-1.770154;0;0.03168917
GO BP;PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048008;47;-1.7677478;0;0.031749047
GO BP;NCRNA PROCESSING;GO:0034470;340;1.7580779;0;0.03180312
GO BP;DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS;GO:0060560;158;-1.7678918;0;0.03185379
GO BP;REGULATION OF GLIOGENESIS;GO:0014013;66;-1.7685034;0;0.031901818
GO BP;ENDODERM FORMATION;GO:0001706;40;-1.7690332;0.004739337;0.03191961
GO BP;ACTOMYOSIN STRUCTURE ORGANIZATION;GO:0031032;139;-1.7680385;0;0.03193998
GO BP;RETINA DEVELOPMENT IN CAMERA TYPE EYE;GO:0060041;92;-1.7591053;0;0.032774433
GO BP;REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051056;256;-1.759252;0;0.032884974
GO BP;RNA DESTABILIZATION;GO:0050779;28;-1.7582273;0.004658385;0.03294379
GO BP;CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION;GO:0048667;387;-1.7561074;0;0.033602737
GO BP;VIRION ASSEMBLY;GO:0019068;37;1.7468116;0;0.034400325
GO BP;REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032231;70;-1.7527913;0;0.03448644
GO BP;REGULATION OF COFACTOR METABOLIC PROCESS;#N/A;28;-1.7537069;0.001623377;0.034512505
GO BP;CELL SUBSTRATE JUNCTION ORGANIZATION;#N/A;76;-1.7528709;0.002894356;0.0346464
GO BP;CEREBELLAR CORTEX MORPHOGENESIS;GO:0021696;22;-1.7517622;0.004862237;0.034765843
GO BP;REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION;#N/A;68;-1.7512057;0.001494768;0.034772962
GO BP;APPENDAGE MORPHOGENESIS;#N/A;100;-1.7486624;0;0.035480343
GO BP;BLASTOCYST FORMATION;GO:0001825;33;-1.748862;0.003072197;0.035532445
GO BP;LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL;#N/A;16;-1.7471799;0.006451613;0.03566237
GO BP;CELL PART MORPHOGENESIS;#N/A;458;-1.7467899;0;0.03566466
GO BP;TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY;GO:0034142;24;-1.7475207;0.003220612;0.03572637
GO BP;DENDRITE MORPHOGENESIS;GO:0048813;103;-1.7456183;0;0.0358765
GO BP;DEVELOPMENTAL CELL GROWTH;GO:0048588;152;-1.7440143;0;0.036341388
GO BP;REGULATION OF BEHAVIOR;GO:0050795;21;-1.7427884;0.006677796;0.03664741
GO BP;POSITIVE REGULATION OF CHROMOSOME ORGANIZATION;GO:2001252;151;-1.7405245;0;0.037309628
GO BP;REGULATION OF NEURON DIFFERENTIATION;GO:0045664;429;-1.7399693;0;0.037392717
GO BP;LIMBIC SYSTEM DEVELOPMENT;GO:0021761;64;-1.7378988;0.002994012;0.037970167
GO BP;REGULATION OF CELL SUBSTRATE ADHESION;GO:0010810;147;-1.7373242;0;0.037979703
GO BP;REGULATION OF DNA METHYLATION;GO:0044030;21;-1.7363218;0.005008347;0.038008742
GO BP;PEPTIDYL LYSINE MODIFICATION;#N/A;325;-1.7332219;0;0.03807292
GO BP;REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY;GO:2000810;18;-1.7356371;0.00681431;0.038161017
GO BP;SYNAPSE ASSEMBLY;GO:0007416;82;-1.7363429;0.001398602;0.038178984
GO BP;CELL PROLIFERATION IN FOREBRAIN;GO:0021846;18;-1.7350291;0.014925373;0.038226333
GO BP;POSITIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY;#N/A;16;-1.7332264;0.006688963;0.038238075
GO BP;AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS;GO:0042987;38;-1.7334358;0;0.038292356
GO BP;LINOLEIC ACID METABOLIC PROCESS;GO:0043651;15;-1.7315067;0.005033557;0.03830344
GO BP;ADP METABOLIC PROCESS;GO:0046031;96;-1.7337447;0;0.03835878
GO BP;REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031344;491;-1.7319026;0;0.038363382
GO BP;DNA METHYLATION OR DEMETHYLATION;#N/A;71;-1.7308501;0.001388889;0.038365357
GO BP;NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000378;41;-1.7339679;0.004709576;0.03843714
GO BP;REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010975;347;-1.7293725;0;0.03879423
GO BP;SYNAPSE ORGANIZATION;GO:0050808;237;-1.7264975;0;0.039152805
GO BP;ALPHA BETA T CELL ACTIVATION;GO:0046631;72;-1.7282016;0;0.03915894
GO BP;MUSCLE CONTRACTION;GO:0006936;188;-1.7260416;0;0.039198212
GO BP;PROTEIN METHYLATION;GO:0006479;146;-1.7267201;0;0.039263066
GO BP;NEGATIVE REGULATION OF ORGAN GROWTH;GO:0046621;22;-1.7271764;0.001669449;0.03933065
GO BP;EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING;GO:0009792;466;-1.721855;0;0.039395176
GO BP;REGULATION OF AXONOGENESIS;GO:0050770;127;-1.7222288;0;0.03941336
GO BP;EMBRYONIC PATTERN SPECIFICATION;GO:0009880;39;-1.7222459;0.004615385;0.03957758
GO BP;POSITIVE REGULATION OF CELL CELL ADHESION;GO:0022409;143;-1.7226225;0.001328021;0.03966512
GO BP;HISTONE H3 K27 METHYLATION;GO:0070734;18;-1.7245315;0.003262643;0.03968711
GO BP;ACTIN FILAMENT ORGANIZATION;GO:0007015;285;-1.7229556;0;0.039716903
GO BP;EPITHELIAL TUBE FORMATION;#N/A;103;-1.720367;0;0.039781366
GO BP;NEUTRAL LIPID METABOLIC PROCESS;GO:0006638;82;-1.7239125;0.001424501;0.03980535
GO BP;CHROMATIN DISASSEMBLY;#N/A;17;-1.7229933;0.004862237;0.03987388
GO BP;POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010976;201;-1.723331;0;0.039895073
GO BP;RETINA MORPHOGENESIS IN CAMERA TYPE EYE;GO:0060042;34;-1.7196561;0.0015625;0.039900027
GO BP;MORPHOGENESIS OF EMBRYONIC EPITHELIUM;GO:0016331;111;-1.7170228;0.002747253;0.040535513
GO BP;INTERLEUKIN 2 PRODUCTION;GO:0032623;39;-1.7172507;0.0048;0.040583517
GO BP;AMEBOIDAL TYPE CELL MIGRATION;GO:0001667;272;-1.7175142;0;0.04067299
GO BP;POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION;GO:0070131;17;1.7257817;0.011709602;0.040798508
GO BP;ALPHA BETA T CELL DIFFERENTIATION;GO:0046632;55;-1.7145169;0;0.041382995
GO BP;SOMITE DEVELOPMENT;GO:0061053;50;-1.7137975;0.007518797;0.041523166
GO BP;ATP BIOSYNTHETIC PROCESS;GO:0006754;41;1.7210723;0.005633803;0.0416792
GO BP;VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY;GO:0038084;24;-1.7119577;0.0128;0.041715875
GO BP;REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;GO:0010769;215;-1.7111952;0;0.041720986
GO BP;REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045619;89;-1.712975;0;0.041726492
GO BP;INCLUSION BODY ASSEMBLY;GO:0070841;19;-1.7115622;0.008517887;0.04173856
GO BP;PROTEIN K48 LINKED DEUBIQUITINATION;GO:0071108;30;-1.7120205;0.006289308;0.041857187
GO BP;POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION;GO:1903039;113;-1.7086614;0.001438849;0.041998297
GO BP;CELLULAR RESPONSE TO ACID CHEMICAL;#N/A;129;-1.7087345;0;0.042122316
GO BP;POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032233;48;-1.7092031;0.002923977;0.04226079
GO BP;CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0050650;16;-1.7088058;0.00620155;0.042261925
GO BP;LONG TERM SYNAPTIC POTENTIATION;GO:0060291;44;-1.7095711;0.001533742;0.042280182
GO BP;NEGATIVE REGULATION OF ORGANELLE ASSEMBLY;#N/A;34;-1.7071227;0.003220612;0.042441126
GO BP;NEUTRAL AMINO ACID TRANSPORT;GO:0015804;24;-1.705663;0.014705882;0.042932943
GO BP;PROTEIN DEPOLYMERIZATION;GO:0051261;83;-1.70313;0.005649718;0.042951472
GO BP;NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051058;46;-1.7034386;0.004504505;0.042972047
GO BP;MAMMARY GLAND EPITHELIUM DEVELOPMENT;GO:0061180;47;-1.7037851;0.004524887;0.04297879
GO BP;SYNAPTIC TRANSMISSION GLUTAMATERGIC;GO:0035249;39;-1.7047917;0.007898894;0.04301366
GO BP;CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC;#N/A;49;-1.7050501;0.004484305;0.04306391
GO BP;REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000177;56;-1.7038088;0.003025719;0.043131486
GO BP;CHROMATIN ASSEMBLY OR DISASSEMBLY;GO:0006333;143;-1.7021757;0;0.043222748
GO BP;MUSCLE ORGAN MORPHOGENESIS;GO:0048644;49;-1.7038244;0.00309119;0.043285426
GO BP;IN UTERO EMBRYONIC DEVELOPMENT;GO:0001701;297;-1.701455;0;0.043404456
GO BP;GLOMERULUS DEVELOPMENT;GO:0032835;34;-1.7008744;0.00913242;0.04346015
GO BP;REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:2000514;31;-1.7002351;0.014285714;0.04352063
GO BP;POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH;GO:0040018;18;-1.6980507;0.006525286;0.044411544
GO BP;MATURATION OF LSU RRNA;GO:0000470;21;1.7087381;0.015267176;0.044664267
GO BP;NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009142;61;1.7103292;0;0.04473449
GO BP;CELL MATRIX ADHESION;GO:0007160;149;-1.6966033;0;0.044922795
GO BP;REGULATION OF ACTIN FILAMENT BASED PROCESS;GO:0032970;275;-1.6944419;0;0.045513537
GO BP;SKELETAL SYSTEM DEVELOPMENT;GO:0001501;309;-1.6924099;0;0.0455642
GO BP;CELL SUBSTRATE ADHESION;GO:0031589;237;-1.6949201;0;0.04560795
GO BP;BRAIN MORPHOGENESIS;GO:0048854;19;-1.6945535;0.011844331;0.045619752
GO BP;ACYLGLYCEROL HOMEOSTASIS;GO:0055090;21;-1.6924939;0.010033445;0.04568188
GO BP;POSITIVE REGULATION OF DEVELOPMENTAL GROWTH;GO:0048639;108;-1.6935906;0.001369863;0.045721747
GO BP;REGULATION OF OSTEOCLAST DIFFERENTIATION;GO:0045670;30;-1.6916434;0.007739938;0.04574688
GO BP;HISTONE H4 ACETYLATION;GO:0043967;57;-1.692654;0;0.04578275
GO BP;LYSOSOMAL TRANSPORT;GO:0007041;90;-1.6928183;0.001453488;0.0458844
GO BP;PHOTOTRANSDUCTION VISIBLE LIGHT;GO:0007603;16;1.7033783;0.012254902;0.046132434
GO BP;SULFUR COMPOUND CATABOLIC PROCESS;#N/A;38;-1.6903647;0.004559271;0.046196934
GO BP;FATTY ACYL COA BIOSYNTHETIC PROCESS;#N/A;27;-1.6897862;0.008077544;0.046253297
GO BP;NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055026;20;-1.6888219;0.006230529;0.04654986
GO BP;POSITIVE REGULATION OF DENDRITE MORPHOGENESIS;GO:0050775;33;-1.6883638;0.006535948;0.046596095
GO BP;NCRNA METABOLIC PROCESS;#N/A;416;1.699499;0;0.04695705
GO BP;SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0007264;428;-1.6869586;0;0.047082804
GO BP;RESPONSE TO WOUNDING;GO:0009611;426;-1.6861366;0;0.047265217
KEGG;MELANOMA;;45;-1.6942679;0.004484305;0.048279572
GO BP;NEUROMUSCULAR JUNCTION DEVELOPMENT;GO:0007528;36;-1.6833025;0.004524887;0.048456732
KEGG;NEUROACTIVE LIGAND RECEPTOR INTERACTION;;56;-1.7390894;0.001488095;0.048463162
GO BP;SISTER CHROMATID COHESION;GO:0007062;53;-1.681458;0.005934718;0.049110886
GO BP;FATTY ACYL COA METABOLIC PROCESS;#N/A;33;-1.6800524;0.006309148;0.049166884
GO BP;POSITIVE REGULATION OF VASCULATURE DEVELOPMENT;#N/A;106;-1.6801579;0.001416431;0.049223457
GO BP;T CELL MIGRATION;GO:0072678;35;-1.680416;0.006097561;0.04927681
GO BP;NEGATIVE REGULATION OF ORGANELLE ORGANIZATION;#N/A;309;-1.6814712;0;0.049279653
GO BP;LONG CHAIN FATTY ACYL COA METABOLIC PROCESS;GO:0035336;19;-1.6806879;0.01754386;0.049321275
GO BP;LENS FIBER CELL DIFFERENTIATION;GO:0070306;17;-1.6736912;0.014376997;0.049617793
GO BP;REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043244;89;-1.6769874;0;0.04967637
GO BP;EMBRYONIC CAMERA TYPE EYE DEVELOPMENT;GO:0031076;22;-1.6771901;0.009950249;0.049746078
GO BP;REGULATION OF VASCULATURE DEVELOPMENT;GO:1901342;193;-1.673744;0;0.049757402
GO BP;LYMPHOCYTE DIFFERENTIATION;GO:0030098;187;-1.6743397;0.00124533;0.04982139
GO BP;FOCAL ADHESION ASSEMBLY;GO:0048041;63;-1.6773251;0.004291846;0.04982873
GO BP;MULTICELLULAR ORGANISMAL SIGNALING;#N/A;88;-1.6780639;0.001457726;0.04983234
GO BP;AORTA MORPHOGENESIS;GO:0035909;21;-1.674611;0.011400651;0.049845677
GO BP;RESPONSE TO LEAD ION;GO:0010288;19;-1.6762221;0.021996615;0.04989426
GO BP;CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING;GO:0051085;26;-1.6737655;0.008143323;0.04990188
GO BP;PRESYNAPSE ORGANIZATION;GO:0099172;18;-1.6775572;0.009569378;0.049912013
GO BP;REGULATION OF CHROMOSOME ORGANIZATION;GO:0033044;293;-1.6724797;0;0.049925786
GO BP;POSITIVE REGULATION OF INTERFERON BETA PRODUCTION;GO:0032728;24;-1.6781706;0.01309329;0.04994979
GO BP;TRANSMISSION OF NERVE IMPULSE;GO:0019226;25;-1.6754774;0;0.04996365
GO BP;CARTILAGE DEVELOPMENT;GO:0051216;113;-1.6749485;0.001381216;0.049996488
GO BP;PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER;#N/A;32;-1.6746141;0.006339144;0.05000804
GO BP;REGULATION OF KERATINOCYTE DIFFERENTIATION;GO:0045616;28;-1.6725054;0.011075949;0.050061323
GO BP;NEUTRAL LIPID CATABOLIC PROCESS;#N/A;29;-1.6755863;0.013677811;0.05006655
GO BP;POSITIVE REGULATION OF LOCOMOTION;GO:0040017;384;-1.6681181;0;0.05028801
GO BP;AXIS SPECIFICATION;GO:0009798;59;-1.6681664;0.005830904;0.05043176
GO BP;CELL CELL ADHESION;GO:0098609;445;-1.6682602;0;0.050537765
GO BP;SCHWANN CELL DIFFERENTIATION;GO:0014037;28;-1.6694498;0.02056962;0.05061573
GO BP;CELL CELL JUNCTION ORGANIZATION;GO:0045216;131;-1.6691692;0;0.05061765
GO BP;POLYSACCHARIDE CATABOLIC PROCESS;#N/A;19;-1.6707069;0.0192;0.050621442
GO BP;POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT;GO:0060999;36;-1.6683505;0.006279435;0.050651982
GO BP;MYOTUBE DIFFERENTIATION;GO:0014902;55;-1.6694738;0.004424779;0.050763067
GO BP;POSITIVE REGULATION OF RECEPTOR INTERNALIZATION;GO:0002092;15;-1.668383;0.022508038;0.05080978
GO BP;REGULATION OF CATION TRANSMEMBRANE TRANSPORT;GO:1904062;169;-1.6695814;0.001297017;0.0508524
GO BP;REGULATION OF CELLULAR RESPONSE TO HEAT;GO:1900034;72;-1.6697887;0.001398602;0.050887372
GO BP;MORPHOGENESIS OF A BRANCHING STRUCTURE;GO:0001763;115;-1.6652293;0.001344086;0.05136224
GO BP;METANEPHROS DEVELOPMENT;GO:0001656;47;-1.6655715;0.003025719;0.051363025
GO BP;CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS;#N/A;73;-1.6647208;0;0.0514719
KEGG;WNT SIGNALING PATHWAY;;100;-1.697971;0;0.051668327
KEGG;PATHWAYS IN CANCER;;236;-1.7160373;0;0.05195106
GO BP;EAR MORPHOGENESIS;GO:0042471;63;-1.6634324;0.003039514;0.05197813
GO BP;PROTEIN LOCALIZATION TO MITOCHONDRION;GO:0070585;121;1.684726;0;0.052026987
GO BP;ALPHA BETA T CELL PROLIFERATION;GO:0046633;17;-1.6623344;0.012987013;0.052270677
GO BP;REGULATION OF ION TRANSMEMBRANE TRANSPORT;GO:0034765;218;-1.6618093;0;0.052286655
GO BP;REGULATION OF COLLATERAL SPROUTING;GO:0048670;15;-1.6614586;0.016694492;0.05230589
GO BP;CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:0035710;46;-1.6610563;0.00622084;0.052324727
GO BP;B CELL DIFFERENTIATION;GO:0030183;75;-1.6619228;0.001416431;0.05239504
GO BP;CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS;#N/A;478;1.6821784;0;0.052418485
GO BP;CELLULAR POLYSACCHARIDE CATABOLIC PROCESS;#N/A;19;-1.662369;0.014925373;0.052421566
GO BP;NEGATIVE REGULATION OF JNK CASCADE;GO:0046329;26;-1.6597298;0.008090615;0.052539244
GO BP;T CELL DIFFERENTIATION;GO:0030217;127;-1.6603327;0.001342282;0.052555237
GO BP;REGULATION OF CELL SUBSTRATE JUNCTION ASSEMBLY;#N/A;46;-1.6597394;0.00456621;0.052691437
GO BP;REGULATION OF TRANSPORTER ACTIVITY;#N/A;145;-1.6578285;0;0.053147107
GO BP;PHOTORECEPTOR CELL DEVELOPMENT;GO:0042461;24;-1.6578715;0.012326657;0.053274594
GO BP;PHOSPHOLIPID DEPHOSPHORYLATION;GO:0046839;29;-1.6567706;0.006557377;0.053521443
GO BP;POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;GO:0048260;37;-1.6564336;0.014947684;0.0535435
KEGG;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC;;44;-1.7027915;0.004392386;0.053554233
GO BP;EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0001837;92;-1.655599;0.002777778;0.053699993
GO BP;TISSUE MORPHOGENESIS;GO:0048729;447;-1.6557363;0;0.053758524
GO BP;TRIGLYCERIDE METABOLIC PROCESS;GO:0006641;65;-1.6545055;0.001492537;0.05408284
GO BP;NEURAL TUBE DEVELOPMENT;GO:0021915;131;-1.651439;0;0.055084396
GO BP;REGULATION OF CELL ADHESION;GO:0030155;424;-1.6515894;0;0.055142485
GO BP;PROTEIN LOCALIZATION TO SYNAPSE;GO:0035418;52;-1.6518042;0.007462686;0.055186275
GO BP;CEREBELLAR CORTEX DEVELOPMENT;GO:0021695;34;-1.6519383;0.013355592;0.055284884
GO BP;WOUND HEALING;GO:0042060;354;-1.6500543;0;0.055700798
GO BP;ENDODERM DEVELOPMENT;GO:0007492;56;-1.6486164;0.004424779;0.0559483
GO BP;MORPHOGENESIS OF AN EPITHELIUM;GO:0002009;378;-1.6481726;0;0.055966377
GO BP;METENCEPHALON DEVELOPMENT;GO:0022037;71;-1.6491557;0.007032349;0.056029085
GO BP;REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY;GO:0050803;134;-1.6487635;0.001345895;0.05603983
GO BP;GLAND DEVELOPMENT;GO:0048732;290;-1.6477342;0;0.05606183
GO BP;AMYLOID BETA METABOLIC PROCESS;GO:0050435;37;-1.6463825;0.00792393;0.056494936
GO BP;MUSCLE SYSTEM PROCESS;GO:0003012;248;-1.6459769;0;0.056511957
GO BP;NEGATIVE REGULATION OF CHROMATIN ORGANIZATION;#N/A;47;-1.6465006;0.001512859;0.056573074
GO BP;REGULATION OF POSTSYNAPSE ORGANIZATION;GO:0099175;65;-1.6455306;0.002971768;0.056604665
GO BP;REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051147;96;-1.6435206;0.00541272;0.057185736
GO BP;REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033135;88;-1.6431886;0.00137931;0.057207216
GO BP;MESENCHYMAL CELL PROLIFERATION;GO:0010463;26;-1.6440206;0.016260162;0.057246987
GO BP;DENDRITIC SPINE DEVELOPMENT;GO:0060996;77;-1.6436003;0;0.057319842
GO BP;FAT CELL DIFFERENTIATION;GO:0045444;139;-1.641587;0;0.057847578
GO BP;REGULATION OF MUSCLE SYSTEM PROCESS;GO:0090257;135;-1.6410418;0;0.057945397
GO BP;REGULATION OF SYNAPTIC PLASTICITY;GO:0048167;101;-1.6407566;0.002728513;0.057967294
GO BP;GLIOGENESIS;GO:0042063;170;-1.6390086;0;0.0585318
GO BP;REGULATION OF BIOMINERALIZATION;#N/A;50;-1.6390767;0.003016591;0.05867436
GO BP;POSITIVE REGULATION OF CELL ADHESION;GO:0045785;242;-1.6375934;0;0.059215073
GO BP;RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION;#N/A;16;1.6636281;0.02955665;0.05974854
GO BP;REGULATION OF EMBRYONIC DEVELOPMENT;GO:0045995;98;-1.6356336;0.002762431;0.05979628
GO BP;REGULATION OF TRANSMEMBRANE TRANSPORT;#N/A;275;-1.6361847;0;0.05982587
GO BP;COLLAGEN CATABOLIC PROCESS;GO:0030574;21;-1.6357447;0.021207178;0.059906796
GO BP;POSTSYNAPSE ORGANIZATION;GO:0099173;110;-1.6343992;0.001328021;0.059936933
GO BP;ENDOCARDIAL CUSHION DEVELOPMENT;GO:0003197;27;-1.6340427;0.011146497;0.059957117
GO BP;POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION;GO:0032743;19;-1.6337028;0.02;0.059993215
GO BP;TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY;GO:0007169;497;-1.6346196;0;0.06001377
GO BP;CAMERA TYPE EYE MORPHOGENESIS;GO:0048593;75;-1.6327094;0.002857143;0.060083963
GO BP;NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;55;-1.6348081;0.001567398;0.060097545
GO BP;REGULATION OF NEUROBLAST PROLIFERATION;GO:1902692;18;-1.6330093;0.008;0.060223565
GO BP;RESPIRATORY SYSTEM DEVELOPMENT;GO:0060541;133;-1.6327351;0.002645503;0.060229495
GO BP;REGULATION OF DEVELOPMENTAL GROWTH;GO:0048638;211;-1.6300002;0.001240695;0.06067295
GO BP;POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031346;284;-1.6307815;0;0.060682308
GO BP;ENDOCARDIAL CUSHION MORPHOGENESIS;GO:0003203;20;-1.631323;0.014827018;0.06070585
GO BP;CYTOPLASMIC SEQUESTERING OF PROTEIN;GO:0051220;22;-1.630998;0.014586709;0.06071355
GO BP;NEGATIVE REGULATION OF ATP METABOLIC PROCESS;#N/A;18;-1.629264;0.018302828;0.060787942
GO BP;ADRENAL GLAND DEVELOPMENT;GO:0030325;16;-1.6289433;0.021702837;0.06081709
GO BP;INTERMEDIATE FILAMENT BASED PROCESS;GO:0045103;37;-1.6300076;0.006309148;0.06083054
GO BP;APPENDAGE DEVELOPMENT;#N/A;119;-1.6294088;0;0.060864534
GO BP;MITOCHONDRIAL TRANSPORT;GO:0006839;218;1.6577274;0;0.060870226
GO BP;REGULATION OF NEURON MIGRATION;GO:2001222;24;-1.6300578;0.033444814;0.060966108
GO BP;MITOTIC SISTER CHROMATID COHESION;GO:0007064;22;-1.6278127;0.013136289;0.061292842
GO BP;AXONEMAL DYNEIN COMPLEX ASSEMBLY;GO:0070286;17;1.6583049;0.02764977;0.06145538
GO BP;T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;GO:0002286;49;-1.627209;0.007440476;0.061464436
GO BP;MITOCHONDRIAL GENOME MAINTENANCE;GO:0000002;20;-1.6242967;0.018151816;0.062818356
GO BP;NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0045744;22;-1.6244031;0.027419355;0.06290527
GO BP;LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE;#N/A;19;-1.6218406;0.02208202;0.06402125
GO BP;POSITIVE REGULATION OF GTPASE ACTIVITY;GO:0043547;282;-1.6197871;0;0.06502705
GO BP;SKIN DEVELOPMENT;GO:0043588;183;-1.6188754;0;0.065401256
GO BP;REGULATION OF CARBOHYDRATE CATABOLIC PROCESS;#N/A;68;-1.6180191;0.002869441;0.06576748
GO BP;POSITIVE REGULATION OF AXONOGENESIS;GO:0050772;61;-1.6172227;0.004392386;0.06613487
GO BP;EXTRACELLULAR MATRIX ASSEMBLY;GO:0085029;28;-1.6159582;0.019017432;0.06625573
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010634;108;-1.6160038;0.001385042;0.06639307
GO BP;REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING;GO:0006349;15;-1.6162463;0.021452146;0.0664342
GO BP;ACTIVATION OF GTPASE ACTIVITY;GO:0090630;71;-1.6153364;0.002828854;0.06644653
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR;GO:2000779;62;-1.6162791;0.002915452;0.066591226
GO BP;CARDIAC MUSCLE TISSUE MORPHOGENESIS;GO:0055008;42;-1.6140924;0.010494753;0.06670488
GO BP;DETERMINATION OF HEART LEFT RIGHT ASYMMETRY;GO:0061371;48;-1.6134444;0.016949153;0.06681489
GO BP;VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0003229;40;-1.6141626;0.007727976;0.06682634
GO BP;REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION;GO:0051480;145;-1.6135467;0.001264223;0.06690582
GO BP;REGULATION OF CHROMATIN SILENCING;GO:0031935;31;-1.6143218;0.014308427;0.06691124
GO BP;POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS;GO:0061003;17;-1.6127023;0.03322259;0.06695749
GO BP;PHOTORECEPTOR CELL DIFFERENTIATION;#N/A;32;-1.6127524;0.012779553;0.067090586
GO BP;REGULATION OF T CELL DIFFERENTIATION;GO:0045580;73;-1.611825;0.001447178;0.06710219
GO BP;MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL;GO:0098815;22;-1.6120534;0.011437909;0.06710447
GO BP;REGULATION OF DENDRITIC SPINE MORPHOGENESIS;GO:0061001;34;-1.6106143;0.012658228;0.06769426
GO BP;PERIPHERAL NERVOUS SYSTEM DEVELOPMENT;GO:0007422;42;-1.609921;0.013740458;0.06772002
GO BP;REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION;GO:0045601;19;-1.6092635;0.017488075;0.067771964
GO BP;REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC;GO:0051966;28;-1.6099527;0.025974026;0.06786854
GO BP;CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT;GO:0030705;157;-1.6093369;0;0.06790182
GO BP;ASTROCYTE DEVELOPMENT;GO:0014002;22;-1.6078961;0.02152318;0.06847496
GO BP;REGULATION OF ACTIN FILAMENT BASED MOVEMENT;#N/A;30;-1.6061418;0.01255887;0.06856008
GO BP;DORSAL VENTRAL PATTERN FORMATION;GO:0009953;47;-1.6066396;0.008915304;0.0686096
GO BP;INTESTINAL ABSORPTION;GO:0050892;24;-1.6063154;0.01836394;0.06862178
GO BP;NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT;#N/A;19;-1.6067642;0.02341137;0.06868976
GO BP;REGULATION OF LIPID METABOLIC PROCESS;GO:0019216;285;-1.60678;0.001177856;0.06884747
GO BP;VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL;GO:0086005;19;-1.6068554;0.013071896;0.06897294
GO BP;REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS;GO:0042304;36;-1.6050411;0.014240506;0.06903231
GO BP;MAINTENANCE OF PROTEIN LOCATION;GO:0045185;86;-1.6037798;0.005617978;0.06961985
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION;GO:0050679;118;-1.6031424;0.004;0.069868036
GO BP;REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION;GO:0046578;181;-1.6019008;0.001236094;0.07031605
GO BP;POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM;GO:1905332;20;-1.6021948;0.024154589;0.07033447
GO BP;FORELIMB MORPHOGENESIS;GO:0035136;24;-1.6015177;0.024115756;0.07038203
GO BP;REGULATION OF TRIGLYCERIDE METABOLIC PROCESS;GO:0090207;26;-1.6010408;0.019261638;0.07056003
GO BP;GLIAL CELL DEVELOPMENT;GO:0021782;68;-1.5993297;0.004225352;0.07060721
GO BP;POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT;#N/A;105;-1.5980816;0.001355014;0.07068703
GO BP;TAXIS;#N/A;339;-1.5983189;0;0.07070887
GO BP;ODONTOGENESIS OF DENTIN CONTAINING TOOTH;GO:0042475;53;-1.5994188;0.010463378;0.070726156
GO BP;ACTIVATION OF MAPKK ACTIVITY;GO:0000186;45;-1.6004255;0.006069803;0.070769094
GO BP;LGI TO ENDOSOME TRANSPORT;#N/A;16;-1.599853;0.024916943;0.07078748
GO BP;NADH METABOLIC PROCESS;GO:0006734;34;-1.5987799;0.017460318;0.07079034
GO BP;TRIGLYCERIDE CATABOLIC PROCESS;GO:0019433;21;-1.600065;0.019672131;0.070824
GO BP;STEROL METABOLIC PROCESS;GO:0016125;120;-1.5983484;0.001347709;0.07085583
GO BP;REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;147;-1.5994428;0;0.07087724
GO BP;POSITIVE REGULATION OF ENDOCYTOSIS;GO:0045807;78;-1.5972073;0.004279601;0.07090466
GO BP;POSITIVE REGULATION OF BLOOD VESSEL DIAMETER;GO:0097755;30;-1.5974423;0.014423077;0.07091264
GO BP;SEX DIFFERENTIATION;GO:0007548;168;-1.5965768;0;0.07111238
GO BP;WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY;GO:0007223;27;-1.5956053;0.014950166;0.0712206
GO BP;REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0008277;65;-1.5960633;0.011283498;0.07122719
GO BP;PROTEIN INSERTION INTO MEMBRANE;GO:0051205;50;1.6333507;0.008720931;0.07129883
GO BP;REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0040029;279;-1.595659;0.001199041;0.071341164
GO BP;MULTIVESICULAR BODY ORGANIZATION;GO:0036257;30;1.6346402;0.008450705;0.07150197
GO BP;MODIFICATION OF SYNAPTIC STRUCTURE;GO:0099563;19;-1.5927502;0.021558871;0.07150466
GO BP;INTRACELLULAR LIPID TRANSPORT;#N/A;39;-1.5928447;0.012403101;0.07159602
GO BP;STEM CELL PROLIFERATION;GO:0072089;75;-1.5930669;0.008474576;0.07162711
GO BP;REGULATION OF HISTONE H3 K4 METHYLATION;GO:0051569;23;-1.5946556;0.026771653;0.071668066
GO BP;PROTEIN LOCALIZATION TO CYTOSKELETON;GO:0044380;56;-1.5931157;0.008733625;0.071766004
GO BP;POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR;GO:2000781;25;-1.5936651;0.028333334;0.071768954
GO BP;CELLULAR RESPONSE TO AMINO ACID STIMULUS;GO:0071230;55;-1.5938474;0.014577259;0.07180373
GO BP;POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE;GO:0070374;103;-1.5932426;0.005594406;0.071850516
GO BP;MYELIN MAINTENANCE;GO:0043217;15;-1.5894256;0.040336136;0.07187184
GO BP;POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0046889;55;-1.5891099;0.010385756;0.071896695
GO BP;MACROMOLECULE DEACYLATION;#N/A;87;-1.5914525;0.004366812;0.071906894
GO BP;POSITIVE REGULATION OF STRESS FIBER ASSEMBLY;GO:0051496;41;-1.5939479;0.013740458;0.07191917
GO BP;NEGATIVE REGULATION OF GROWTH;GO:0045926;159;-1.5887599;0;0.071927086
GO BP;REGULATION OF TRANS SYNAPTIC SIGNALING;#N/A;240;-1.5895877;0;0.071956836
GO BP;SCHWANN CELL DEVELOPMENT;GO:0014044;22;-1.5898029;0.021885522;0.07198857
GO BP;POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I;GO:0045943;19;-1.5901148;0.026533997;0.07200925
GO BP;COFACTOR CATABOLIC PROCESS;#N/A;35;-1.5884252;0.015527951;0.07202635
GO BP;PITUITARY GLAND DEVELOPMENT;GO:0021983;15;-1.5914919;0.025906736;0.07204777
GO BP;RESPONSE TO VITAMIN;#N/A;61;-1.590849;0.005882353;0.07207388
GO BP;DNA DEMETHYLATION;GO:0080111;18;-1.5905448;0.018181818;0.072093986
GO BP;REGULATION OF BONE MINERALIZATION;GO:0030500;40;-1.5875648;0.012987013;0.072105266
GO BP;CIRCULATORY SYSTEM PROCESS;#N/A;275;-1.5880723;0;0.07210955
GO BP;REGULATION OF PROTEIN POLYMERIZATION;#N/A;162;-1.5901854;0.001282051;0.07212751
GO BP;POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045621;51;-1.5877602;0.012931035;0.0721286
GO BP;PROTEIN LOCALIZATION TO NUCLEUS;GO:0034504;213;-1.5868237;0;0.07238304
GO BP;RHYTHMIC BEHAVIOR;GO:0007622;22;-1.5865033;0.029220778;0.07238534
GO BP;REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA;GO:0061418;70;1.6297497;0.00625;0.07249794
GO BP;GPI ANCHOR METABOLIC PROCESS;GO:0006505;29;1.6282382;0.010869565;0.07251497
GO BP;LEUKOCYTE CELL CELL ADHESION;GO:0007159;177;-1.5859683;0.002547771;0.07260067
GO BP;NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000178;18;-1.5846109;0.024390243;0.07269388
GO BP;REGULATION OF CATION CHANNEL ACTIVITY;#N/A;73;-1.5846984;0.004249292;0.07278874
GO BP;REGULATION OF MUSCLE ADAPTATION;#N/A;60;-1.5854111;0.008955224;0.072826155
GO BP;REGULATION OF MUSCLE CONTRACTION;GO:0006937;85;-1.5847683;0.00286123;0.07290721
GO BP;POSITIVE REGULATION OF AXON EXTENSION;GO:0045773;36;-1.5849283;0.03154574;0.07296334
GO BP;IRON SULFUR CLUSTER ASSEMBLY;GO:0016226;20;1.6252073;0.020151133;0.07319487
GO BP;BONE DEVELOPMENT;GO:0060348;137;-1.5834013;0.002570694;0.07324634
GO BP;DE NOVO PROTEIN FOLDING;#N/A;35;-1.5826972;0.016025642;0.073529236
GO BP;GLUCOSE CATABOLIC PROCESS;GO:0006007;30;-1.5815634;0.025276462;0.07380756
GO BP;NEURAL TUBE FORMATION;GO:0001841;92;-1.5816154;0.001347709;0.07392152
GO BP;POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010718;36;-1.5817453;0.019908117;0.073971584
GO BP;REGULATION OF HEART RATE BY CARDIAC CONDUCTION;GO:0086091;20;-1.5804714;0.030546624;0.074416734
GO BP;NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002762;24;-1.5795462;0.030150754;0.07485376
GO BP;REGULATION OF FAT CELL DIFFERENTIATION;GO:0045598;82;-1.5782689;0.009803922;0.07539467
GO BP;REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION;GO:1901532;70;1.6159631;0.003278689;0.075496584
GO BP;MUSCLE STRUCTURE DEVELOPMENT;GO:0061061;395;-1.578282;0;0.0755367
GO BP;DEVELOPMENTAL MATURATION;#N/A;161;-1.5774918;0.001290323;0.07574821
GO BP;EMBRYONIC DIGIT MORPHOGENESIS;GO:0042733;45;-1.576955;0.021806853;0.07576457
GO BP;CYTOKINE PRODUCTION;GO:0001816;441;-1.5767126;0;0.075795665
GO BP;REPRODUCTIVE SYSTEM DEVELOPMENT;GO:0061458;294;-1.5770603;0.00116144;0.075865716
KEGG;STEROID BIOSYNTHESIS;;16;-1.640205;0.028764805;0.07619693
GO BP;PROTEIN HETEROTETRAMERIZATION;GO:0051290;34;1.6160614;0.005617978;0.07634671
GO BP;LATE ENDOSOME TO VACUOLE TRANSPORT;GO:0045324;16;1.6172067;0.035443038;0.07653171
GO BP;LIPID MODIFICATION;GO:0030258;181;-1.5751855;0.001256281;0.076683894
GO BP;BEHAVIOR;GO:0007610;309;-1.5749115;0;0.07672042
GO BP;RESPONSE TO NADOTROPIN;#N/A;21;1.6105882;0.015625;0.07692811
GO BP;POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS;#N/A;33;-1.5730357;0.022328548;0.077000335
GO BP;PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;253;-1.5734668;0.001226994;0.077034175
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I;GO:0042590;57;1.6118655;0.008720931;0.0770701
GO BP;SOMITOGENESIS;GO:0001756;36;-1.5731277;0.01993865;0.07708448
GO BP;DNA METHYLATION;GO:0006306;57;-1.573537;0.010510511;0.07714644
GO BP;NEGATIVE REGULATION OF NEURON DIFFERENTIATION;GO:0045665;141;-1.5737075;0.005427409;0.07720375
GO BP;REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030856;82;-1.573841;0.005594406;0.07726626
GO BP;NOTCH SIGNALING PATHWAY;GO:0007219;125;-1.5714662;0.002666667;0.07775465
GO BP;RAS PROTEIN SIGNAL TRANSDUCTION;GO:0007265;341;-1.5716219;0;0.07782042
GO BP;LYMPH VESSEL DEVELOPMENT;GO:0001945;16;-1.5692434;0.020689655;0.077862106
GO BP;MICROTUBULE CYTOSKELETON ORGANIZATION;GO:0000226;456;-1.5711124;0;0.07786282
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900181;19;-1.5697381;0.028052805;0.077898525
GO BP;REGULATION OF GLIAL CELL DIFFERENTIATION;#N/A;36;-1.569443;0.024671054;0.07790955
GO BP;BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS;GO:0001569;18;-1.5703869;0.036789298;0.077921756
GO BP;LONG CHAIN FATTY ACID METABOLIC PROCESS;GO:0001676;64;-1.5699012;0.010542168;0.0779413
GO BP;POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS;GO:0044089;382;-1.5701191;0;0.0779696
GO BP;SYNAPTIC TRANSMISSION GABAERGIC;GO:0051932;24;-1.5688484;0.03081664;0.07797793
GO BP;MALE SEX DIFFERENTIATION;GO:0046661;107;-1.5703984;0.002805049;0.078073576
GO BP;RENAL FILTRATION;GO:0097205;15;-1.57048;0.03343949;0.07819143
GO BP;NEGATIVE REGULATION OF OSSIFICATION;GO:0030279;41;-1.5679526;0.018927446;0.07840145
GO BP;NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION;GO:1902532;373;-1.5677767;0.001157407;0.07840404
GO BP;RRNA CATABOLIC PROCESS;GO:0016075;15;1.605843;0.04050633;0.078592725
GO BP;NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT;GO:0010977;109;-1.5669547;0.006934813;0.078840874
GO BP;CELLULAR RESPONSE TO HEAT;GO:0034605;110;-1.5665228;0.005449591;0.078951545
GO BP;MUSCLE ORGAN DEVELOPMENT;GO:0007517;234;-1.5644773;0.002463054;0.0796659
GO BP;NUCLEOSOME ORGANIZATION;GO:0034728;138;-1.5646284;0.001298701;0.07969698
GO BP;RESPONSE TO EPIDERMAL GROWTH FACTOR;GO:0070849;39;-1.5647665;0.02488336;0.07973989
GO BP;NEGATIVE REGULATION OF GLIOGENESIS;#N/A;24;-1.5640638;0.040257648;0.079774074
GO BP;POSITIVE REGULATION OF MRNA METABOLIC PROCESS;#N/A;64;-1.5648896;0.009859155;0.07980736
GO BP;NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0031333;101;-1.5649801;0.004065041;0.0798798
GO BP;REGULATION OF STEROID METABOLIC PROCESS;GO:0019218;88;-1.5631034;0.005486968;0.0799622
GO BP;REGULATION OF GTPASE ACTIVITY;GO:0043087;338;-1.5631106;0;0.080112435
GO BP;MONOCARBOXYLIC ACID METABOLIC PROCESS;GO:0032787;450;-1.563351;0;0.08014655
GO BP;NEURON FATE COMMITMENT;GO:0048663;19;-1.5622044;0.034768213;0.08039828
GO BP;ERROR FREE TRANSLESION SYNTHESIS;GO:0070987;19;1.6009713;0.030690538;0.080509156
GO BP;BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE;GO:0048754;87;-1.5618123;0.006973501;0.080515765
GO BP;RESPONSE TO AMMONIUM ION;#N/A;87;-1.5599607;0.004149378;0.08079814
GO BP;INTRASPECIES INTERACTION BETWEEN ORGANISMS;#N/A;24;-1.5599688;0.022875817;0.080945335
GO BP;REGULATION OF DENDRITE DEVELOPMENT;GO:0050773;115;-1.5608097;0.001324503;0.08099405
GO BP;REGULATION OF ANATOMICAL STRUCTURE SIZE;#N/A;328;-1.5600015;0;0.0810766
GO BP;POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0045815;54;-1.5601397;0.010622155;0.08114045
GO BP;ESTABLISHMENT OF CELL POLARITY;GO:0030010;115;-1.560284;0.005540166;0.08119708
GO BP;CARDIAC MUSCLE CELL ACTION POTENTIAL;GO:0086001;40;-1.5586522;0.013824885;0.08130423
GO BP;REGULATION OF SYSTEM PROCESS;#N/A;292;-1.5589703;0;0.081366
KEGG;COLORECTAL CANCER;;51;-1.625793;0.002985075;0.081366554
GO BP;CELLULAR RESPONSE TO RETINOIC ACID;GO:0071300;40;-1.5586978;0.013636364;0.081414156
GO BP;HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0015012;17;-1.5574082;0.035472974;0.081883155
GO BP;REGULATION OF MITOTIC SPINDLE ASSEMBLY;GO:1901673;19;-1.5574597;0.03322259;0.081998594
GO BP;HIPPO SIGNALING;GO:0035329;37;-1.5551072;0.021806853;0.082912706
GO BP;ENDOTHELIAL CELL MIGRATION;GO:0043542;139;-1.5547968;0.002642008;0.08295033
GO BP;REGULATION OF ACTIN FILAMENT ORGANIZATION;GO:0110053;184;-1.5552424;0.00128041;0.08298542
GO BP;REGULATION OF LONG TERM SYNAPTIC POTENTIATION;GO:1900271;26;-1.5552781;0.032208588;0.08311365
GO BP;HINDLIMB MORPHOGENESIS;GO:0035137;24;-1.5553745;0.036741216;0.08320293
GO BP;NEGATIVE REGULATION OF PROTEIN POLYMERIZATION;GO:0032272;55;-1.5522362;0.013493253;0.08341011
GO BP;REGULATION OF MESENCHYMAL CELL PROLIFERATION;GO:0010464;21;-1.5532484;0.032310177;0.083442755
GO BP;NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION;GO:0031345;130;-1.5536207;0.002628121;0.08346258
GO BP;REGULATION OF B CELL DIFFERENTIATION;GO:0045577;18;-1.5523118;0.024834437;0.08348897
GO BP;FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX;GO:0001732;15;1.5938673;0.033898305;0.08349275
GO BP;LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;97;-1.5537905;0.004126547;0.083522074
GO BP;LEUKOCYTE DIFFERENTIATION;GO:0002521;284;-1.5533069;0;0.08354534
GO BP;REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;GO:0046822;90;-1.5526356;0.007012623;0.08357062
GO BP;HIPPOCAMPUS DEVELOPMENT;GO:0021766;52;-1.5523486;0.010703363;0.083618104
GO BP;RHO PROTEIN SIGNAL TRANSDUCTION;GO:0007266;150;-1.5527184;0.005102041;0.08367312
GO BP;NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION;GO:1905208;15;-1.5511569;0.020797227;0.08398825
GO BP;EPHRIN RECEPTOR SIGNALING PATHWAY;GO:0048013;70;-1.5508646;0.002890173;0.08407996
GO BP;RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;53;1.5913981;0.015015015;0.08416118
GO BP;NEGATIVE REGULATION OF DNA METABOLIC PROCESS;#N/A;94;-1.550409;0.008595988;0.08424735
GO BP;MITOTIC SPINDLE ASSEMBLY;GO:0090307;52;-1.5491719;0.022727273;0.08491735
GO BP;POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION;GO:0032727;15;-1.5488278;0.02915952;0.08502676
GO BP;LYMPHOCYTE MIGRATION;GO:0072676;48;-1.5482258;0.009022556;0.08531187
GO BP;REGULATION OF GROWTH;GO:0040008;445;-1.5477079;0;0.08543701
GO BP;CHROMATIN ASSEMBLY;GO:0031497;122;-1.5477605;0.002649007;0.08551611
GO BP;NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I;GO:0042790;16;-1.5471197;0.033840947;0.0856827
GO BP;CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0048738;139;-1.5467302;0.002604167;0.08578096
GO BP;GLIAL CELL DIFFERENTIATION;GO:0010001;123;-1.5464597;0.005354752;0.08579442
GO BP;POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;GO:0046638;27;-1.545927;0.030864198;0.085881956
GO BP;NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION;GO:0008285;446;-1.5459398;0;0.0860298
GO BP;RESPONSE TO AUDITORY STIMULUS;GO:0010996;17;-1.5454856;0.028846154;0.08606079
GO BP;ADAPTIVE THERMOGENESIS;GO:1990845;102;-1.5450468;0.009776536;0.08619724
GO BP;KERATINOCYTE DIFFERENTIATION;GO:0030216;103;-1.5447037;0.005263158;0.086283036
GO BP;REGULATION OF OSSIFICATION;GO:0030278;114;-1.5437261;0.005312085;0.08646791
GO BP;NEGATIVE REGULATION OF BIOMINERALIZATION;GO:0110150;16;-1.5439798;0.034722224;0.086573936
GO BP;RESPONSE TO ANESTHETIC;GO:0072347;38;-1.5437497;0.026113672;0.08660212
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOUS RECOMBINATION;#N/A;38;-1.543307;0.02056962;0.08661331
GO BP;EYE PHOTORECEPTOR CELL DIFFERENTIATION;GO:0001754;25;-1.5430385;0.01618123;0.08665618
GO BP;NEUROINFLAMMATORY RESPONSE;GO:0150076;31;-1.5421369;0.02153846;0.08708602
GO BP;DIVALENT INORGANIC CATION HOMEOSTASIS;GO:0072507;239;-1.5409671;0.001218027;0.08740479
GO BP;POSITIVE REGULATION OF GLIOGENESIS;GO:0014015;38;-1.5414721;0.022222223;0.087444335
GO BP;REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0046890;142;-1.5410053;0.002570694;0.087530315
GO BP;POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION;GO:0002053;16;-1.5411142;0.0513245;0.08756543
GO BP;POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:2000273;18;-1.5392964;0.023809524;0.0882574
GO BP;REGULATION OF DNA RECOMBINATION;GO:0000018;78;-1.5394566;0.010189229;0.08828082
GO BP;NEGATIVE REGULATION OF MACROAUTOPHAGY;GO:0016242;31;-1.5375606;0.03421462;0.088876285
GO BP;POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034123;16;-1.5372509;0.043117743;0.088978596
GO BP;REGULATION OF DENDRITE MORPHOGENESIS;GO:0048814;67;-1.5376064;0.010057472;0.08898181
GO BP;LYMPHOCYTE COSTIMULATION;#N/A;28;-1.5379989;0.018151816;0.08900055
GO BP;INOSITOL PHOSPHATE MEDIATED SIGNALING;GO:0048016;37;-1.5377499;0.010785825;0.08904063
GO BP;REGULATION OF PEPTIDYL LYSINE ACETYLATION;#N/A;44;-1.5363964;0.01875902;0.08926636
GO BP;REGULATION OF CELL CELL ADHESION;GO:0022407;235;-1.5360152;0;0.08937119
GO BP;POSITIVE REGULATION OF ORGANELLE ASSEMBLY;GO:1902117;64;-1.5364269;0.019345239;0.089408085
GO BP;RENAL SYSTEM PROCESS;GO:0003014;63;-1.5357027;0.010719755;0.089441784
GO BP;ANATOMICAL STRUCTURE MATURATION;#N/A;99;-1.535265;0.006756757;0.08956664
GO BP;DEMETHYLATION;GO:0070988;46;-1.5347533;0.02012384;0.08958198
GO BP;SODIUM ION TRANSMEMBRANE TRANSPORT;GO:0035725;82;-1.5348463;0.011204482;0.08968103
GO BP;POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;63;-1.5338235;0.013392857;0.089814425
GO BP;REGULATION OF RESPONSE TO WOUNDING;GO:1903034;112;-1.5340023;0.00660502;0.08984984
GO BP;OUTFLOW TRACT MORPHOGENESIS;GO:0003151;52;-1.5340776;0.024853801;0.08994455
GO BP;POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION;GO:0001938;55;-1.5329545;0.012857143;0.09025922
GO BP;REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0043254;330;-1.5317955;0;0.09068574
GO BP;PATTERN SPECIFICATION PROCESS;GO:0007389;245;-1.5318807;0;0.09075408
GO BP;PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II;#N/A;32;-1.5319917;0.025039123;0.09080572
GO BP;MAMMARY GLAND DEVELOPMENT;GO:0030879;97;-1.5310645;0.002824859;0.091107085
GO BP;CELLULAR RESPONSE TO NITROGEN COMPOUND;#N/A;446;-1.5303277;0;0.09149957
GO BP;ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE;#N/A;17;-1.5299231;0.041254126;0.09163379
GO BP;RESPONSE TO GROWTH FACTOR;GO:0070848;485;-1.5295007;0;0.09181905
GO BP;REGULATION OF WOUND HEALING;GO:0061041;90;-1.529246;0.006993007;0.09183205
GO BP;MITOCHONDRIAL RNA PROCESSING;GO:0000963;16;1.5780126;0.031862747;0.091894045
GO BP;NEGATIVE REGULATION OF CHROMATIN SILENCING;GO:0031936;15;-1.5288277;0.043551087;0.091999784
KEGG;N GLYCAN BIOSYNTHESIS;;41;1.5226023;0.012422361;0.092476025
GO BP;AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS;GO:0042982;52;-1.5253614;0.021802325;0.09292753
GO BP;T CELL CYTOKINE PRODUCTION;GO:0002369;17;-1.5271738;0.028475711;0.09292787
GO BP;SYNAPTIC SIGNALING;GO:0099536;361;-1.5246083;0;0.09295815
GO BP;POSITIVE REGULATION OF JNK CASCADE;GO:0046330;95;-1.5255133;0.006973501;0.092981465
GO BP;CELL GROWTH;#N/A;330;-1.5268605;0;0.09300063
GO BP;PROTEOGLYCAN BIOSYNTHETIC PROCESS;GO:0030166;36;-1.5248786;0.030448718;0.093022816
GO BP;MESENCHYME MORPHOGENESIS;#N/A;31;-1.5262059;0.027508091;0.093031876
GO BP;ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY;GO:0061339;17;-1.5246775;0.045826513;0.09303575
GO BP;EYE PHOTORECEPTOR CELL DEVELOPMENT;GO:0042462;18;-1.5272433;0.049751244;0.093037814
GO BP;POSITIVE REGULATION OF ORGANELLE ORGANIZATION;GO:0010638;493;-1.5263517;0;0.09306375
GO BP;MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS;#N/A;152;-1.5259413;0.002684564;0.09307993
GO BP;NERVOUS SYSTEM PROCESS;GO:0050877;484;-1.5264874;0;0.09310197
GO BP;CELL FATE DETERMINATION;GO:0001709;20;-1.5249904;0.039184954;0.09310505
GO BP;RETINOIC ACID RECEPTOR SIGNALING PATHWAY;GO:0048384;21;-1.5255386;0.028481012;0.09310648
GO BP;GENETIC IMPRINTING;GO:0071514;23;-1.5256487;0.032894738;0.0931666
GO BP;REGULATION OF TUBE SIZE;GO:0035150;65;-1.5241169;0.013157895;0.09318004
GO BP;CENTROSOME DUPLICATION;GO:0051298;62;-1.5237129;0.015082956;0.093363665
GO BP;NEURON PROJECTION REGENERATION;GO:0031102;40;-1.5232884;0.032208588;0.09336419
GO BP;XENOBIOTIC TRANSPORT;GO:0042908;16;-1.5233513;0.04130809;0.093457825
GO BP;CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0030038;74;-1.5229106;0.011396011;0.093484335
GO BP;PROTEIN AUTOPHOSPHORYLATION;GO:0046777;174;-1.5226728;0.003826531;0.0935084
GO BP;EMBRYONIC EYE MORPHOGENESIS;GO:0048048;18;-1.522111;0.0330033;0.0936316
GO BP;REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION;GO:1903053;26;-1.5222279;0.03215434;0.093701646
KEGG;REGULATION OF AUTOPHAGY;;18;1.5354261;0.045918368;0.09399921
GO BP;RESPONSE TO ISCHEMIA;GO:0002931;34;-1.5207256;0.029457364;0.094059475
GO BP;STEROL BIOSYNTHETIC PROCESS;GO:0016126;68;-1.5210899;0.016081871;0.094080724
GO BP;REGULATION OF OLIDENDROCYTE DIFFERENTIATION;#N/A;21;-1.5208352;0.037617553;0.0941277
GO BP;RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN;#N/A;171;-1.5212451;0.001272265;0.0941332
GO BP;GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY;GO:0007214;16;-1.5197622;0.04464286;0.094651856
GO BP;CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT;GO:0060706;22;-1.5172696;0.04620462;0.09577242
GO BP;MESENCHYMAL CELL DIFFERENTIATION;GO:0048762;135;-1.5173136;0;0.095895566
GO BP;PROTEIN TRANSPORT ALONG MICROTUBULE;GO:0098840;61;-1.5175256;0.020289855;0.09589761
GO BP;NEGATIVE REGULATION OF MAP KINASE ACTIVITY;GO:0043407;53;-1.517549;0.024205748;0.09603906
GO BP;REGULATION OF MULTICELLULAR ORGANISM GROWTH;GO:0040014;42;-1.5165192;0.021909233;0.09619377
GO BP;REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I;#N/A;28;-1.5152872;0.03291536;0.09667935
GO BP;MRNA TRANSCRIPTION;GO:0009299;20;-1.5153426;0.031746034;0.09677989
GO BP;SMOOTH MUSCLE CELL PROLIFERATION;GO:0048659;90;-1.5148395;0.012747875;0.09683973
GO BP;EPIDERMIS DEVELOPMENT;GO:0008544;202;-1.5154539;0.002528445;0.096845515
GO BP;LYMPHOCYTE ACTIVATION;GO:0046649;370;-1.5125476;0;0.097773775
GO BP;BLASTOCYST DEVELOPMENT;GO:0001824;81;-1.5130318;0.010159652;0.09779747
GO BP;CYTOKINE METABOLIC PROCESS;GO:0042107;63;-1.513177;0.015602837;0.09783087
GO BP;PROTEIN POLYMERIZATION;GO:0051258;208;-1.5133669;0.001282051;0.09784743
GO BP;LENS DEVELOPMENT IN CAMERA TYPE EYE;GO:0002088;51;-1.5127274;0.01529052;0.09790837
GO BP;TEMPERATURE HOMEOSTASIS;GO:0001659;105;-1.5125636;0.008253095;0.097915344
GO BP;REGULATION OF MEMBRANE POTENTIAL;GO:0042391;210;-1.5112754;0.005031447;0.09863136
GO BP;NEGATIVE REGULATION OF CALCIUM ION TRANSPORT;GO:0051926;23;-1.510809;0.03448276;0.09885926
GO BP;PROTEIN DNA COMPLEX DISASSEMBLY;GO:0032986;18;-1.5105932;0.032786883;0.09886441
GO BP;EXTRACELLULAR MATRIX DISASSEMBLY;GO:0022617;53;-1.5103414;0.02173913;0.098893024
GO BP;ACTION POTENTIAL;GO:0001508;66;-1.5091094;0.019287834;0.09925752
GO BP;CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT;GO:0021680;20;-1.5092472;0.055374593;0.09927965
GO BP;ENDOCRINE PROCESS;#N/A;35;-1.5096123;0.014218009;0.09929963
GO BP;POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;22;-1.5087146;0.049586777;0.09941194
GO BP;ERK1 AND ERK2 CASCADE;GO:0070371;176;-1.5092585;0.007692308;0.099419974
GO BP;TRNA METABOLIC PROCESS;GO:0006399;163;1.5655859;0;0.0996316
GO BP;EMBRYONIC HEART TUBE DEVELOPMENT;GO:0035050;58;-1.5077499;0.018126888;0.099995166
GO BP;ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY;GO:0007163;174;-1.5068994;0.002574003;0.10006671
GO BP;NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;124;-1.5072274;0.013623978;0.10011502
GO BP;POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION;#N/A;28;-1.5069954;0.038034864;0.1001428
GO BP;GLYCOSPHINLIPID BIOSYNTHETIC PROCESS;#N/A;17;-1.5073336;0.055369128;0.10020648
GO BP;REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010717;60;-1.506298;0.011461319;0.10038604
KEGG;SPLICEOSOME;;121;1.4691578;0.007843138;0.100737624
GO BP;MESENCHYME DEVELOPMENT;GO:0060485;170;-1.5051916;0.00257732;0.10102108
GO BP;DNA DOUBLE STRAND BREAK PROCESSING;GO:0000729;22;-1.5043423;0.057971016;0.10123662
GO BP;NEPHRON DEVELOPMENT;GO:0072006;79;-1.5047227;0.013043478;0.10124279
GO BP;SKELETAL MUSCLE TISSUE REGENERATION;GO:0043403;26;-1.5044214;0.029508196;0.101309806
GO BP;SERTOLI CELL DIFFERENTIATION;GO:0060008;15;-1.5038205;0.04467354;0.101525135
GO BP;COCHLEA DEVELOPMENT;GO:0090102;29;-1.5032032;0.02799378;0.10158813
GO BP;POSITIVE REGULATION OF MUSCLE CONTRACTION;#N/A;19;-1.5035194;0.041597337;0.10161376
GO BP;MUSCLE TISSUE DEVELOPMENT;GO:0060537;244;-1.5033089;0.003694581;0.10163738
GO BP;ORGANIC ACID BIOSYNTHETIC PROCESS;#N/A;238;-1.5019487;0.001253133;0.10231203
GO BP;INSULIN SECRETION;GO:0030073;128;-1.502021;0.005405406;0.102392174
GO BP;REGULATION OF EPIDERMIS DEVELOPMENT;GO:0045682;57;-1.5013516;0.020467836;0.10265042
KEGG;GLYCEROLIPID METABOLISM;;38;-1.593657;0.01369863;0.10286208
KEGG;RNA POLYMERASE;;25;1.4926614;0.049222797;0.103275605
GO BP;PROTEIN N LINKED GLYCOSYLATION;GO:0006487;65;1.558647;0.00990099;0.10329282
GO BP;POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS;GO:0036003;21;-1.5000827;0.04326123;0.1034259
GO BP;COENZYME BIOSYNTHETIC PROCESS;#N/A;124;-1.49969;0.005326232;0.10364006
GO BP;NEUROMUSCULAR PROCESS;GO:0050905;54;-1.4990867;0.020378457;0.10397326
GO BP;CYTOSKELETON DEPENDENT CYTOKINESIS;GO:0061640;83;-1.4983717;0.018361581;0.10412168
GO BP;REGULATION OF NIK NF KAPPAB SIGNALING;GO:1901222;61;-1.498529;0.017830608;0.10417029
GO BP;STEROID METABOLIC PROCESS;GO:0008202;208;-1.4986081;0.002518892;0.10424854
GO BP;CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN;GO:0035967;140;-1.49741;0.010596027;0.10481267
KEGG;NUCLEOTIDE EXCISION REPAIR;;41;1.4524941;0.032448377;0.104849346
KEGG;ETHER LIPID METABOLISM;;22;1.4412986;0.058981232;0.10486857
GO BP;HEPATICOBILIARY SYSTEM DEVELOPMENT;#N/A;109;-1.4966997;0.009497965;0.10527181
GO BP;CYTOKINESIS;#N/A;134;-1.4957285;0.006666667;0.10578833
GO BP;POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001238;34;-1.4959323;0.0407855;0.105791606
GO BP;MUSCLE CELL DEVELOPMENT;GO:0055001;104;-1.4951807;0.008298756;0.10606682
GO BP;POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION;GO:2000179;30;-1.4943712;0.048062015;0.1061026
GO BP;GLIAL CELL ACTIVATION;#N/A;25;-1.4949431;0.05987055;0.10615752
GO BP;NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY;#N/A;17;-1.493902;0.05685619;0.10617137
GO BP;RNA CAPPING;#N/A;33;1.5533357;0.024193548;0.10621028
GO BP;FATTY ACID BIOSYNTHETIC PROCESS;GO:0006633;104;-1.4943904;0.010958904;0.10623682
GO BP;PEPTIDYL LYSINE ACETYLATION;GO:0018394;137;-1.494567;0.009510869;0.10625186
GO BP;PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION;GO:0046856;23;-1.4939911;0.032;0.10627269
GO BP;NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT;#N/A;72;-1.4920003;0.01925926;0.10744746
GO BP;REGULATION OF STRIATED MUSCLE CONTRACTION;GO:0006942;53;-1.4912207;0.030390738;0.10751635
GO BP;IMPORT INTO CELL;#N/A;461;-1.4920768;0;0.107530616
GO BP;MOLTING CYCLE PROCESS;#N/A;56;-1.4913635;0.020618556;0.10755444
GO BP;MAINTENANCE OF LOCATION;#N/A;229;-1.4914335;0.003708282;0.107639246
GO BP;NEURON RECOGNITION;GO:0008038;27;-1.4916095;0.04075235;0.10764868
GO BP;POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT;GO:0034767;74;-1.4897721;0.014326648;0.10799259
GO BP;EMBRYONIC PLACENTA DEVELOPMENT;GO:0001892;68;-1.4901327;0.020497805;0.10802517
GO BP;HISTONE H4 K16 ACETYLATION;GO:0043984;20;-1.4899007;0.03931624;0.10805762
GO BP;FIBROBLAST MIGRATION;GO:0010761;30;-1.4894636;0.03497615;0.10813721
GO BP;REGULATION OF ION TRANSPORT;GO:0043269;320;-1.4892489;0.001149425;0.108150475
GO BP;RESPONSE TO TYPE I INTERFERON;GO:0034340;56;-1.4903059;0.031837918;0.108152166
GO BP;CHROMATIN REMODELING;GO:0006338;140;-1.4901596;0.005242464;0.108152874
KEGG;GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS;;22;1.4706163;0.050377835;0.10820142
GO BP;MEMBRANE DISASSEMBLY;#N/A;15;1.5476024;0.04040404;0.10823501
GO BP;NCRNA 3 END PROCESSING;#N/A;34;1.5486093;0.020887729;0.10858439
GO BP;REGULATION OF ERYTHROCYTE DIFFERENTIATION;GO:0045646;35;-1.4871682;0.043818466;0.10950503
GO BP;POSITIVE REGULATION OF CELL MATRIX ADHESION;GO:0001954;36;-1.4872569;0.032520324;0.10958447
GO BP;DNA PACKAGING;GO:0006323;155;-1.4866843;0.009370817;0.10974034
GO BP;CALCIUM MEDIATED SIGNALING;GO:0019722;105;-1.4864845;0.005563282;0.109747924
GO BP;PROTEIN ADP RIBOSYLATION;GO:0006471;30;-1.485908;0.038720537;0.10990776
GO BP;POSITIVE REGULATION OF CYTOKINE PRODUCTION;GO:0001819;244;-1.4856927;0.001236094;0.10993365
GO BP;EPITHELIAL CELL MORPHOGENESIS;GO:0003382;22;-1.4854672;0.041025642;0.10997208
GO BP;REGULATION OF ATP METABOLIC PROCESS;GO:1903578;96;-1.485971;0.009589041;0.11001348
GO BP;RESPONSE TO FIBROBLAST GROWTH FACTOR;GO:0071774;94;-1.4851103;0.015714286;0.11013454
GO BP;MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL;GO:0086010;20;-1.4829832;0.052287582;0.110611446
GO BP;B CELL ACTIVATION;GO:0042113;142;-1.4830793;0.010638298;0.110708244
GO BP;REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0030947;23;-1.4830852;0.045234248;0.11086046
GO BP;ENDOCARDIAL CUSHION FORMATION;GO:0003272;15;-1.4820706;0.034965035;0.11094902
GO BP;CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND;GO:0071407;383;-1.4838717;0;0.1109728
GO BP;TYPE 2 IMMUNE RESPONSE;GO:0042092;17;-1.4831208;0.05107084;0.110995725
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE;GO:0003073;39;-1.4832939;0.036363635;0.110997505
GO BP;REGULATION OF LYMPHOCYTE MIGRATION;GO:2000401;33;-1.482384;0.03834356;0.11100981
GO BP;EMBRYONIC DIGESTIVE TRACT DEVELOPMENT;GO:0048566;18;-1.4821532;0.045234248;0.11103369
GO BP;ENDOSOME TO LYSOSOME TRANSPORT;GO:0008333;48;-1.4817953;0.020280812;0.111069255
GO BP;FORMATION OF PRIMARY GERM LAYER;GO:0001704;82;-1.4833711;0.014513788;0.11107256
GO BP;HISTONE H4 K5 ACETYLATION;GO:0043981;16;-1.4835228;0.047038328;0.11113549
GO BP;CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION;GO:0086002;29;-1.4813473;0.04107425;0.11129063
GO BP;NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902750;88;1.5420252;0.009803922;0.11151699
GO BP;CELL RECOGNITION;GO:0008037;66;-1.4807094;0.025714286;0.11170885
GO BP;GASTRULATION;GO:0007369;132;-1.4805504;0.011811024;0.11172005
GO BP;POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION;GO:0048661;61;-1.4801124;0.030656934;0.11189143
GO BP;CILIARY BASAL BODY PLASMA MEMBRANE DOCKING;#N/A;95;-1.4796292;0.012261581;0.112168655
GO BP;REGULATION OF CELL PROJECTION ASSEMBLY;GO:0060491;142;-1.4790714;0.010322581;0.11246585
GO BP;NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:2000272;27;1.537462;0.011173184;0.11274519
GO BP;REGULATION OF CENTRIOLE REPLICATION;GO:0046599;20;-1.4783021;0.05371248;0.11283677
KEGG;TIGHT JUNCTION;;102;-1.5524262;0.008253095;0.112845294
GO BP;TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR;GO:0006283;70;1.5387563;0.00931677;0.11290628
GO BP;REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0040036;20;-1.4783134;0.052721087;0.112980716
GO BP;NAD METABOLIC PROCESS;GO:0019674;41;-1.4774636;0.025157232;0.11325111
GO BP;REGULATION OF NOTCH SIGNALING PATHWAY;GO:0008593;73;-1.4774873;0.017291067;0.11338495
GO BP;ENSHEATHMENT OF NEURONS;#N/A;94;-1.4770669;0.018387552;0.113451086
KEGG;ENDOMETRIAL CANCER;;45;-1.5735527;0.015060241;0.11409457
GO BP;REGULATION OF AUTOPHAGY OF MITOCHONDRION;GO:1903146;37;-1.4755218;0.038819876;0.11415769
GO BP;CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES;GO:0098742;104;-1.4756858;0.017931035;0.11418376
GO BP;REGULATION OF NERVOUS SYSTEM PROCESS;GO:0031644;63;-1.4752904;0.017621145;0.11419724
GO BP;LIPID DROPLET ORGANIZATION;GO:0034389;16;-1.4760299;0.05357143;0.114200994
GO BP;CARDIAC CHAMBER MORPHOGENESIS;#N/A;90;-1.4757797;0.01;0.11426401
KEGG;MTOR SIGNALING PATHWAY;;42;-1.5389117;0.018348623;0.114291824
GO BP;REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010632;160;-1.4734362;0.006587615;0.11439734
GO BP;T CELL ACTIVATION;GO:0042110;249;-1.4732244;0.002415459;0.1144182
GO BP;AMINOGLYCAN CATABOLIC PROCESS;#N/A;41;-1.4734392;0.02799378;0.114543475
GO BP;CELL ADHESION MEDIATED BY INTEGRIN;GO:0033627;48;-1.4743382;0.030257186;0.114558004
GO BP;DIENCEPHALON DEVELOPMENT;GO:0021536;27;-1.4746618;0.05529226;0.11459443
GO BP;MAINTENANCE OF CELL NUMBER;#N/A;134;-1.4740695;0.01310616;0.11461638
GO BP;POSITIVE REGULATION OF ERBB SIGNALING PATHWAY;GO:1901186;23;-1.473473;0.046774194;0.11465998
GO BP;POSITIVE REGULATION OF GROWTH;GO:0045927;171;-1.4743412;0.007518797;0.114705496
GO BP;REGIONALIZATION;GO:0003002;183;-1.4737765;0.002587322;0.11472145
GO BP;RESPONSE TO NUTRIENT;GO:0007584;146;-1.4735484;0.008064516;0.11473995
GO BP;CILIUM ORGANIZATION;GO:0044782;312;-1.4716848;0;0.1148627
GO BP;LIPID PHOSPHORYLATION;GO:0046834;49;-1.4718124;0.020989506;0.11490718
GO BP;CELLULAR RESPONSE TO VIRUS;GO:0098586;35;-1.4718765;0.0398773;0.115003094
GO BP;ANIMAL ORGAN MATURATION;#N/A;15;-1.4723469;0.051666666;0.115017466
GO BP;MUSCLE CELL DIFFERENTIATION;GO:0042692;220;-1.4719558;0;0.11506967
GO BP;BONE MORPHOGENESIS;GO:0060349;70;-1.4720912;0.03301238;0.11509169
GO BP;PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE;GO:1903539;27;-1.4712161;0.02799378;0.11513106
GO BP;ORGANELLE TRANSPORT ALONG MICROTUBULE;GO:0072384;72;-1.4709918;0.019174041;0.11514692
GO BP;REGULATION OF GASTRULATION;GO:0010470;31;-1.4706945;0.05466238;0.115256436
GO BP;REGULATION OF SPINDLE ORGANIZATION;#N/A;37;-1.4705142;0.035384614;0.11527373
GO BP;REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION;GO:0051150;20;-1.469053;0.059602648;0.11618743
GO BP;DNA MODIFICATION;GO:0006304;92;-1.4690908;0.013774104;0.11631697
GO BP;MICROTUBULE BASED MOVEMENT;GO:0007018;216;-1.467769;0.006090134;0.11668645
GO BP;NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045668;26;-1.4675815;0.05778491;0.11670199
GO BP;HEART VALVE DEVELOPMENT;GO:0003170;46;-1.4680027;0.03405573;0.116774626
GO BP;NEGATIVE REGULATION OF CELL AGING;GO:0090344;19;1.5308853;0.037220843;0.11678336
GO BP;SOMATIC STEM CELL DIVISION;GO:0048103;18;-1.4673041;0.0591133;0.11680652
GO BP;NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION;GO:0045599;32;-1.4677875;0.04245283;0.11682088
GO BP;NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION;GO:0010812;46;-1.4680927;0.03374233;0.11684082
GO BP;REGULATION OF INSULIN SECRETION;GO:0050796;109;-1.4668375;0.019125683;0.116978936
KEGG;THYROID CANCER;;23;-1.5537139;0.016207455;0.11775093
GO BP;REGULATION OF ACTION POTENTIAL;GO:0098900;32;-1.4653372;0.0547504;0.11813374
GO BP;NEGATIVE REGULATION OF COAGULATION;GO:0050819;33;-1.464451;0.043010753;0.11848514
GO BP;POSITIVE REGULATION OF DNA METABOLIC PROCESS;#N/A;151;-1.464732;0.007822686;0.11853344
GO BP;RESPONSE TO COPPER ION;GO:0046688;23;-1.4644861;0.06535948;0.11859806
KEGG;CHRONIC MYELOID LEUKEMIA;;62;-1.5405134;0.015060241;0.1188226
GO BP;POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION;GO:0010595;74;-1.4638201;0.017518248;0.118928105
GO BP;PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE;#N/A;15;1.5268371;0.04761905;0.118934505
GO BP;NEGATIVE REGULATION OF MAPK CASCADE;GO:0043409;123;-1.4635482;0.012228261;0.11901734
GO BP;NEGATIVE REGULATION OF B CELL ACTIVATION;GO:0050869;18;-1.4631724;0.05882353;0.11905723
GO BP;REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:2000649;36;-1.4632609;0.041602466;0.11913188
GO BP;MAINTENANCE OF LOCATION IN CELL;GO:0051651;77;-1.4628412;0.024182077;0.119228624
GO BP;POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS;GO:0042108;34;-1.4619076;0.04265403;0.11947033
KEGG;LYSINE DEGRADATION;;39;-1.5585806;0.010401188;0.1195349
GO BP;MACROMOLECULE METHYLATION;#N/A;252;-1.4619405;0.003645201;0.119584866
GO BP;POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS;#N/A;17;-1.4619517;0.05466238;0.11972193
GO BP;PEPTIDYL TYROSINE AUTOPHOSPHORYLATION;GO:0038083;22;-1.462103;0.06741573;0.119734704
GO BP;MEMBRANE DOCKING;#N/A;168;-1.4614706;0.0125;0.119744115
GO BP;REGULATION OF MAPK CASCADE;GO:0043408;464;-1.460855;0.002227172;0.119884685
GO BP;REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900180;94;-1.4604119;0.022727273;0.11996634
GO BP;REGULATION OF HORMONE SECRETION;GO:0046883;145;-1.4609413;0.010191083;0.11996748
GO BP;STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051146;165;-1.461062;0.003826531;0.12000615
GO BP;RECEPTOR CATABOLIC PROCESS;GO:0032801;34;-1.4604698;0.04265403;0.12007597
GO BP;MYOFIBRIL ASSEMBLY;GO:0030239;40;-1.4593282;0.036163524;0.12035705
GO BP;REGULATION OF CELL SIZE;GO:0008361;133;-1.459772;0.016;0.120387614
GO BP;PHOSPHATIDYLINOSITOL PHOSPHORYLATION;GO:0046854;41;-1.4593551;0.029051987;0.120475896
GO BP;MICROTUBULE BASED TRANSPORT;GO:0099111;155;-1.4594624;0.013157895;0.12051314
GO BP;REGULATION OF METAL ION TRANSPORT;#N/A;193;-1.4583377;0.006377551;0.121064655
GO BP;REGULATION OF DNA METABOLIC PROCESS;#N/A;275;-1.4578971;0.001191895;0.12114859
GO BP;MULTI ORGANISM BEHAVIOR;#N/A;31;-1.4576616;0.064714946;0.121195175
GO BP;SMOOTHENED SIGNALING PATHWAY;GO:0007224;108;-1.457909;0.012064343;0.12129467
GO BP;NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION;#N/A;123;-1.4569616;0.025572006;0.12149623
GO BP;MOLTING CYCLE;#N/A;67;-1.4570805;0.02238806;0.121539004
GO BP;PROTEIN DEMETHYLATION;GO:0006482;25;-1.4561647;0.055;0.12191201
GO BP;REGULATION OF RESPONSE TO DRUG;GO:2001023;45;-1.4561783;0.0311042;0.122040994
GO BP;POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS;#N/A;297;-1.4552777;0.001166861;0.12254179
GO BP;INSULIN RECEPTOR SIGNALING PATHWAY;GO:0008286;108;-1.4541698;0.015341702;0.12255899
GO BP;REGULATION OF MITOPHAGY;#N/A;16;-1.4542011;0.05851979;0.12268151
GO BP;MYELIN ASSEMBLY;GO:0032288;16;-1.4545879;0.085178874;0.1227876
GO BP;G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007186;338;-1.454241;0.001153403;0.1227951
GO BP;RESPONSE TO HEAT;GO:0009408;137;-1.454746;0.006802721;0.12279925
GO BP;TUBE CLOSURE;GO:0060606;79;-1.4542719;0.02351314;0.122926064
GO BP;NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY;GO:0006294;27;1.5205666;0.042134833;0.122967385
KEGG;SYSTEMIC LUPUS ERYTHEMATOSUS;;69;1.4084444;0.028301887;0.123254254
GO BP;MULTIVESICULAR BODY SORTING PATHWAY;GO:0071985;32;1.5183363;0.028571429;0.123760015
GO BP;REGULATION OF PEPTIDE HORMONE SECRETION;GO:0090276;124;-1.4513704;0.018766755;0.12483727
GO BP;REGULATION OF LAMELLIPODIUM ORGANIZATION;#N/A;35;-1.4514021;0.0521327;0.12496064
GO BP;EAR DEVELOPMENT;GO:0043583;123;-1.4495312;0.013793103;0.12566654
GO BP;METANEPHRIC NEPHRON DEVELOPMENT;GO:0072210;18;-1.4499652;0.05374593;0.12571615
GO BP;MATURE B CELL DIFFERENTIATION;GO:0002335;17;-1.4495827;0.067434214;0.12577033
GO BP;NEGATIVE REGULATION OF CELL GROWTH;GO:0030308;123;-1.4497293;0.012211669;0.12577935
GO BP;CARBOHYDRATE CATABOLIC PROCESS;GO:0016052;156;-1.4492296;0.012096774;0.12579189
GO BP;NEGATIVE REGULATION OF AXONOGENESIS;GO:0050771;46;-1.4500251;0.03500761;0.1258389
GO BP;CHONDROCYTE DIFFERENTIATION;GO:0002062;73;-1.448786;0.029085873;0.12603445
GO BP;POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION;#N/A;148;-1.4484342;0.010610079;0.12605287
GO BP;NEGATIVE REGULATION OF HISTONE METHYLATION;GO:0031061;17;-1.4480865;0.06301824;0.12606855
GO BP;CELL PROJECTION ASSEMBLY;GO:0030031;453;-1.448492;0;0.12615809
GO BP;REGULATION OF CALCIUM ION TRANSPORT;GO:0051924;122;-1.4480946;0.015727391;0.12621304
GO BP;NEGATIVE REGULATION OF CELL MATRIX ADHESION;GO:0001953;27;-1.4466995;0.057663128;0.12700449
GO BP;MULTICELLULAR ORGANISMAL MOVEMENT;#N/A;30;-1.4467837;0.051155116;0.1270529
GO BP;REGULATION OF CELL ACTIVATION;GO:0050865;303;-1.4458866;0.001183432;0.12761784
GO BP;EPIDERMAL CELL DIFFERENTIATION;GO:0009913;140;-1.4454876;0.006775068;0.12781833
GO BP;VIRAL RNA GENOME REPLICATION;GO:0039694;23;-1.4445462;0.049668875;0.12804608
GO BP;REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY;GO:0050856;25;-1.4448521;0.049679488;0.12809299
GO BP;POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II;GO:1902895;22;-1.4449543;0.062295083;0.1281545
GO BP;CELLULAR RESPONSE TO ALCOHOL;#N/A;50;-1.4445626;0.036363635;0.12818266
GO BP;REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN;GO:0033628;33;-1.4433185;0.055732485;0.12856334
GO BP;OSTEOBLAST PROLIFERATION;GO:0033687;18;-1.4436175;0.08080808;0.12856662
GO BP;SECOND MESSENGER MEDIATED SIGNALING;GO:0019932;191;-1.4434414;0.006257822;0.12857866
GO BP;POSITIVE REGULATION OF TELOMERE MAINTENANCE;GO:0032206;46;-1.4436449;0.03937008;0.1286944
GO BP;NEURON PROJECTION EXTENSION;GO:1990138;117;-1.4429259;0.009485095;0.12874144
GO BP;REGULATION OF HORMONE LEVELS;GO:0010817;282;-1.4417224;0.001206273;0.12899213
GO BP;TELENCEPHALON GLIAL CELL MIGRATION;#N/A;16;-1.4415565;0.0703125;0.12899432
GO BP;RENAL SYSTEM VASCULATURE DEVELOPMENT;#N/A;17;-1.4423329;0.07258064;0.12903018
GO BP;ENDOCYTOSIS;GO:0006897;379;-1.4421487;0.002267574;0.12905207
GO BP;NEGATIVE REGULATION OF VIRAL GENOME REPLICATION;GO:0045071;33;-1.4419683;0.06329114;0.1290529
GO BP;REGULATION OF DNA REPAIR;GO:0006282;98;-1.4417982;0.0260631;0.12907277
GO BP;RESPONSE TO COCAINE;GO:0042220;27;-1.442418;0.05221519;0.12908596
GO BP;TRABECULA MORPHOGENESIS;GO:0061383;33;-1.4410685;0.039936103;0.12933299
GO BP;VIRAL GENOME REPLICATION;GO:0019079;86;-1.440055;0.024045262;0.13012952
GO BP;RESPONSE TO PLATELET DERIVED GROWTH FACTOR;GO:0036119;17;-1.4395485;0.071428575;0.13044643
GO BP;STEROL HOMEOSTASIS;GO:0055092;62;-1.4384617;0.032448377;0.13131814
GO BP;GENERATION OF PRECURSOR METABOLITES AND ENERGY;GO:0006091;425;1.5064844;0;0.13148564
GO BP;HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE;GO:0048873;17;-1.4376942;0.07224959;0.13189164
GO BP;MITOCHONDRIAL RNA METABOLIC PROCESS;GO:0000959;45;1.5073687;0.024169184;0.1319685
KEGG;ABC TRANSPORTERS;;30;-1.5162702;0.03776435;0.13240045
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION;GO:0030835;30;-1.4365475;0.052380953;0.13280255
GO BP;REGULATION OF DENDRITIC SPINE DEVELOPMENT;GO:0060998;60;-1.4363493;0.037956204;0.13281219
GO BP;POSITIVE REGULATION OF NEURON DEATH;GO:1901216;75;-1.4360788;0.031837918;0.13287646
GO BP;VASCULAR PROCESS IN CIRCULATORY SYSTEM;#N/A;81;-1.4355723;0.025210084;0.13316888
GO BP;NEGATIVE REGULATION OF HYDROLASE ACTIVITY;GO:0051346;277;-1.4348239;0.00120048;0.13338898
GO BP;DIACYLGLYCEROL METABOLIC PROCESS;GO:0046339;16;-1.4350492;0.080515295;0.13348275
GO BP;RESPONSE TO ALKALOID;#N/A;64;-1.4348567;0.032496307;0.13351783
GO BP;CHAPERONE MEDIATED PROTEIN FOLDING;GO:0061077;52;-1.4342339;0.04398827;0.13368464
GO BP;REGULATION OF T CELL MIGRATION;GO:2000404;25;-1.4343338;0.0631068;0.13371992
GO BP;CELLULAR RESPONSE TO CALCIUM ION;GO:0071277;47;-1.4337221;0.039829303;0.13404709
GO BP;THIOESTER METABOLIC PROCESS;#N/A;86;-1.4333693;0.024657534;0.13423112
GO BP;NEGATIVE REGULATION OF DNA RECOMBINATION;GO:0045910;36;-1.4307103;0.046801873;0.13526621
GO BP;INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0048009;21;-1.4320765;0.06867672;0.135298
GO BP;POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT;GO:0045684;23;-1.4317313;0.07324841;0.13531421
GO BP;INNERVATION;GO:0060384;17;-1.4307753;0.06972789;0.13536605
GO BP;MAINTENANCE OF PROTEIN LOCATION IN CELL;GO:0032507;60;-1.4310708;0.01997147;0.13536929
GO BP;EMBRYONIC PLACENTA MORPHOGENESIS;GO:0060669;19;-1.4318027;0.07236842;0.1353991
GO BP;HORMONE TRANSPORT;#N/A;179;-1.4314702;0.00622665;0.13543248
GO BP;PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;32;-1.4312843;0.05736434;0.135468
GO BP;DIGESTIVE SYSTEM DEVELOPMENT;GO:0055123;88;-1.4311258;0.031746034;0.13547419
GO BP;ENDOTHELIAL CELL CHEMOTAXIS;GO:0035767;15;-1.4302841;0.087314665;0.1355093
GO BP;REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051153;57;-1.4307796;0.034074076;0.13551965
GO BP;POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS;GO:1901522;19;-1.4297323;0.06403941;0.13557225
GO BP;REGULATION OF CELLULAR COMPONENT SIZE;#N/A;269;-1.4297812;0.003601441;0.13567524
GO BP;REGULATION OF EXTENT OF CELL GROWTH;#N/A;82;-1.4298254;0.022284122;0.13579105
GO BP;NEGATIVE REGULATION OF CELL MOTILITY;GO:2000146;174;-1.4292237;0.008928572;0.13592789
GO BP;ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS;GO:0032469;19;-1.4288098;0.0742496;0.13598491
GO BP;MACROPHAGE ACTIVATION;GO:0042116;46;-1.428817;0.049475264;0.13613063
GO BP;PROGRAMMED NECROTIC CELL DEATH;GO:0097300;33;-1.4280328;0.05496183;0.13648613
GO BP;INTERMEDIATE FILAMENT ORGANIZATION;GO:0045109;15;-1.4276726;0.091819696;0.13652018
GO BP;NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051148;34;-1.4278395;0.048211507;0.1365224
GO BP;BIOMINERALIZATION;#N/A;95;-1.4274546;0.023192361;0.13657504
GO BP;CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS;GO:0035924;35;-1.4280539;0.04718417;0.13661775
GO BP;POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050731;109;-1.4269929;0.01369863;0.13674772
GO BP;POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT;GO:0010828;29;-1.4268298;0.069767445;0.13675691
GO BP;REGULATION OF CARDIAC MUSCLE CONTRACTION;GO:0055117;46;-1.4271263;0.04552352;0.1367753
GO BP;REGULATION OF CHOLESTEROL EFFLUX;GO:0010874;19;-1.4261374;0.0698052;0.1371417
GO BP;MITOTIC CYTOKINESIS;GO:0000281;65;-1.425938;0.028985508;0.13720085
GO BP;HISTONE H2A UBIQUITINATION;GO:0033522;24;-1.4261477;0.07617504;0.13728857
GO BP;DOSAGE COMPENSATION;GO:0007549;18;-1.4245118;0.07666667;0.13848582
GO BP;EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:0008625;67;-1.4235976;0.037369207;0.13883944
GO BP;RESPONSE TO MECHANICAL STIMULUS;GO:0009612;138;-1.4237536;0.013351135;0.1388412
GO BP;POSITIVE REGULATION OF DNA REPAIR;GO:0045739;51;-1.4239725;0.057607092;0.13892512
GO BP;REGULATION OF LIPASE ACTIVITY;#N/A;53;-1.4238285;0.037537538;0.13893567
GO BP;STEROID HORMONE MEDIATED SIGNALING PATHWAY;GO:0043401;134;-1.4231094;0.02008032;0.13921553
GO BP;NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS;#N/A;416;-1.4229289;0;0.1392399
GO BP;RECEPTOR METABOLIC PROCESS;GO:0043112;129;-1.4222229;0.02077922;0.13936053
GO BP;ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS;#N/A;19;-1.4222668;0.07890223;0.13945499
GO BP;UNSATURATED FATTY ACID METABOLIC PROCESS;GO:0033559;62;-1.4224963;0.05147059;0.13953014
GO BP;POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014068;51;-1.4223499;0.04197901;0.13954833
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030858;28;-1.421628;0.063565895;0.13960843
GO BP;POSTSYNAPTIC MEMBRANE ORGANIZATION;GO:0001941;23;-1.4214656;0.06973059;0.13962501
GO BP;RECEPTOR MEDIATED ENDOCYTOSIS;GO:0006898;169;-1.421713;0.012953368;0.13968222
GO BP;INNER EAR RECEPTOR CELL DEVELOPMENT;GO:0060119;28;-1.4207183;0.07098766;0.14007904
GO BP;PEPTIDE HORMONE SECRETION;GO:0030072;149;-1.4208391;0.009283819;0.14011128
GO BP;POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION;#N/A;17;-1.420526;0.085141905;0.14011453
GO BP;EMBRYONIC AXIS SPECIFICATION;GO:0000578;21;-1.420035;0.0806962;0.14014213
GO BP;RESPONSE TO RETINOIC ACID;GO:0032526;76;-1.4203477;0.020143885;0.1401484
GO BP;OSSIFICATION;GO:0001503;244;-1.4200569;0.006105006;0.14027499
GO BP;REGULATION OF PROTEIN IMPORT;#N/A;47;-1.4196253;0.027355623;0.14038084
GO BP;VENTRICULAR SEPTUM DEVELOPMENT;GO:0003281;55;-1.4194617;0.044992745;0.14038415
GO BP;HORMONE MEDIATED SIGNALING PATHWAY;GO:0009755;151;-1.4188242;0.019582245;0.1406919
GO BP;SPHINLIPID BIOSYNTHETIC PROCESS;#N/A;82;-1.4188806;0.041608877;0.14078364
GO BP;NEGATIVE REGULATION OF LOCOMOTION;GO:0040013;209;-1.4177362;0.007566204;0.14136569
GO BP;INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY;GO:0035735;39;-1.4175199;0.043613706;0.14141573
GO BP;NEGATIVE REGULATION OF HISTONE MODIFICATION;#N/A;32;-1.4178349;0.054602183;0.14142375
GO BP;FATTY ACID METABOLIC PROCESS;GO:0006631;261;-1.4178827;0.007380074;0.14151752
GO BP;CELLULAR RESPONSE TO HORMONE STIMULUS;GO:0032870;456;-1.4170494;0;0.14172326
GO BP;POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS;#N/A;15;-1.4167926;0.103270225;0.14182469
GO BP;EMBRYONIC FORELIMB MORPHOGENESIS;GO:0035115;19;-1.4165926;0.08183306;0.14186746
GO BP;RECEPTOR CLUSTERING;GO:0043113;37;-1.4162805;0.05537975;0.14204556
GO BP;REGULATION OF TELOMERE MAINTENANCE;GO:0032204;75;-1.4159192;0.033333335;0.1420905
GO BP;MODIFICATION OF POSTSYNAPTIC STRUCTURE;GO:0099010;15;-1.4159715;0.08681135;0.1421935
GO BP;FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0008543;75;-1.4151013;0.04895105;0.14281198
GO BP;AXONEME ASSEMBLY;GO:0035082;37;1.4878107;0.02972973;0.14306559
GO BP;SPLICEOSOMAL SNRNP ASSEMBLY;GO:0000387;37;1.4889892;0.039772727;0.14328004
GO BP;POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION;GO:0051149;52;-1.4144706;0.04585799;0.1433033
GO BP;NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0043124;32;-1.4141098;0.0625;0.14348722
KEGG;NATURAL KILLER CELL MEDIATED CYTOTOXICITY;;57;-1.4952272;0.015827337;0.14381821
GO BP;PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0032984;270;1.4896094;0;0.14392792
GO BP;CARBOHYDRATE TRANSMEMBRANE TRANSPORT;GO:0034219;76;-1.4129199;0.04172662;0.14450605
GO BP;CYTOPLASMIC TRANSLATIONAL INITIATION;GO:0002183;27;1.4900796;0.03875969;0.14486378
GO BP;REGULATION OF CELL KILLING;#N/A;34;-1.4123871;0.07108239;0.144898
GO BP;CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS;#N/A;16;-1.412076;0.08056872;0.14507689
KEGG;TGF BETA SIGNALING PATHWAY;;56;-1.4891129;0.032934133;0.14533192
KEGG;PROSTATE CANCER;;76;-1.497714;0.017569546;0.14646289
GO BP;SMOOTH MUSCLE CELL APOPTOTIC PROCESS;#N/A;16;-1.4102715;0.09060956;0.14678113
KEGG;PYRIMIDINE METABOLISM;;82;1.3715655;0.051903114;0.14691603
GO BP;DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS;GO:0046545;57;-1.409954;0.043115437;0.14696315
GO BP;ADAPTIVE IMMUNE RESPONSE;GO:0002250;193;-1.4090985;0.006188119;0.14739305
GO BP;POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900078;17;-1.4093331;0.08139535;0.14744997
GO BP;REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903827;422;-1.4091713;0.003382187;0.14747915
GO BP;CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002367;60;-1.4087553;0.05112782;0.14758824
KEGG;RENAL CELL CARCINOMA;;57;-1.4813995;0.029027576;0.14774539
GO BP;RESPONSE TO PURINE CONTAINING COMPOUND;#N/A;90;-1.4079809;0.027510317;0.14825575
GO BP;PROTEIN LOCALIZATION TO MEMBRANE;GO:0072657;491;1.4803028;0;0.1486859
GO BP;RESPONSE TO STEROL;#N/A;22;-1.4073387;0.07337884;0.14873432
GO BP;PROTEIN ACETYLATION;GO:0006473;162;-1.406796;0.016731016;0.14915083
GO BP;MATURATION OF SSU RRNA;GO:0030490;46;1.4782674;0.028011205;0.14947557
GO BP;HISTONE MRNA METABOLIC PROCESS;#N/A;24;1.476743;0.03562341;0.14964014
GO BP;CORTICAL CYTOSKELETON ORGANIZATION;GO:0030865;43;-1.4057177;0.058646616;0.15015155
GO BP;MICROTUBULE ORGANIZING CENTER ORGANIZATION;GO:0031023;121;-1.404722;0.019762846;0.15071595
GO BP;CELLULAR RESPONSE TO LIPID;GO:0071396;375;-1.4048254;0.003378379;0.15076208
GO BP;ENDOCRINE SYSTEM DEVELOPMENT;GO:0035270;66;-1.4048901;0.04041916;0.15084304
GO BP;RESPONSE TO INTERLEUKIN 1;GO:0070555;132;1.4737555;0.004132231;0.15105858
GO BP;SMOOTH MUSCLE CELL MIGRATION;GO:0014909;53;-1.4039774;0.047687862;0.15112685
GO BP;REGULATION OF SPINDLE ASSEMBLY;GO:0090169;25;-1.4040837;0.0625;0.15118663
GO BP;CARDIAC CELL DEVELOPMENT;GO:0055006;54;-1.4032408;0.045722716;0.15176004
GO BP;HEART TRABECULA MORPHOGENESIS;GO:0061384;23;-1.4021782;0.078688525;0.1517601
GO BP;MIRNA METABOLIC PROCESS;GO:0010586;30;-1.4024671;0.07154742;0.15177633
GO BP;NUCLEOTIDE PHOSPHORYLATION;GO:0046939;104;-1.402505;0.029411765;0.15189345
GO BP;REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY;GO:0010803;40;-1.4022069;0.05727554;0.15189399
GO BP;CELLULAR RESPONSE TO AMMONIUM ION;GO:0071242;52;-1.4027276;0.0461997;0.1519621
GO BP;INTRACELLULAR RECEPTOR SIGNALING PATHWAY;GO:0030522;202;-1.4025801;0.009987515;0.15197654
KEGG;INSULIN SIGNALING PATHWAY;;105;-1.473941;0.012211669;0.1519986
GO BP;POSITIVE REGULATION OF CATABOLIC PROCESS;#N/A;347;-1.4028033;0.003476246;0.15205994
GO BP;POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION;GO:0045648;24;-1.4016672;0.08852459;0.15215231
GO BP;LEARNING;GO:0007612;76;-1.4014937;0.041265473;0.1521653
GO BP;REGULATION OF MYOTUBE DIFFERENTIATION;GO:0010830;24;-1.4006228;0.07460318;0.15270983
GO BP;REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT;#N/A;15;-1.4007248;0.084745765;0.15276548
GO BP;ENDOTHELIAL CELL PROLIFERATION;GO:0001935;84;-1.3991762;0.02586207;0.15343161
GO BP;EPITHELIAL CELL PROLIFERATION;GO:0050673;253;-1.3994098;0.009744215;0.15352418
GO BP;METHYLATION;GO:0032259;292;-1.3995332;0.006024096;0.15354343
GO BP;PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:0072659;216;-1.3992013;0.006090134;0.15357383
GO BP;REGULATION OF SISTER CHROMATID COHESION;GO:0007063;22;-1.3988956;0.07928803;0.15358165
GO BP;DNA GEOMETRIC CHANGE;GO:0032392;107;-1.3996313;0.032078102;0.15360363
GO BP;EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT;#N/A;24;-1.3983581;0.08227848;0.15402414
GO BP;NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;88;1.4695046;0.007194245;0.15411034
GO BP;POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS;GO:0120162;62;-1.3978388;0.034833092;0.15422007
GO BP;REGULATION OF PROTEIN EXPORT FROM NUCLEUS;GO:0046825;35;-1.3978626;0.082170546;0.1543585
GO BP;NEGATIVE REGULATION OF TRANSPORTER ACTIVITY;GO:0032410;39;-1.3975219;0.08;0.1544521
GO BP;REGULATION OF PROTEIN ACETYLATION;#N/A;54;-1.3964988;0.04407295;0.15489464
GO BP;IMPORT INTO NUCLEUS;GO:0051170;128;-1.3963352;0.032894738;0.15490977
GO BP;GLYCEROLIPID CATABOLIC PROCESS;#N/A;43;-1.3965379;0.06779661;0.15501256
GO BP;REGULATION OF EPIDERMAL CELL DIFFERENTIATION;GO:0045604;41;-1.3965528;0.06278027;0.15515265
GO BP;METHYLATION DEPENDENT CHROMATIN SILENCING;#N/A;17;-1.3956977;0.08415841;0.15524165
GO BP;SECONDARY METABOLITE BIOSYNTHETIC PROCESS;#N/A;15;-1.3966073;0.09688013;0.15525798
GO BP;CARBOHYDRATE TRANSPORT;GO:0008643;98;-1.3957803;0.029166667;0.15529884
GO BP;GAMETE GENERATION;GO:0007276;414;-1.3952037;0.002272727;0.15560481
GO BP;CARDIAC MUSCLE CELL CONTRACTION;GO:0086003;41;-1.394204;0.06278714;0.15652205
GO BP;PROTEIN KINASE B SIGNALING;GO:0043491;149;-1.3938519;0.020645162;0.15655452
GO BP;SPECIFICATION OF SYMMETRY;#N/A;90;-1.3938944;0.027285129;0.15667844
GO BP;HOMOTYPIC CELL CELL ADHESION;GO:0034109;56;-1.3926574;0.0605613;0.15769224
GO BP;RECEPTOR SIGNALING PATHWAY VIA STAT;#N/A;73;-1.3922102;0.048034936;0.15801817
GO BP;CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT;GO:0072111;15;-1.3912485;0.09516129;0.15809086
GO BP;REGULATION OF BLOOD CIRCULATION;GO:1903522;133;-1.391336;0.018324608;0.15817308
GO BP;METAL ION TRANSPORT;GO:0030001;471;-1.3910309;0.002202643;0.15817387
GO BP;REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;148;-1.3913414;0.023383768;0.15832955
GO BP;POSITIVE REGULATION OF RESPONSE TO WOUNDING;#N/A;44;-1.3913517;0.058551617;0.15848252
GO BP;STRIATED MUSCLE CONTRACTION;GO:0006941;99;-1.3914195;0.031811897;0.15856688
GO BP;NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035024;17;-1.3915256;0.10135135;0.15861562
GO BP;REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:1903169;76;-1.389994;0.043939393;0.15917233
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001243;80;-1.3896908;0.048022598;0.15934157
GO BP;NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS;GO:0009132;122;-1.3893311;0.024128687;0.15941806
GO BP;B CELL PROLIFERATION;GO:0042100;44;-1.3893851;0.06727829;0.15950766
GO BP;SEXUAL REPRODUCTION;GO:0019953;485;-1.3890073;0.001113586;0.15959165
GO BP;RNA STABILIZATION;GO:0043489;38;-1.3887824;0.043062203;0.1597085
KEGG;AXON GUIDANCE;;89;-1.4584072;0.02183406;0.159889
GO BP;NEGATIVE REGULATION OF PEPTIDASE ACTIVITY;GO:0010466;132;-1.3883952;0.027237354;0.15996909
GO BP;GENE SILENCING;GO:0016458;229;-1.3880312;0.009975063;0.16007414
GO BP;RESPONSE TO ESTRADIOL;GO:0032355;87;-1.388136;0.04628331;0.16011009
GO BP;MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002573;121;-1.3874952;0.025165563;0.16032197
GO BP;REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY;GO:0099601;34;-1.3870476;0.06549521;0.16046096
GO BP;RETROGRADE AXONAL TRANSPORT;GO:0008090;15;-1.3875103;0.086235486;0.16046482
GO BP;NEGATIVE REGULATION OF VIRAL LIFE CYCLE;#N/A;49;-1.387064;0.056402437;0.16060603
GO BP;OSTEOCLAST DIFFERENTIATION;GO:0030316;55;-1.3860756;0.061946902;0.16071764
GO BP;CARDIAC MUSCLE CONTRACTION;GO:0060048;80;-1.3866414;0.036764707;0.16074707
GO BP;PURINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;351;-1.3861939;0.005767013;0.16075282
GO BP;POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS;#N/A;25;-1.3862959;0.073836274;0.16079153
GO BP;CARBOHYDRATE HOMEOSTASIS;#N/A;160;-1.3864077;0.02486911;0.16083369
GO BP;REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES;GO:1901031;24;-1.3855737;0.088785045;0.1610725
GO BP;CARDIAC MUSCLE CELL DIFFERENTIATION;GO:0055007;78;-1.38515;0.04834254;0.16138737
KEGG;ERBB SIGNALING PATHWAY;;70;-1.4520779;0.020558003;0.16159284
GO BP;HISTONE UBIQUITINATION;GO:0016574;43;-1.3843486;0.05479452;0.16212846
GO BP;SULFUR COMPOUND BIOSYNTHETIC PROCESS;#N/A;135;-1.3833703;0.018791946;0.16283731
GO BP;NCRNA EXPORT FROM NUCLEUS;#N/A;36;-1.383051;0.083981335;0.16289054
GO BP;GLUTAMINE METABOLIC PROCESS;GO:0006541;18;-1.3834335;0.11201299;0.16292989
GO BP;REGULATION OF MACROPHAGE ACTIVATION;GO:0043030;27;-1.3831116;0.08450704;0.16298676
GO BP;VESICLE TARGETING TO FROM OR WITHIN LGI;#N/A;63;1.4593905;0.015873017;0.16307366
GO BP;REGULATION OF ENDOCYTOSIS;GO:0030100;149;-1.382192;0.022193212;0.16370076
GO BP;FILOPODIUM ASSEMBLY;GO:0046847;47;-1.3808519;0.07067669;0.16435634
GO BP;POSITIVE REGULATION OF LIPID METABOLIC PROCESS;GO:0045834;90;-1.38121;0.046676096;0.16448358
GO BP;POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL;GO:0051281;16;-1.3808588;0.100340135;0.16451505
GO BP;RESPONSE TO ACID CHEMICAL;#N/A;229;-1.3812933;0.015815085;0.16453925
GO BP;HOMEOSTASIS OF NUMBER OF CELLS;GO:0048872;173;-1.380894;0.016666668;0.16463456
KEGG;PANCREATIC CANCER;;57;-1.4587089;0.031007752;0.16534723
GO BP;CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY;GO:0033962;19;-1.3792254;0.10787671;0.16581216
GO BP;PHOTOTRANSDUCTION;GO:0007602;23;1.455512;0.06321839;0.16581671
GO BP;MEMBRANE BIOGENESIS;GO:0044091;27;-1.3792847;0.074132495;0.1659129
GO BP;POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT;GO:0048643;15;-1.3789127;0.091973245;0.16603266
GO BP;NEGATIVE REGULATION OF DNA REPLICATION;GO:0008156;30;-1.3786558;0.09090909;0.1661298
GO BP;CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING;#N/A;422;-1.3783909;0.002252252;0.16625695
GO BP;FEMALE PREGNANCY;GO:0007565;117;-1.3780297;0.030104712;0.16649182
GO BP;RESPONSE TO EXTRACELLULAR STIMULUS;GO:0009991;352;-1.3776059;0.004700352;0.16680449
GO BP;INFLAMMATORY RESPONSE;GO:0006954;349;-1.3769269;0.009367681;0.16742927
GO BP;PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;70;1.4483341;0.013468013;0.16778205
GO BP;TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0006368;74;1.4500033;0.006968641;0.1686625
GO BP;CLEAVAGE INVOLVED IN RRNA PROCESSING;GO:0000469;21;1.4487039;0.067961164;0.16877694
GO BP;REGULATION OF CELL AGING;#N/A;38;1.451151;0.056149732;0.16904972
GO BP;PROTEIN ACYLATION;GO:0043543;200;-1.3749055;0.01923077;0.16934891
GO BP;OOCYTE DIFFERENTIATION;GO:0009994;27;-1.3750248;0.09593496;0.16937448
GO BP;PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014065;95;-1.3742837;0.03862661;0.16988513
GO BP;REGENERATION;#N/A;125;-1.374059;0.020325202;0.16996251
GO BP;JNK CASCADE;GO:0007254;149;-1.3736647;0.026007803;0.17003575
GO BP;PINOCYTOSIS;GO:0006907;17;-1.373722;0.10367893;0.17014195
GO BP;POSITIVE REGULATION OF CELL ACTIVATION;#N/A;174;-1.372915;0.024547804;0.17056161
GO BP;LOCOMOTORY BEHAVIOR;GO:0007626;102;-1.3730012;0.03739612;0.17062679
GO BP;EXCRETION;GO:0007588;29;-1.3721131;0.087692305;0.17132407
GO BP;SMOOTH MUSCLE CONTRACTION;GO:0006939;47;-1.3710253;0.06716418;0.17222367
GO BP;NEGATIVE REGULATION OF DEPHOSPHORYLATION;GO:0035305;86;-1.3708482;0.043243244;0.17226456
GO BP;REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY;#N/A;17;-1.3710839;0.10232558;0.17231324
GO BP;TISSUE REMODELING;GO:0048771;95;-1.3702642;0.04347826;0.17275499
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;#N/A;38;-1.3700289;0.075038284;0.17285673
GO BP;POSITIVE REGULATION OF CELL SUBSTRATE ADHESION;GO:0010811;85;-1.3697505;0.04101839;0.17300044
GO BP;CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT;GO:0061005;29;-1.3687764;0.081203006;0.17335697
GO BP;REGULATION OF CELL DIVISION;GO:0051302;111;-1.3688319;0.035952065;0.17346606
GO BP;CYTOSOLIC CALCIUM ION TRANSPORT;#N/A;99;-1.3682164;0.040221915;0.17347611
GO BP;ALPHA AMINO ACID BIOSYNTHETIC PROCESS;#N/A;52;-1.368957;0.058565155;0.17349727
GO BP;POSITIVE REGULATION OF INSULIN SECRETION;GO:0032024;47;-1.3684201;0.07535322;0.17358264
GO BP;REGULATION OF LYMPHOCYTE ACTIVATION;GO:0051249;233;-1.368226;0.02586207;0.17362577
GO BP;MICROTUBULE NUCLEATION;GO:0007020;24;-1.368965;0.10569106;0.17365603
GO BP;INTRACILIARY TRANSPORT;GO:0042073;47;-1.3674866;0.07366771;0.17367959
GO BP;PEPTIDYL SERINE MODIFICATION;#N/A;225;-1.3677382;0.010843374;0.17370403
GO BP;POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING;GO:1901224;44;-1.367868;0.07286822;0.1737234
GO BP;REGULATION OF LIPOPROTEIN LIPASE ACTIVITY;#N/A;15;-1.3675438;0.1056338;0.1737813
GO BP;POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043536;40;-1.3689661;0.08054711;0.17382108
GO BP;POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN;GO:0042531;27;-1.3669752;0.09516616;0.1741116
GO BP;NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH;#N/A;68;-1.3664478;0.06241135;0.17439419
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT;#N/A;18;-1.366487;0.08361204;0.17450674
KEGG;ADHERENS JUNCTION;;61;-1.4360611;0.03748126;0.17463969
GO BP;FEMALE SEX DIFFERENTIATION;#N/A;68;-1.3644751;0.061959654;0.17587504
GO BP;REGULATION OF MUSCLE HYPERTROPHY;#N/A;43;-1.3645504;0.065625;0.17591736
GO BP;REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:0072593;174;-1.3646586;0.018158237;0.17595649
GO BP;REGULATION OF SYNAPSE ASSEMBLY;GO:0051963;45;-1.3649157;0.06495468;0.17599456
GO BP;CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL;GO:0097553;75;-1.3646748;0.04674221;0.17610934
GO BP;ENDOCRINE HORMONE SECRETION;#N/A;18;-1.3637354;0.10638298;0.17656663
GO BP;NEGATIVE REGULATION OF PHOSPHORYLATION;GO:0042326;331;-1.3631066;0.006952491;0.17681052
GO BP;RESPONSE TO ESTROGEN;GO:0043627;49;-1.3627388;0.06803797;0.17688501
GO BP;CARDIAC CONDUCTION;GO:0061337;66;-1.3628967;0.054263566;0.17689067
GO BP;DNA DEALKYLATION;#N/A;24;-1.3631645;0.09836066;0.17690226
GO BP;VESICLE CYTOSKELETAL TRAFFICKING;GO:0099518;47;-1.363243;0.08006279;0.17696112
GO BP;NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT;GO:0032387;41;-1.3619725;0.064417176;0.17766885
GO BP;NATURAL KILLER CELL ACTIVATION;GO:0030101;32;-1.361314;0.082170546;0.17810135
GO BP;DENDRITE EXTENSION;GO:0097484;19;-1.3614472;0.102389075;0.17812227
GO BP;POSITIVE REGULATION OF KINASE ACTIVITY;GO:0033674;410;-1.3611172;0.006872852;0.17813104
GO BP;PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007205;15;-1.3605411;0.114754096;0.17813128
GO BP;REGULATION OF STEROID BIOSYNTHETIC PROCESS;GO:0050810;69;-1.360945;0.037249282;0.17818438
GO BP;G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER;GO:0007187;71;-1.3607696;0.06646526;0.17819966
GO BP;INTERFERON GAMMA MEDIATED SIGNALING PATHWAY;GO:0060333;47;-1.360575;0.07121662;0.1782454
GO BP;REGULATION OF CYTOKINESIS;GO:0032465;66;-1.3600038;0.061971832;0.17861813
GO BP;PEPTIDYL TYROSINE MODIFICATION;#N/A;227;-1.3595688;0.014833127;0.17901546
GO BP;REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;100;-1.3591415;0.040983606;0.17937328
GO BP;ODONTOGENESIS;GO:0042476;81;-1.3588712;0.046961326;0.17953
GO BP;POST LGI VESICLE MEDIATED TRANSPORT;#N/A;95;-1.3578414;0.03739612;0.18058659
GO BP;CELLULAR RESPONSE TO STEROL;GO:0036315;16;-1.3575771;0.11965812;0.18059665
GO BP;EMBRYONIC HINDLIMB MORPHOGENESIS;GO:0035116;18;-1.3576967;0.11333334;0.18059722
GO BP;G2 DNA DAMAGE CHECKPOINT;#N/A;27;-1.3571061;0.1007874;0.18084632
GO BP;MULTICELLULAR ORGANISM REPRODUCTION;#N/A;497;-1.3572133;0.006681514;0.18086624
GO BP;REGULATION OF DEPHOSPHORYLATION;GO:0035303;163;-1.3565421;0.03320562;0.1813515
GO BP;GLUCOSE IMPORT;GO:0046323;46;-1.3562112;0.080058224;0.1815771
GO BP;PROTEIN AUTOUBIQUITINATION;GO:0051865;60;-1.3556447;0.059766766;0.18168357
GO BP;RESPONSE TO FOOD;GO:0032094;17;-1.355712;0.11952862;0.18178342
GO BP;MITOPHAGY;GO:0000423;21;-1.3557689;0.105882354;0.18187423
GO BP;UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS;GO:0006636;37;-1.3551254;0.09048362;0.18212798
GO BP;POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY;GO:1901890;23;-1.3548331;0.1008;0.18215871
GO BP;REGULATION OF ENDOTHELIAL CELL MIGRATION;GO:0010594;111;-1.3548717;0.025;0.18228044
GO BP;REGULATION OF RESPONSE TO OXIDATIVE STRESS;GO:1902882;63;-1.3543612;0.067064084;0.1825874
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001236;107;-1.3536749;0.03956344;0.18308437
GO BP;REGULATION OF PHOSPHOLIPID METABOLIC PROCESS;GO:1903725;59;-1.3531002;0.073846154;0.1830964
GO BP;DIGESTION;GO:0007586;55;-1.3536775;0.07794118;0.18324904
GO BP;RESPONSE TO PEPTIDE HORMONE;GO:0043434;298;-1.353101;0.013017751;0.18326277
GO BP;SODIUM ION TRANSPORT;GO:0006814;123;-1.3531764;0.03462604;0.18334155
GO BP;REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000377;120;-1.3526021;0.038043477;0.18335432
GO BP;RESPONSE TO TRANSFORMING GROWTH FACTOR BETA;GO:0071559;166;-1.3526771;0.031290743;0.18344449
GO BP;POSITIVE REGULATION OF MAPK CASCADE;GO:0043410;326;-1.353189;0.009280742;0.18349586
GO BP;ORGANIC HYDROXY COMPOUND TRANSPORT;GO:0015850;126;-1.3517678;0.03924222;0.18417753
GO BP;LIPID HOMEOSTASIS;GO:0055088;98;-1.3512603;0.055172414;0.18429928
GO BP;POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903829;262;-1.3514838;0.016826924;0.18437448
GO BP;CARDIOCYTE DIFFERENTIATION;GO:0035051;99;-1.3513122;0.047156725;0.18440671
GO BP;AXON EXTENSION;GO:0048675;92;-1.350883;0.052556816;0.18454549
GO BP;ZINC ION HOMEOSTASIS;GO:0055069;20;-1.350562;0.10440457;0.18459526
GO BP;ALPHA AMINO ACID CATABOLIC PROCESS;#N/A;79;-1.3506643;0.05891016;0.18462244
GO BP;B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;GO:0002312;47;-1.3495705;0.066273935;0.185451
GO BP;METAL ION HOMEOSTASIS;GO:0055065;340;-1.3496515;0.011764706;0.18552652
GO BP;MYELOID CELL DIFFERENTIATION;GO:0030099;280;-1.3491153;0.009650181;0.18583529
GO BP;POLARIZED EPITHELIAL CELL DIFFERENTIATION;GO:0030859;15;-1.3485725;0.12765957;0.1861046
GO BP;SYNAPSE MATURATION;GO:0060074;16;-1.3487141;0.13722126;0.18611246
GO BP;POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0070304;119;-1.3482798;0.04973822;0.18613343
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:2000651;15;-1.3483362;0.12258065;0.18623841
GO BP;DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY;#N/A;39;-1.3478556;0.070754714;0.18651406
GO BP;NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS;#N/A;448;-1.3472512;0.005688282;0.18655924
GO BP;RESPONSE TO FLUID SHEAR STRESS;GO:0034405;25;-1.3472675;0.08955224;0.1867077
GO BP;NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION;GO:0014912;18;-1.3474171;0.12241653;0.18671225
GO BP;POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0051091;165;-1.3474443;0.036082473;0.18683752
GO BP;MULTI MULTICELLULAR ORGANISM PROCESS;#N/A;128;-1.3468767;0.030303031;0.18684886
GO BP;POSITIVE REGULATION OF BLOOD CIRCULATION;#N/A;34;-1.3466322;0.098101266;0.1869566
GO BP;REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:1900024;46;-1.3462945;0.072530866;0.18720056
GO BP;NEGATIVE REGULATION OF GENE SILENCING;#N/A;29;-1.3453374;0.0990566;0.18821749
GO BP;NEGATIVE REGULATION OF CELL ACTIVATION;GO:0050866;104;-1.3448154;0.04691689;0.18868528
GO BP;NEGATIVE REGULATION OF HEMOPOIESIS;GO:1903707;90;-1.3445868;0.05138889;0.18878551
GO BP;CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:0070588;170;-1.3441052;0.028720627;0.18919377
GO BP;VACUOLAR TRANSPORT;GO:0007034;125;-1.3439647;0.048648648;0.18922223
GO BP;REGULATION OF SMOOTH MUSCLE CONTRACTION;GO:0006940;26;-1.3437126;0.10151515;0.18940203
GO BP;ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE;GO:0030968;105;-1.3429712;0.051841747;0.18997176
GO BP;POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION;GO:0014911;27;-1.3428179;0.11404958;0.1899938
GO BP;REGULATION OF PHOSPHATASE ACTIVITY;GO:0010921;134;-1.3430558;0.039726026;0.19002739
GO BP;PROTEIN TRANSMEMBRANE TRANSPORT;GO:0071806;52;1.4243416;0.027607363;0.1902601
GO BP;NEGATIVE REGULATION OF RNA SPLICING;GO:0033119;25;1.426761;0.06005222;0.190429
GO BP;NEGATIVE REGULATION OF CELL ADHESION;GO:0007162;173;-1.3414818;0.029449424;0.19046742
GO BP;RIBOSE PHOSPHATE METABOLIC PROCESS;GO:0019693;329;-1.3414924;0.014002333;0.19062118
GO BP;PROTEIN LIPID COMPLEX ASSEMBLY;GO:0065005;27;-1.3415004;0.0923825;0.19077526
GO BP;DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS;GO:0045137;137;-1.3416063;0.042857144;0.19081844
GO BP;REGULATION OF B CELL ACTIVATION;GO:0050864;72;-1.3416355;0.06666667;0.19094321
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION;#N/A;24;1.4250146;0.07105263;0.19095422
GO BP;NEGATIVE REGULATION OF ION TRANSPORT;GO:0043271;72;-1.3419317;0.054896142;0.19097643
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;GO:0008630;89;-1.3417796;0.061340943;0.19098388
GO BP;STEROL TRANSPORT;GO:0015918;65;-1.340707;0.06882022;0.19124566
GO BP;SPINDLE ORGANIZATION;GO:0007051;153;-1.3402889;0.035526317;0.19155197
KEGG;HYPERTROPHIC CARDIOMYOPATHY HCM;;49;-1.4179415;0.0529595;0.19205785
GO BP;POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION;GO:0051057;46;-1.3392544;0.075414784;0.1926701
GO BP;ALCOHOL METABOLIC PROCESS;#N/A;251;-1.339046;0.02238806;0.1927654
GO BP;PLACENTA DEVELOPMENT;GO:0001890;113;-1.3388646;0.045822103;0.19282731
GO BP;NEGATIVE REGULATION OF WOUND HEALING;GO:0061045;47;-1.3386918;0.08012327;0.1928924
GO BP;NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;#N/A;17;-1.3381072;0.12727273;0.19312784
GO BP;POSITIVE REGULATION OF CELL GROWTH;GO:0030307;117;-1.3382957;0.045212764;0.1932341
GO BP;HEART PROCESS;GO:0003015;143;-1.3381141;0.03471295;0.19328716
GO BP;PROTEIN SUMOYLATION;GO:0016925;69;-1.3377287;0.059743956;0.19344506
GO BP;PROTEIN HYDROXYLATION;GO:0018126;23;-1.3370811;0.12479201;0.1940845
GO BP;POSITIVE REGULATION OF JUN KINASE ACTIVITY;GO:0043507;53;-1.336847;0.07941177;0.19421089
GO BP;OSTEOBLAST DIFFERENTIATION;GO:0001649;141;-1.3358126;0.03934871;0.1948016
GO BP;PLATELET DEGRANULATION;GO:0002576;83;-1.3360354;0.062937066;0.19487628
GO BP;POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:1900026;33;-1.3358287;0.116564415;0.19494951
GO BP;CELLULAR RESPONSE TO AMYLOID BETA;GO:1904646;23;-1.3360885;0.12060302;0.19498311
GO BP;CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS;GO:0071375;224;-1.3351316;0.012422361;0.1953458
GO BP;WALKING BEHAVIOR;GO:0090659;18;-1.3351969;0.1280389;0.19543543
GO BP;NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;37;-1.3346801;0.10494753;0.1955317
GO BP;GLUCOSE METABOLIC PROCESS;GO:0006006;160;-1.3342013;0.030585106;0.195609
GO BP;TISSUE REGENERATION;GO:0042246;45;-1.3347521;0.08854962;0.19562016
GO BP;ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE;GO:0061844;26;1.4149215;0.08900524;0.19564429
GO BP;ACTIN FILAMENT DEPOLYMERIZATION;GO:0030042;39;-1.3342892;0.0953125;0.19566591
GO BP;MITOTIC DNA REPLICATION;GO:1902969;15;-1.3343573;0.1323283;0.19574894
GO BP;DIVALENT INORGANIC CATION TRANSPORT;#N/A;259;-1.3336731;0.015700484;0.196085
GO BP;MALE GAMETE GENERATION;GO:0048232;324;-1.3331823;0.011709602;0.196177
GO BP;MUSCLE CELL PROLIFERATION;GO:0033002;120;-1.3332952;0.05866303;0.19619761
GO BP;DOPAMINERGIC NEURON DIFFERENTIATION;GO:0071542;18;-1.3333693;0.13225806;0.19628291
GO BP;REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE;GO:1902473;18;-1.3328362;0.12414966;0.19647942
GO BP;CELLULAR RESPONSE TO PEPTIDE;GO:1901653;263;-1.3324089;0.018979834;0.19649355
GO BP;RESPONSE TO AMINO ACID;GO:0043200;90;-1.3326325;0.056899004;0.19654311
GO BP;BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043534;79;-1.3324293;0.07162921;0.19663654
GO BP;NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION;#N/A;67;-1.3316745;0.07100592;0.19689074
GO BP;REGULATION OF VIRAL GENOME REPLICATION;GO:0045069;64;-1.3319486;0.06395349;0.19692367
GO BP;HEMATOPOIETIC STEM CELL DIFFERENTIATION;GO:0060218;64;1.4150759;0.02173913;0.19698699
GO BP;MITOTIC SPINDLE ORGANIZATION;GO:0007052;99;-1.3314223;0.049586777;0.19703284
GO BP;NEGATIVE REGULATION OF MULTI ORGANISM PROCESS;#N/A;128;-1.3316761;0.033602152;0.19705945
GO BP;DNA CONFORMATION CHANGE;GO:0071103;260;-1.3312285;0.018957347;0.1971194
GO BP;RESPONSE TO INTERFERON GAMMA;GO:0034341;103;-1.3305007;0.052186176;0.19734897
GO BP;PLASMA MEMBRANE ORGANIZATION;GO:0007009;70;-1.3307227;0.08784773;0.1973875
GO BP;POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS;#N/A;17;-1.3305793;0.13673806;0.19741394
KEGG;ADIPOCYTOKINE SIGNALING PATHWAY;;49;-1.3921516;0.055059522;0.1975212
GO BP;RESPONSE TO PH;GO:0009268;21;-1.3307445;0.12580645;0.1975251
GO BP;ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY;GO:0032509;25;1.4156197;0.08357349;0.19781078
GO BP;SPINDLE ASSEMBLY;GO:0051225;95;-1.329969;0.05730659;0.19784676
KEGG;COMPLEMENT AND COAGULATION CASCADES;;29;-1.4091932;0.06570513;0.1980136
GO BP;REGULATION OF JUN KINASE ACTIVITY;GO:0043506;60;-1.3295357;0.07634731;0.19807978
GO BP;RESPONSE TO OSMOTIC STRESS;GO:0006970;60;-1.3293834;0.07902299;0.19810638
GO BP;POSITIVE REGULATION OF STEROID METABOLIC PROCESS;#N/A;17;-1.3295802;0.11241611;0.19819844
GO BP;REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0051090;278;-1.3289611;0.01668653;0.19833398
GO BP;RESPONSE TO PEPTIDE;#N/A;348;-1.3290957;0.01871345;0.19833711
GO BP;LEUKOCYTE MIGRATION;GO:0050900;223;-1.3287966;0.023030303;0.19841953
GO BP;SEGMENTATION;GO:0035282;52;-1.3279781;0.08083832;0.19845858
GO BP;REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002761;64;-1.327858;0.077380955;0.19845948
GO BP;EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:0097191;160;-1.3283137;0.040897097;0.19851452
GO BP;VIRAL BUDDING;GO:0046755;24;1.416343;0.07579462;0.19853866
GO BP;CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE;GO:0070192;51;-1.3281457;0.085383505;0.19857663
GO BP;POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION;GO:0051495;167;-1.3283762;0.032042723;0.19859165
GO BP;REGULATION OF T CELL ACTIVATION;GO:0050863;169;-1.3279866;0.038659792;0.19861852
GO BP;AMINOGLYCAN METABOLIC PROCESS;#N/A;99;-1.3284372;0.05034965;0.19867834
GO BP;VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION;GO:1904738;16;-1.3274585;0.12173913;0.19878638
GO BP;NON MOTILE CILIUM ASSEMBLY;GO:1905515;49;-1.3272727;0.093701996;0.19888347
GO BP;CELLULAR RESPONSE TO INORGANIC SUBSTANCE;GO:0071241;141;-1.32692;0.043941412;0.19918822
GO BP;PROTEIN LOCALIZATION TO CHROMATIN;GO:0071168;27;-1.3267071;0.1042654;0.19930387
GO BP;RESPONSE TO HYPEROXIA;#N/A;17;-1.3259578;0.11478261;0.19991724
GO BP;REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING;GO:0014066;81;-1.3256315;0.066091955;0.20000353
GO BP;REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035023;105;-1.3259968;0.047945205;0.20003575
GO BP;REGULATION OF KIDNEY DEVELOPMENT;#N/A;28;-1.3250626;0.108864695;0.20006838
GO BP;POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;113;-1.3256843;0.056527592;0.20010513
GO BP;REGULATION OF LEUKOCYTE MIGRATION;GO:0002685;100;-1.3251548;0.058487874;0.20011567
GO BP;REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0070302;167;-1.3253616;0.039190896;0.20016356
GO BP;FATTY ACID DERIVATIVE METABOLIC PROCESS;#N/A;96;-1.3251663;0.04551724;0.20026498
GO BP;REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0008589;63;-1.3237934;0.08236994;0.20033038
GO BP;RESPONSE TO INTERLEUKIN 4;GO:0070670;22;-1.323876;0.13220339;0.2003835
GO BP;DNA RECOMBINATION;GO:0006310;234;-1.323972;0.025893958;0.20040989
GO BP;NEGATIVE REGULATION OF RESPONSE TO WOUNDING;#N/A;57;-1.3240063;0.09210526;0.20053254
GO BP;KIDNEY EPITHELIUM DEVELOPMENT;GO:0072073;77;-1.3241322;0.07650273;0.2005415
GO BP;CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS;#N/A;137;-1.3244895;0.039726026;0.20059466
GO BP;CHOLESTEROL EFFLUX;GO:0033344;32;-1.3241899;0.0953125;0.20063552
GO BP;LIPID LOCALIZATION;GO:0010876;254;-1.3242946;0.024479805;0.20066535
GO BP;RESPONSE TO INTERLEUKIN 6;GO:0070741;24;-1.3232617;0.12006319;0.20086727
GO BP;REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY;GO:0043467;128;-1.3231065;0.048275862;0.20091054
KEGG;NOTCH SIGNALING PATHWAY;;38;-1.3940685;0.07064364;0.20107204
GO BP;SKELETAL MUSCLE CONTRACTION;GO:0003009;20;-1.3226258;0.12478921;0.20139347
GO BP;REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;#N/A;70;-1.321922;0.09130435;0.20179279
GO BP;NECROTIC CELL DEATH;GO:0070265;39;-1.3220377;0.09035222;0.20180583
GO BP;REPLICATION FORK PROCESSING;GO:0031297;31;-1.3220787;0.110935025;0.20191668
GO BP;NERVE DEVELOPMENT;GO:0021675;43;-1.3213774;0.09309791;0.20199466
GO BP;RESPONSE TO BMP;#N/A;107;-1.3214443;0.06327373;0.20207873
GO BP;ION HOMEOSTASIS;GO:0050801;453;-1.3215032;0.00770077;0.20216694
GO BP;MUSCLE FIBER DEVELOPMENT;GO:0048747;38;-1.3209829;0.10344828;0.20232677
GO BP;PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS;GO:0006515;28;-1.3207555;0.104477614;0.20246835
GO BP;ANTERIOR POSTERIOR PATTERN SPECIFICATION;GO:0009952;112;-1.3204986;0.05277778;0.2026397
GO BP;REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0033157;185;-1.3202523;0.040201005;0.20280881
GO BP;VERY LONG CHAIN FATTY ACID METABOLIC PROCESS;GO:0000038;24;-1.3199601;0.10747664;0.2030268
GO BP;RECEPTOR LOCALIZATION TO SYNAPSE;GO:0097120;37;-1.3193246;0.103186645;0.20336191
GO BP;PLATELET ACTIVATION;GO:0030168;93;-1.3193632;0.060734462;0.20348528
GO BP;CHROMOSOME SEGREGATION;GO:0007059;280;-1.3194251;0.019347038;0.20356712
GO BP;SECONDARY PALATE DEVELOPMENT;GO:0062009;15;-1.3185112;0.15656565;0.20422678
GO BP;NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051444;16;1.4063467;0.07908163;0.20490827
GO BP;REGULATION OF PROTEIN TARGETING TO MEMBRANE;#N/A;27;-1.3177447;0.123664126;0.2049596
GO BP;SENSORY PERCEPTION OF LIGHT STIMULUS;GO:0050953;92;-1.3178129;0.0776699;0.2050372
GO BP;MUSCLE CELL MIGRATION;#N/A;62;-1.3173605;0.069767445;0.20527612
GO BP;B CELL APOPTOTIC PROCESS;GO:0001783;21;-1.3172045;0.12151067;0.20530087
KEGG;GLIOMA;;50;-1.3951362;0.05891016;0.20568885
GO BP;RESPONSE TO INSULIN;GO:0032868;201;-1.316549;0.029040404;0.20597918
GO BP;POSITIVE REGULATION OF MACROAUTOPHAGY;GO:0016239;58;-1.3152543;0.09261939;0.20615895
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS;#N/A;19;-1.314859;0.13725491;0.20617992
GO BP;REGULATION OF INFLAMMATORY RESPONSE;GO:0050727;175;-1.3149624;0.04510309;0.20620842
GO BP;REGULATION OF STEROL TRANSPORT;#N/A;32;-1.3152844;0.10906298;0.20627786
GO BP;NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;58;-1.3150171;0.08037094;0.20630321
GO BP;DIGESTIVE SYSTEM PROCESS;#N/A;43;-1.3145876;0.09984152;0.20639022
GO BP;CELLULAR AMINO ACID CATABOLIC PROCESS;GO:0009063;96;-1.3153023;0.075898804;0.20642136
GO BP;RESPONSE TO INORGANIC SUBSTANCE;GO:0010035;369;-1.3160208;0.018285714;0.20649552
GO BP;REGULATION OF MAP KINASE ACTIVITY;GO:0043405;237;-1.3143694;0.02586207;0.20651712
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;48;-1.315317;0.10725076;0.20657218
GO BP;NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION;GO:0048662;25;-1.3154123;0.12539186;0.20660497
GO BP;NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0033144;27;-1.3156705;0.12948518;0.20662624
GO BP;INOSITOL LIPID MEDIATED SIGNALING;GO:0048017;123;-1.314075;0.05466667;0.20673665
GO BP;HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES;GO:0007157;20;-1.315449;0.12816189;0.2067368
GO BP;RESPONSE TO ALCOHOL;GO:0097305;138;-1.3156859;0.053333335;0.20677967
GO BP;REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT;GO:0010827;52;-1.3132352;0.09461427;0.20770478
GO BP;REGULATION OF CHROMOSOME SEGREGATION;GO:0051983;93;-1.3130713;0.06536857;0.20777546
GO BP;MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA;#N/A;34;1.4026929;0.04278075;0.2078131
GO BP;FATTY ACID TRANSPORT;GO:0015908;61;-1.3125329;0.09745128;0.20800045
GO BP;DOUBLE STRAND BREAK REPAIR;GO:0006302;213;-1.3123355;0.028290283;0.2080964
GO BP;PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY;#N/A;16;-1.3125554;0.12841092;0.20813984
GO BP;ORGAN GROWTH;GO:0035265;111;-1.3126699;0.069863014;0.20815952
GO BP;REGULATION OF CALCINEURIN MEDIATED SIGNALING;GO:0106056;27;-1.3113061;0.13375796;0.20934103
GO BP;REGULATION OF ENDOCRINE PROCESS;#N/A;15;-1.3111012;0.14940578;0.2094474
GO BP;REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071900;379;-1.3108225;0.018099548;0.2096493
GO BP;PROTEIN LOCALIZATION TO LYSOSOME;GO:0061462;33;-1.3104774;0.13247173;0.20993543
GO BP;POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION;GO:0045840;38;-1.3102589;0.11574074;0.2100476
GO BP;BONE MINERALIZATION;GO:0030282;68;-1.310092;0.095870204;0.21008694
GO BP;INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT;GO:0065002;45;1.3994395;0.056047197;0.21035832
GO BP;POSITIVE REGULATION OF KIDNEY DEVELOPMENT;GO:0090184;20;-1.3095206;0.15297906;0.21067831
GO BP;ANION TRANSMEMBRANE TRANSPORT;GO:0098656;183;-1.3090032;0.042145595;0.21088552
KEGG;JAK STAT SIGNALING PATHWAY;;73;-1.3958987;0.035816617;0.21095178
GO BP;REGULATION OF FIBROBLAST MIGRATION;GO:0010762;21;-1.3090454;0.1338843;0.21099243
GO BP;REGULATION OF INTRACELLULAR TRANSPORT;GO:0032386;276;-1.3091131;0.023980815;0.21107478
GO BP;REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL;GO:0010522;50;-1.308591;0.102831595;0.2112441
GO BP;POSITIVE REGULATION OF HORMONE SECRETION;GO:0046887;71;-1.3081591;0.07560628;0.21167193
GO BP;PURINE CONTAINING COMPOUND CATABOLIC PROCESS;#N/A;42;-1.3078195;0.12324493;0.21197662
GO BP;NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT;#N/A;51;-1.3074694;0.10248447;0.2122922
GO BP;NEGATIVE REGULATION OF VIRAL PROCESS;GO:0048525;61;-1.3071386;0.08575804;0.21254429
GO BP;LEUKOCYTE PROLIFERATION;GO:0070661;155;-1.3069727;0.051861703;0.21259613
KEGG;LONG TERM POTENTIATION;;47;-1.3690414;0.07573416;0.21290705
GO BP;RRNA TRANSCRIPTION;GO:0009303;31;-1.3065263;0.14196567;0.21303701
KEGG;AMYOTROPHIC LATERAL SCLEROSIS ALS;;40;-1.3730001;0.082125604;0.21309553
KEGG;VIRAL MYOCARDITIS;;36;-1.3642964;0.079877116;0.21354307
KEGG;ECM RECEPTOR INTERACTION;;54;-1.3767333;0.063675836;0.21364987
GO BP;POSITIVE REGULATION OF TRANSFERASE ACTIVITY;#N/A;472;-1.3058255;0.013114754;0.2137637
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION;GO:0030837;44;-1.3056899;0.11094225;0.2137684
GO BP;POSITIVE REGULATION OF FAT CELL DIFFERENTIATION;GO:0045600;41;-1.3048193;0.10843374;0.21474965
GO BP;DNA INTEGRITY CHECKPOINT;#N/A;145;-1.304516;0.058047492;0.21497534
GO BP;REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;312;-1.303895;0.021608643;0.21510755
GO BP;POTASSIUM ION TRANSPORT;GO:0006813;87;-1.3041356;0.086834736;0.21514295
GO BP;SMAD PROTEIN SIGNAL TRANSDUCTION;GO:0060395;42;-1.3040042;0.10296412;0.21514417
KEGG;SNARE INTERACTIONS IN VESICULAR TRANSPORT;;35;1.2963631;0.09803922;0.21517321
GO BP;POSITIVE REGULATION OF HEMOPOIESIS;#N/A;109;-1.3036083;0.07005495;0.215187
GO BP;CELLULAR AMINO ACID BIOSYNTHETIC PROCESS;GO:0008652;64;-1.3037108;0.088757396;0.21520483
GO BP;VIRAL LIFE CYCLE;GO:0019058;243;-1.3031433;0.025179856;0.21530896
GO BP;ORGANIC CATION TRANSPORT;GO:0015695;19;-1.3041371;0.11570248;0.21531086
GO BP;HISTONE H2A MONOUBIQUITINATION;GO:0035518;17;-1.3031803;0.14166667;0.21542837
GO BP;MYOTUBE CELL DEVELOPMENT;GO:0014904;20;-1.3028643;0.15231788;0.21546285
GO BP;REGULATION OF HAIR CYCLE;GO:0042634;20;-1.3032308;0.15916398;0.21552926
GO BP;MULTICELLULAR ORGANISMAL HOMEOSTASIS;GO:0048871;288;-1.3024743;0.025029797;0.2158538
GO BP;REGULATION OF LIPID CATABOLIC PROCESS;GO:0050994;35;-1.3021954;0.1216;0.21607095
GO BP;RESPIRATORY SYSTEM PROCESS;GO:0003016;19;-1.3019742;0.16211878;0.21619533
GO BP;REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0033143;61;-1.3018452;0.094752185;0.21622525
GO BP;REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061097;56;-1.3014934;0.10650887;0.21653397
GO BP;MUSCLE CELL APOPTOTIC PROCESS;#N/A;47;-1.300884;0.10769231;0.21664721
GO BP;RESPONSE TO CATECHOLAMINE;#N/A;47;-1.3010929;0.10117302;0.21669027
GO BP;POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING;GO:0051897;95;-1.3012124;0.07391911;0.21671441
GO BP;POSITIVE REGULATION OF INTRACELLULAR TRANSPORT;GO:0032388;169;-1.3009305;0.054616384;0.21674848
GO BP;POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001022;80;-1.3005505;0.09361702;0.21696118
GO BP;REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001020;183;-1.3000901;0.048447207;0.21741377
GO BP;REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;216;-1.2996641;0.034146342;0.21784404
GO BP;ORGANIC HYDROXY COMPOUND METABOLIC PROCESS;#N/A;344;-1.2992085;0.019790454;0.21832116
GO BP;POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071902;244;-1.2986562;0.036900368;0.21886548
GO BP;PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION;#N/A;227;-1.29816;0.04040404;0.21903218
GO BP;POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION;#N/A;82;-1.2982253;0.08163265;0.2191115
GO BP;GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE;GO:0061615;23;-1.2983378;0.14398734;0.21912843
GO BP;REGULATION OF EXECUTION PHASE OF APOPTOSIS;#N/A;21;-1.2976167;0.14046822;0.21927872
GO BP;REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045667;72;-1.2977318;0.09682081;0.2192814
GO BP;DETECTION OF MECHANICAL STIMULUS;GO:0050982;19;-1.2978348;0.1704918;0.21931665
GO BP;TYROSINE PHOSPHORYLATION OF STAT PROTEIN;GO:0007260;35;-1.297156;0.124223605;0.2195653
GO BP;MAMMARY GLAND DUCT MORPHOGENESIS;GO:0060603;19;-1.2970309;0.15231788;0.21956898
GO BP;CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION;GO:0086019;19;-1.2972493;0.13848631;0.2196066
GO BP;NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS;#N/A;110;-1.2967225;0.08551724;0.21982561
GO BP;CELLULAR RESPONSE TO STEROID HORMONE STIMULUS;GO:0071383;174;-1.2954663;0.04915912;0.22140773
GO BP;NEUROTRANSMITTER RECEPTOR TRANSPORT;#N/A;31;-1.2953287;0.13036565;0.22142448
GO BP;CELLULAR RESPONSE TO FATTY ACID;GO:0071398;29;-1.2939545;0.13270143;0.22316071
GO BP;AXO DENDRITIC TRANSPORT;GO:0008088;56;-1.293796;0.10656934;0.22321676
GO BP;GLUTAMATE SECRETION;GO:0014047;23;-1.2934718;0.14724919;0.22331986
GO BP;MATERNAL PLACENTA DEVELOPMENT;GO:0001893;28;-1.2934834;0.14402619;0.22347766
GO BP;COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION;#N/A;75;-1.2930775;0.105563484;0.22368057
GO BP;REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT;GO:1902305;43;-1.2922896;0.13561848;0.22460821
GO BP;REGULATION OF COAGULATION;#N/A;52;-1.2918407;0.11415525;0.22506733
GO BP;PROTEIN CONTAINING COMPLEX REMODELING;#N/A;19;-1.2915695;0.14434783;0.22524166
GO BP;RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;66;1.3869764;0.02431611;0.22526655
GO BP;REGULATION OF PHACYTOSIS;#N/A;48;1.3853145;0.057692308;0.22588046
GO BP;RESPONSE TO FATTY ACID;GO:0070542;48;-1.2908778;0.11702128;0.22605091
GO BP;REGULATION OF B CELL PROLIFERATION;GO:0030888;35;-1.2899442;0.109375;0.22651768
GO BP;NEGATIVE REGULATION OF INFLAMMATORY RESPONSE;GO:0050728;76;-1.2899998;0.076358296;0.22661537
GO BP;PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;123;-1.2902286;0.07180851;0.22662908
GO BP;PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION;#N/A;36;-1.2903434;0.14263323;0.22662956
GO BP;CARDIAC SEPTUM MORPHOGENESIS;GO:0060411;53;-1.290038;0.10339943;0.22672656
GO BP;COGNITION;GO:0050890;161;-1.2894173;0.053177692;0.22703871
GO BP;CELL CELL SIGNALING BY WNT;GO:0198738;381;-1.2892442;0.022067364;0.227109
GO BP;RESPONSE TO ANTINEOPLASTIC AGENT;#N/A;75;-1.2890406;0.10504202;0.227235
GO BP;NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING;#N/A;30;-1.2885822;0.14126985;0.22735937
GO BP;MONONUCLEAR CELL DIFFERENTIATION;#N/A;20;-1.288805;0.14308426;0.22742727
GO BP;TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;GO:0007178;223;-1.2886564;0.03349876;0.22743751
GO BP;NEURON DEATH;GO:0070997;242;-1.2881318;0.036432162;0.22784492
GO BP;POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051155;29;-1.2878679;0.13858268;0.22807786
GO BP;NEGATIVE REGULATION OF DNA REPAIR;#N/A;28;-1.2875602;0.1255814;0.2281565
KEGG;APOPTOSIS;;61;-1.3497028;0.062407132;0.22822262
GO BP;PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS;#N/A;26;-1.2875885;0.12676056;0.22830257
GO BP;FEMALE GAMETE GENERATION;GO:0007292;85;-1.2871556;0.09272468;0.2283703
GO BP;STEROID BIOSYNTHETIC PROCESS;GO:0006694;143;-1.2872629;0.06357616;0.22838275
GO BP;ORGANIC ACID TRANSMEMBRANE TRANSPORT;GO:1903825;92;-1.2869691;0.09490085;0.2284665
GO BP;REGULATION OF SECRETION;GO:0051046;450;-1.2859664;0.016629713;0.22906098
GO BP;MAST CELL MEDIATED IMMUNITY;GO:0002448;31;-1.2863375;0.1527559;0.2290625
GO BP;RETROGRADE VESICLE MEDIATED TRANSPORT LGI TO ENDOPLASMIC RETICULUM;#N/A;78;-1.2861341;0.09052925;0.22916237
GO BP;CALCINEURIN MEDIATED SIGNALING;GO:0097720;33;-1.2863812;0.15132606;0.22916372
GO BP;RECOMBINATIONAL REPAIR;GO:0000725;119;-1.2859759;0.0665742;0.22921887
GO BP;INTRACELLULAR STEROL TRANSPORT;GO:0032366;21;-1.2851863;0.15103339;0.22994287
GO BP;REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034121;41;-1.2850233;0.123880595;0.2300022
GO BP;NEUROTRANSMITTER BIOSYNTHETIC PROCESS;GO:0042136;54;-1.2844169;0.1146789;0.2303316
GO BP;GLYCEROLIPID METABOLIC PROCESS;GO:0046486;304;-1.2842293;0.03782506;0.23043287
GO BP;POSITIVE REGULATION OF TRANSPORTER ACTIVITY;GO:0032411;59;-1.2844498;0.10438729;0.23045744
GO BP;FEEDING BEHAVIOR;GO:0007631;31;-1.2844958;0.14374034;0.23057796
GO BP;REGULATION OF STEM CELL POPULATION MAINTENANCE;GO:2000036;26;-1.28329;0.14420062;0.23156556
GO BP;POSITIVE REGULATION OF CELL DIVISION;GO:0051781;46;-1.282949;0.14200298;0.231873
GO BP;FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS;#N/A;63;-1.2824728;0.117117114;0.23236695
GO BP;INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE;#N/A;42;-1.2821784;0.12361331;0.2326459
GO BP;MUSCLE ADAPTATION;#N/A;73;-1.2814107;0.12;0.23304386
GO BP;REGULATION OF PHOSPHOLIPASE C ACTIVITY;#N/A;18;-1.2817717;0.175;0.23304863
GO BP;SPROUTING ANGIOGENESIS;GO:0002040;76;-1.2816108;0.09843081;0.23310518
GO BP;ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS;#N/A;40;-1.2814288;0.1305638;0.2331966
GO BP;AMINO ACID TRANSMEMBRANE TRANSPORT;GO:0003333;50;-1.2809038;0.10612855;0.23358007
KEGG;SMALL CELL LUNG CANCER;;71;-1.341756;0.06497175;0.23410407
GO BP;RIG I SIGNALING PATHWAY;GO:0039529;15;-1.2802365;0.16422765;0.23438147
GO BP;ACTIVATED T CELL PROLIFERATION;GO:0050798;23;-1.279188;0.1627907;0.23573905
GO BP;REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION;#N/A;33;-1.2790319;0.1201849;0.23577952
GO BP;POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION;GO:0090277;57;-1.2785755;0.12005857;0.23606595
GO BP;SNARE COMPLEX ASSEMBLY;GO:0035493;17;-1.2786744;0.16134454;0.23610087
GO BP;NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC;GO:0045814;99;-1.2779083;0.07637907;0.23685989
GO BP;LYMPHOCYTE CHEMOTAXIS;GO:0048247;22;-1.2775187;0.15814696;0.23726498
GO BP;SISTER CHROMATID SEGREGATION;GO:0000819;167;-1.276967;0.057840616;0.2378518
GO BP;PODOSOME ASSEMBLY;GO:0071800;16;-1.275595;0.1706081;0.23966369
GO BP;RECEPTOR BIOSYNTHETIC PROCESS;#N/A;16;-1.2747233;0.16608997;0.24007758
GO BP;POSITIVE REGULATION OF CILIUM ASSEMBLY;GO:0045724;21;-1.2747685;0.16390729;0.24018934
GO BP;MEMBRANE PROTEIN PROTEOLYSIS;GO:0033619;43;-1.2744702;0.13441655;0.24025291
GO BP;POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION;GO:0001956;15;-1.2749579;0.1697479;0.24026136
GO BP;REGULATION OF KERATINOCYTE PROLIFERATION;GO:0010837;22;-1.2750679;0.16530278;0.24028715
GO BP;PROTEIN IMPORT;GO:0017038;153;-1.2743196;0.07225806;0.24029763
GO BP;CELL DIVISION;GO:0051301;492;-1.2747835;0.026845638;0.24034211
GO BP;SIGNAL RELEASE;GO:0023061;267;-1.2739266;0.042424243;0.2405295
GO BP;REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS;#N/A;16;-1.2739763;0.18791947;0.24063945
KEGG;INOSITOL PHOSPHATE METABOLISM;;49;-1.3333582;0.08108108;0.24096851
GO BP;POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION;GO:0045687;23;-1.2730093;0.17757009;0.24152552
GO BP;CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS;GO:0060351;30;-1.2728734;0.14927769;0.24154471
GO BP;REGULATION OF MYELINATION;GO:0031641;28;-1.2724317;0.16640253;0.24163698
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL;GO:0003044;20;-1.2722884;0.1663808;0.2416416
GO BP;DENDRITIC CELL DIFFERENTIATION;GO:0097028;16;-1.2725455;0.19211823;0.24165994
GO BP;KERATINOCYTE PROLIFERATION;GO:0043616;31;-1.2730298;0.14630225;0.24167116
GO BP;POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;#N/A;68;-1.2726531;0.11175617;0.24168171
GO BP;CELLULAR ION HOMEOSTASIS;GO:0006873;358;-1.2716899;0.032146957;0.24213925
GO BP;PROTEIN LOCALIZATION TO CILIUM;GO:0061512;45;-1.271797;0.12946428;0.24216996
GO BP;REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;36;-1.271457;0.1267388;0.24230869
GO BP;REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS;#N/A;98;-1.271228;0.10481586;0.24246606
GO BP;REGULATION OF GLUCOSE METABOLIC PROCESS;GO:0010906;87;-1.2710826;0.09873061;0.2424885
GO BP;POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT;#N/A;22;-1.2706517;0.15296052;0.24296257
GO BP;NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;#N/A;35;-1.2701423;0.14710484;0.2431642
GO BP;ACTIN POLYMERIZATION OR DEPOLYMERIZATION;GO:0008154;147;-1.2701509;0.07522698;0.24333209
GO BP;PEPTIDE SECRETION;GO:0002790;352;-1.2701913;0.035796765;0.24344723
GO BP;CIRCADIAN RHYTHM;GO:0007623;138;-1.2696288;0.06836461;0.24375479
GO BP;PROTEIN LOCALIZATION TO LGI APPARATUS;#N/A;24;-1.2690463;0.16071428;0.24412397
GO BP;PROTEIN TARGETING TO LYSOSOME;GO:0006622;20;-1.268938;0.15682968;0.24412984
GO BP;ERYTHROCYTE HOMEOSTASIS;GO:0034101;95;-1.2692285;0.09581646;0.24420588
GO BP;TOXIN TRANSPORT;GO:1901998;33;-1.269093;0.14420062;0.24423926
GO BP;REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000278;90;-1.2685583;0.10795455;0.24452062
GO BP;CELLULAR RESPONSE TO INSULIN STIMULUS;GO:0032869;167;-1.2681664;0.07470511;0.24493368
GO BP;ORGANIC ANION TRANSPORT;GO:0015711;308;-1.2677851;0.03452381;0.24495211
GO BP;POSITIVE REGULATION OF MUSCLE HYPERTROPHY;#N/A;21;-1.2678492;0.14876033;0.24503273
GO BP;AUTONOMIC NERVOUS SYSTEM DEVELOPMENT;GO:0048483;24;-1.2675253;0.1328;0.2450351
GO BP;NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS;GO:0120163;34;-1.2672062;0.14649682;0.24515982
GO BP;MUSCLE HYPERTROPHY;GO:0014896;61;-1.2675451;0.12298682;0.24518421
GO BP;NEPHRON EPITHELIUM DEVELOPMENT;#N/A;57;-1.2678723;0.13233082;0.24518934
GO BP;MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS;GO:1902850;123;-1.2672617;0.080729164;0.24524936
GO BP;REGULATION OF LEUKOCYTE DEGRANULATION;#N/A;29;-1.2669815;0.15227629;0.2453056
GO BP;REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE;#N/A;16;-1.2663319;0.1632;0.24601983
GO BP;CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION;#N/A;93;-1.2654363;0.0982906;0.2466036
GO BP;GLUCOCORTICOID METABOLIC PROCESS;GO:0008211;16;-1.2652638;0.17447495;0.24667728
GO BP;RESPONSE TO TEMPERATURE STIMULUS;GO:0009266;175;-1.2655053;0.05859375;0.24667962
GO BP;SELECTIVE AUTOPHAGY;GO:0061912;45;-1.2656244;0.14463453;0.24670228
GO BP;NUCLEAR CHROMOSOME SEGREGATION;GO:0098813;225;-1.2657144;0.05700124;0.24675258
GO BP;ALCOHOL CATABOLIC PROCESS;#N/A;35;-1.2650528;0.15748031;0.24680561
GO BP;RESPONSE TO SALT STRESS;GO:0009651;17;-1.2645537;0.17045455;0.24736883
GO BP;DECIDUALIZATION;GO:0046697;17;-1.2639053;0.19931857;0.24816093
GO BP;REGULATION OF VACUOLE ORGANIZATION;GO:0044088;42;-1.2636297;0.14053254;0.2483915
GO BP;POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT;GO:0040019;26;-1.263462;0.16536662;0.2484473
GO BP;CELLULAR RESPONSE TO BIOTIC STIMULUS;#N/A;136;-1.2630639;0.08141112;0.24884127
GO BP;LUNG MORPHOGENESIS;GO:0060425;33;-1.2629298;0.124423966;0.24887417
GO BP;RESPONSE TO CALCIUM ION;GO:0051592;88;-1.2623814;0.11189802;0.24900757
GO BP;RESPONSE TO METAL ION;GO:0010038;238;-1.2625763;0.057953145;0.24906673
GO BP;REGULATION OF PEPTIDASE ACTIVITY;GO:0052547;266;-1.2626534;0.0498132;0.24912533
GO BP;RESPONSE TO AXON INJURY;GO:0048678;52;-1.262414;0.1173913;0.24912938
GO BP;CELL VOLUME HOMEOSTASIS;GO:0006884;19;-1.2620698;0.19435216;0.24929248
GO BP;NON RECOMBINATIONAL REPAIR;GO:0000726;79;-1.2617862;0.094233476;0.24954817
GO BP;POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION;GO:1902745;24;-1.261591;0.18597063;0.24968038
GO BP;CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR;GO:0042994;15;-1.261452;0.19141914;0.24970484
GO BP;ALCOHOL BIOSYNTHETIC PROCESS;#N/A;126;-1.2612898;0.08990318;0.24977565
GO BP;DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE;GO:0042769;36;1.3674155;0.051575933;0.24984434
GO BP;REGULATION OF FATTY ACID OXIDATION;GO:0046320;23;-1.2605978;0.17580645;0.25069132
GO BP;RESPONSE TO STEROID HORMONE;GO:0048545;255;-1.2602333;0.04704463;0.25069296
GO BP;GASTRULATION WITH MOUTH FORMING SECOND;GO:0001702;24;-1.2604505;0.15136877;0.2507175
GO BP;RESPONSE TO LEUKEMIA INHIBITORY FACTOR;GO:1990823;78;-1.2603267;0.101865135;0.25073394
GO BP;ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007193;23;-1.2598264;0.16306156;0.2511049
GO BP;CELLULAR RESPONSE TO CAMP;GO:0071320;31;-1.2595686;0.16746412;0.25130653
GO BP;ALPHA AMINO ACID METABOLIC PROCESS;GO:1901605;150;-1.2588503;0.085051544;0.25224417
GO BP;REGULATION OF BODY FLUID LEVELS;GO:0050878;307;-1.2585657;0.050179213;0.25251457
GO BP;REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY;GO:0060765;22;-1.2583497;0.15955766;0.25267822
GO BP;FOREBRAIN CELL MIGRATION;GO:0021885;36;-1.2569748;0.16207455;0.2545683
GO BP;NEURONAL STEM CELL POPULATION MAINTENANCE;GO:0097150;19;-1.2564275;0.18290599;0.2552051
GO BP;FAT SOLUBLE VITAMIN METABOLIC PROCESS;#N/A;20;-1.2552747;0.18885449;0.2567255
GO BP;3 UTR MEDIATED MRNA STABILIZATION;#N/A;16;-1.2550433;0.1875;0.25689566
GO BP;NUCLEOBASE CONTAINING COMPOUND TRANSPORT;#N/A;213;-1.2540433;0.06443618;0.25828916
GO BP;SENSORY PERCEPTION;GO:0007600;235;-1.2535207;0.06119951;0.25892907
GO BP;REGULATION OF NUCLEASE ACTIVITY;#N/A;17;1.360027;0.09313726;0.25946623
GO BP;REGULATION OF PROTEIN DEACETYLATION;GO:0090311;34;-1.25284;0.14992025;0.2595998
GO BP;POSITIVE REGULATION OF HISTONE DEACETYLATION;GO:0031065;15;-1.2529352;0.20315236;0.25965
GO BP;CELL MATURATION;GO:0048469;92;-1.252643;0.12792297;0.2597402
KEGG;NICOTINATE AND NICOTINAMIDE METABOLISM;;21;-1.3182364;0.14054927;0.25982493
GO BP;CELL CHEMOTAXIS;GO:0060326;135;-1.2522829;0.104575165;0.26013792
GO BP;NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION;GO:0050805;36;-1.2516737;0.1796875;0.26054677
GO BP;HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES;GO:0007156;50;-1.2517655;0.13157895;0.26059747
GO BP;POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS;GO:0060760;32;-1.2518119;0.14375988;0.26070428
GO BP;POSITIVE REGULATION OF BONE MINERALIZATION;GO:0030501;22;-1.250515;0.19318181;0.2621835
GO BP;METANEPHROS MORPHOGENESIS;GO:0003338;16;-1.2498808;0.18760195;0.26300398
GO BP;RESPONSE TO MORPHINE;GO:0043278;15;-1.2496853;0.19463088;0.26310143
GO BP;HORMONE METABOLIC PROCESS;GO:0042445;119;-1.2492596;0.097693354;0.26343137
GO BP;KIDNEY MORPHOGENESIS;GO:0060993;49;-1.2492833;0.13617021;0.26357388
GO BP;STEM CELL DIVISION;GO:0017145;32;-1.2482724;0.16207455;0.26468793
GO BP;STRIATED MUSCLE CELL APOPTOTIC PROCESS;#N/A;27;-1.2481478;0.1696;0.26470813
GO BP;NEGATIVE REGULATION OF PROTEOLYSIS;GO:0045861;208;-1.247608;0.06265664;0.2650136
GO BP;CHONDROCYTE DEVELOPMENT;GO:0002063;28;-1.2478033;0.168239;0.26506853
GO BP;POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION;GO:2000758;25;-1.2476549;0.16666667;0.26511076
GO BP;NEURAL RETINA DEVELOPMENT;GO:0003407;37;-1.2470826;0.15197569;0.2654336
GO BP;NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER;GO:0097756;35;-1.2470863;0.17412141;0.2656095
GO BP;POSTSYNAPTIC SPECIALIZATION ORGANIZATION;#N/A;16;-1.2463292;0.18791947;0.26639655
GO BP;POSITIVE REGULATION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION;#N/A;23;-1.2461625;0.1968;0.2664802
GO BP;CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS;#N/A;21;-1.245674;0.1923077;0.26711756
GO BP;POSITIVE REGULATION OF LIPID CATABOLIC PROCESS;GO:0050996;15;-1.2453684;0.19897959;0.26742584
GO BP;REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS;GO:2000300;42;-1.2442834;0.16515152;0.2689477
GO BP;COAGULATION;#N/A;207;-1.2440758;0.076030925;0.26909262
GO BP;AMINO ACID IMPORT;#N/A;15;-1.2436765;0.17935702;0.26913312
GO BP;HEART GROWTH;#N/A;53;-1.2438645;0.15407854;0.26922587
GO BP;REGULATION OF LIPID KINASE ACTIVITY;GO:0043550;43;-1.2437265;0.15692307;0.26924837
GO BP;REGULATION OF RESPONSE TO CYTOKINE STIMULUS;#N/A;114;-1.2427297;0.10249308;0.27043888
GO BP;POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS;GO:0035774;22;-1.2425854;0.1842546;0.27050593
GO BP;COMPLEMENT ACTIVATION;GO:0006956;24;1.3516347;0.100271;0.27059245
GO BP;REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOUS END JOINING;#N/A;17;-1.2413242;0.19516407;0.27235618
GO BP;PROTEIN LOCALIZATION TO ENDOSOME;GO:0036010;24;-1.2410057;0.18488745;0.2726732
GO BP;P38MAPK CASCADE;GO:0038066;34;-1.2404422;0.16843702;0.27338025
GO BP;NEURON APOPTOTIC PROCESS;GO:0051402;165;-1.239982;0.093023255;0.27393416
GO BP;RESPONSE TO CAMP;GO:0051591;60;-1.2391948;0.12790698;0.27496907
GO BP;MYOBLAST FUSION;GO:0007520;19;-1.2390752;0.18316832;0.27497268
GO BP;NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;#N/A;18;1.3475205;0.12169312;0.27523497
GO BP;FC EPSILON RECEPTOR SIGNALING PATHWAY;GO:0038095;91;1.3460113;0.046979867;0.27577084
KEGG;DILATED CARDIOMYOPATHY;;49;-1.2957892;0.11844078;0.27729076
KEGG;HEDGEHOG SIGNALING PATHWAY;;32;-1.2995238;0.13578275;0.27741256
GO BP;RESPONSE TO AMYLOID BETA;GO:1904645;25;-1.2371608;0.19376026;0.27793056
GO BP;POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS;GO:0043525;45;-1.2368804;0.15718563;0.27818692
GO BP;REGULATION OF FILOPODIUM ASSEMBLY;GO:0051489;38;-1.2363544;0.147929;0.27882946
GO BP;REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS;#N/A;177;-1.2360543;0.089147285;0.27915528
GO BP;POSITIVE REGULATION OF CELL DEATH;GO:0010942;498;-1.2356365;0.032474805;0.2796313
GO BP;REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE;GO:0060688;29;-1.2352059;0.19575115;0.28016847
GO BP;REGULATION OF CARDIOCYTE DIFFERENTIATION;#N/A;35;-1.2350405;0.1746988;0.280227
GO BP;REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY;#N/A;26;-1.2338128;0.16915423;0.2812854
GO BP;REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050730;150;-1.2338635;0.09908735;0.28138065
GO BP;REGULATION OF HOMOTYPIC CELL CELL ADHESION;#N/A;18;-1.234201;0.18573798;0.28140306
GO BP;DEVELOPMENTAL INDUCTION;#N/A;16;-1.2339109;0.21052632;0.28149253
GO BP;REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT;GO:1901379;37;-1.2339438;0.19694656;0.2816156
GO BP;LGI TO PLASMA MEMBRANE TRANSPORT;#N/A;57;-1.2331799;0.15336463;0.2817554
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION;GO:0045620;30;-1.2332438;0.1719243;0.28184035
GO BP;RHYTHMIC PROCESS;GO:0048511;190;-1.2333413;0.09565217;0.28187862
KEGG;BLADDER CANCER;;36;-1.3003399;0.12111801;0.28249615
GO BP;LAMELLIPODIUM MORPHOGENESIS;GO:0072673;15;-1.2321655;0.19178082;0.2829852
GO BP;POSITIVE REGULATION OF PROTEIN DEACETYLATION;GO:0090312;18;-1.232269;0.18811882;0.28300864
GO BP;RESPONSE TO CARBOHYDRATE;GO:0009743;160;-1.2318417;0.099871956;0.28333238
GO BP;MITOTIC NUCLEAR DIVISION;GO:0140014;232;-1.2317176;0.072704084;0.28335053
GO BP;POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000573;57;-1.2313317;0.13549337;0.28379062
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:1902253;26;1.3393344;0.08988764;0.2845928
GO BP;MECHANORECEPTOR DIFFERENTIATION;GO:0042490;40;-1.2300173;0.16488549;0.28535616
GO BP;ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007189;42;-1.2301227;0.17160687;0.28537828
GO BP;MITOCHONDRION LOCALIZATION;GO:0051646;38;-1.2301455;0.16297469;0.28554285
GO BP;NEPHRON MORPHOGENESIS;GO:0072028;41;-1.2297541;0.16949153;0.28561628
GO BP;INTERFERON BETA PRODUCTION;GO:0032608;39;-1.2295231;0.1578125;0.2857741
GO BP;ANION TRANSPORT;GO:0006820;384;-1.2282952;0.053056516;0.2877274
GO BP;RESPONSE TO NICOTINE;GO:0035094;24;-1.2281678;0.18668832;0.28776821
GO BP;REGULATION OF MUSCLE ORGAN DEVELOPMENT;GO:0048634;82;-1.2278787;0.14;0.28786156
GO BP;AMINO ACID TRANSPORT;GO:0006865;83;-1.2279139;0.13848397;0.28799233
KEGG;PHOSPHATIDYLINOSITOL SIGNALING SYSTEM;;62;-1.282082;0.1161103;0.28833717
GO BP;DNA REPLICATION;GO:0006260;242;-1.2272588;0.07701711;0.2887009
GO BP;HYDROGEN PEROXIDE METABOLIC PROCESS;GO:0042743;30;-1.2269427;0.18512659;0.28900564
GO BP;RESPONSE TO XENOBIOTIC STIMULUS;GO:0009410;158;-1.2259969;0.10709505;0.28965983
GO BP;POSITIVE REGULATION OF LEUKOCYTE MIGRATION;GO:0002687;69;-1.226064;0.15977176;0.28972173
GO BP;INORGANIC ANION TRANSMEMBRANE TRANSPORT;#N/A;63;-1.2263564;0.16176471;0.2898113
GO BP;RESPONSE TO ATP;GO:0033198;16;-1.2261121;0.23076923;0.28982896
GO BP;NEGATIVE REGULATION OF SECRETION;GO:0051048;111;-1.2262127;0.12881806;0.2898616
GO BP;LOCALIZATION WITHIN MEMBRANE;GO:0051668;61;-1.2254366;0.15703703;0.29018164
GO BP;CARDIAC ATRIUM DEVELOPMENT;#N/A;22;-1.2255135;0.18962723;0.29024398
KEGG;PENTOSE PHOSPHATE PATHWAY;;22;-1.2844689;0.14634146;0.29040653
GO BP;RENAL TUBULE DEVELOPMENT;GO:0061326;52;-1.2251996;0.17424242;0.2904104
GO BP;ARACHIDONIC ACID SECRETION;GO:0050482;15;1.334316;0.12776412;0.29111597
GO BP;REGULATION OF STEM CELL PROLIFERATION;GO:0072091;43;-1.224653;0.1694153;0.29113343
GO BP;PHOSPHATIDIC ACID METABOLIC PROCESS;GO:0046473;29;-1.224468;0.18466353;0.2912463
GO BP;CELLULAR CARBOHYDRATE CATABOLIC PROCESS;#N/A;36;-1.2239071;0.184375;0.29199553
GO BP;POSITIVE REGULATION OF STEROL TRANSPORT;#N/A;18;-1.2234553;0.1959799;0.29256868
GO BP;SEMI LUNAR VALVE DEVELOPMENT;GO:1905314;25;-1.222133;0.1816694;0.29344404
GO BP;DNA TEMPLATED TRANSCRIPTION INITIATION;GO:0006352;199;-1.2225462;0.08196721;0.293527
GO BP;REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION;#N/A;26;-1.2221879;0.18611987;0.29353818
GO BP;LEUKOCYTE APOPTOTIC PROCESS;#N/A;66;-1.222282;0.1491228;0.2935661
GO BP;POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY;GO:0031334;182;-1.222605;0.10545906;0.2936257
GO BP;PURINE NUCLEOSIDE METABOLIC PROCESS;GO:0042278;52;-1.2226889;0.16272189;0.29367423
GO BP;ADULT BEHAVIOR;GO:0030534;74;-1.2218386;0.12820514;0.29372564
GO BP;CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION;GO:0021799;20;-1.2223011;0.23404256;0.29373235
GO BP;CELLULAR RESPONSE TO EXTERNAL STIMULUS;#N/A;242;-1.221618;0.09241706;0.29390982
GO BP;EPIDERMIS MORPHOGENESIS;GO:0048730;16;-1.2205557;0.19166666;0.2943178
GO BP;MYELOID CELL HOMEOSTASIS;GO:0002262;112;-1.2210983;0.13286713;0.29436946
GO BP;NEGATIVE REGULATION OF DEFENSE RESPONSE;#N/A;119;-1.2207476;0.123159304;0.2943761
GO BP;CELLULAR CARBOHYDRATE METABOLIC PROCESS;GO:0044262;207;-1.220856;0.10526316;0.2943966
GO BP;REGULATION OF HISTONE DEACETYLATION;GO:0031063;22;-1.2205806;0.21587302;0.29446742
GO BP;POSITIVE REGULATION OF FIBROBLAST PROLIFERATION;GO:0048146;37;-1.2211394;0.16744915;0.29451028
GO BP;REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY;GO:0043666;91;-1.2208956;0.13636364;0.29451686
GO BP;REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;#N/A;146;-1.2199538;0.11703511;0.29514432
GO BP;REGULATION OF NUCLEAR DIVISION;#N/A;151;-1.2196026;0.12403101;0.29554546
GO BP;ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS;GO:0002460;127;-1.2194511;0.12722299;0.29561794
KEGG;GLYCOSAMINOGLYCAN DEGRADATION;;16;-1.2741252;0.17880794;0.29568997
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC;GO:0000291;35;1.3301898;0.0989011;0.29607067
GO BP;INTEGRIN MEDIATED SIGNALING PATHWAY;GO:0007229;73;-1.2189971;0.14878398;0.29616052
GO BP;RESPONSE TO ACTIVITY;GO:0014823;44;1.3287562;0.08955224;0.29658318
GO BP;BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS;GO:0060444;16;-1.2185519;0.22091062;0.29672152
GO BP;REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM;GO:0070861;21;1.3261625;0.11878453;0.29682457
GO BP;POSITIVE REGULATION OF ION TRANSPORT;GO:0043270;131;-1.2182128;0.1025974;0.297152
GO BP;RNA 5 END PROCESSING;#N/A;18;1.3271179;0.12432432;0.29727775
GO BP;POSITIVE REGULATION OF MITOTIC CELL CYCLE;GO:0045931;126;-1.2177536;0.12732096;0.2977462
GO BP;POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS;#N/A;85;-1.2174736;0.14992929;0.29800248
GO BP;PROTEIN CONTAINING COMPLEX LOCALIZATION;GO:0031503;243;-1.2165283;0.074788906;0.29938152
GO BP;NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT;GO:0034763;66;-1.2163352;0.1612426;0.29950428
GO BP;PEPTIDYL THREONINE MODIFICATION;#N/A;95;-1.2161369;0.12962963;0.2996196
GO BP;REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;#N/A;39;-1.2158339;0.16846986;0.2999175
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSPORT;GO:0051928;59;-1.2155414;0.15835777;0.3000371
GO BP;NEGATIVE REGULATION OF TOR SIGNALING;GO:0032007;37;-1.215547;0.19178082;0.30022016
GO BP;REGULATION OF CHROMATIN BINDING;#N/A;19;-1.2153207;0.22818792;0.30022877
GO BP;ESTABLISHMENT OF RNA LOCALIZATION;#N/A;178;-1.2151386;0.11111111;0.30032387
GO BP;REGULATION OF WNT SIGNALING PATHWAY;GO:0030111;268;-1.2150166;0.07526882;0.3003604
GO BP;MICROTUBULE ANCHORING;GO:0034453;24;-1.2134614;0.2166405;0.3027834
GO BP;COENZYME METABOLIC PROCESS;#N/A;209;-1.2128626;0.09823678;0.3032406
GO BP;CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS;#N/A;21;-1.2129214;0.21869783;0.3033393
GO BP;REGULATION OF NEUROTRANSMITTER TRANSPORT;#N/A;76;-1.2129745;0.15429403;0.30342272
GO BP;LYMPHOCYTE APOPTOTIC PROCESS;#N/A;47;-1.2123634;0.1784108;0.3036692
GO BP;SYNAPSIS;GO:0007129;34;-1.2124741;0.19255663;0.3036999
GO BP;ACTIN FILAMENT POLYMERIZATION;GO:0030041;129;-1.2118074;0.12601626;0.3039844
GO BP;POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION;GO:1903599;18;-1.2118937;0.2;0.3040359
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE;GO:0032205;33;-1.212003;0.18408737;0.3040547
GO BP;CELLULAR RESPONSE TO STARVATION;GO:0009267;120;-1.2114052;0.13506493;0.30408952
GO BP;RESPONSE TO ORGANOPHOSPHORUS;GO:0046683;79;-1.2115848;0.14245014;0.3041615
GO BP;NEGATIVE REGULATION OF GTPASE ACTIVITY;GO:0034260;38;-1.211455;0.19701493;0.30419922
GO BP;POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0090316;126;-1.2108755;0.12466488;0.3042272
GO BP;NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2000117;63;-1.2109646;0.16494845;0.304255
GO BP;CELLULAR RESPONSE TO OSMOTIC STRESS;GO:0071470;30;-1.2111611;0.19551282;0.30430698
GO BP;RESPONSE TO INCREASED OXYGEN LEVELS;#N/A;24;-1.2110344;0.21269841;0.30433068
GO BP;REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS;GO:0045540;41;-1.2103674;0.18282989;0.30490968
GO BP;RESPONSE TO FUNGUS;GO:0009620;18;-1.2098516;0.21938775;0.3053657
GO BP;SPECIFICATION OF ANIMAL ORGAN IDENTITY;GO:0010092;18;-1.2099302;0.20701168;0.3054245
GO BP;DEFENSE RESPONSE TO VIRUS;GO:0051607;146;-1.2087865;0.12165775;0.30546153
GO BP;REGULATION OF PROTEOLYSIS;GO:0030162;490;-1.2087936;0.06497797;0.3056484
GO BP;POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS;GO:1903020;15;-1.2094309;0.23604466;0.30572137
GO BP;REGULATION OF CIRCADIAN RHYTHM;GO:0042752;78;-1.2095261;0.16239317;0.3057429
GO BP;POSITIVE REGULATION OF CELL CYCLE;GO:0045787;296;-1.2087955;0.08439306;0.30583948
GO BP;SENSORY PERCEPTION OF PAIN;GO:0019233;41;-1.2079848;0.19418961;0.3058598
GO BP;CHROMOSOME LOCALIZATION;#N/A;68;-1.2080725;0.16302766;0.30591372
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:1902041;43;-1.2088548;0.18759018;0.30593908
GO BP;REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;#N/A;48;-1.208155;0.19667171;0.30595878
GO BP;POLYOL CATABOLIC PROCESS;#N/A;22;-1.2089275;0.20476191;0.30599445
GO BP;IMPORT ACROSS PLASMA MEMBRANE;GO:0098739;66;-1.2083753;0.16981132;0.30599722
GO BP;REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS;GO:0070228;33;-1.2077892;0.18838304;0.3060215
GO BP;MONOAMINE TRANSPORT;GO:0015844;33;-1.2076479;0.19629057;0.30606437
GO BP;OOCYTE MATURATION;GO:0001556;17;-1.2089732;0.20100503;0.3061143
GO BP;POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION;GO:0032757;26;-1.2081666;0.21928461;0.3061323
GO BP;INOSITOL PHOSPHATE METABOLIC PROCESS;GO:0043647;54;-1.2090006;0.18473282;0.3062585
GO BP;REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:0070201;499;-1.2073053;0.062569834;0.30627856
GO BP;REGULATION OF CENTROSOME CYCLE;GO:0046605;53;-1.2074043;0.17814371;0.30628693
GO BP;POSITIVE REGULATION OF HEART CONTRACTION;GO:0045823;21;-1.205937;0.21702838;0.3080764
GO BP;HISTONE MONOUBIQUITINATION;GO:0010390;28;-1.2060208;0.21009772;0.30812502
GO BP;POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION;GO:0043923;16;-1.2060671;0.23176661;0.30825046
GO BP;PEPTIDYL SERINE DEPHOSPHORYLATION;GO:0070262;15;-1.2057023;0.21921922;0.30827633
GO BP;POSITIVE REGULATION OF OSSIFICATION;GO:0045778;55;-1.2054378;0.17804155;0.30837336
GO BP;REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:1901019;46;-1.205538;0.20543806;0.30838767
GO BP;RESPONSE TO INTERLEUKIN 12;GO:0070671;37;1.3183504;0.10526316;0.3084071
GO BP;POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;47;-1.2052878;0.18099548;0.3084364
GO BP;REGULATION OF BLOOD PRESSURE;GO:0008217;86;-1.2044799;0.16078985;0.3096471
GO BP;REGULATION OF LIPID LOCALIZATION;#N/A;86;-1.2034225;0.16388889;0.311353
GO BP;ACTIN CYTOSKELETON REORGANIZATION;GO:0031532;80;-1.203303;0.16737589;0.31136364
GO BP;POLYOL METABOLIC PROCESS;#N/A;91;-1.203053;0.17059639;0.3115934
GO BP;REGULATION OF EXOCYTOSIS;GO:0017157;141;-1.20288;0.14058356;0.31167865
GO BP;L AMINO ACID TRANSPORT;GO:0015807;38;-1.2022059;0.17538461;0.3124445
GO BP;FATTY ACID TRANSMEMBRANE TRANSPORT;#N/A;18;-1.202292;0.23754153;0.31249446
GO BP;REGULATION OF REGULATED SECRETORY PATHWAY;GO:1903305;93;-1.201877;0.16309012;0.31285092
GO BP;DETECTION OF VISIBLE LIGHT;GO:0009584;24;1.3141664;0.1164557;0.313662
GO BP;REGULATION OF SODIUM ION TRANSPORT;GO:0002028;54;-1.2010058;0.17797889;0.31418172
GO BP;PLATELET AGGREGATION;GO:0070527;44;-1.200644;0.1867647;0.3146429
GO BP;CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT;#N/A;20;-1.2002927;0.19430485;0.3150603
GO BP;NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOUS RECOMBINATION;#N/A;16;-1.1996467;0.23489933;0.31602532
GO BP;EPITHELIAL CELL APOPTOTIC PROCESS;GO:1904019;69;-1.1979808;0.17360115;0.3187475
GO BP;REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH;#N/A;46;-1.1972339;0.16640253;0.31945124
GO BP;DNA BIOSYNTHETIC PROCESS;GO:0071897;160;-1.1972944;0.12755102;0.31955725
GO BP;POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;GO:1904894;37;-1.1973655;0.21711569;0.319627
GO BP;VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE;#N/A;85;-1.1968973;0.17846608;0.31965944
GO BP;REGULATION OF GENE SILENCING;#N/A;129;-1.1966505;0.12903225;0.31969532
GO BP;SKELETAL MUSCLE ORGAN DEVELOPMENT;GO:0060538;99;-1.1969347;0.14908579;0.3197833
GO BP;REGULATION OF AUTOPHASOME ASSEMBLY;#N/A;35;-1.1966534;0.21198156;0.31988916
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL;GO:0010524;21;-1.1962348;0.21405229;0.32005098
GO BP;AUTOPHAGY OF MITOCHONDRION;GO:0000422;65;-1.196324;0.17391305;0.3201007
KEGG;NON SMALL CELL LUNG CANCER;;47;-1.2498487;0.15558912;0.32082665
GO BP;STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE;GO:0031098;211;-1.1955142;0.13341646;0.32088262
GO BP;REGULATION OF BMP SIGNALING PATHWAY;GO:0030510;58;-1.1956149;0.19270073;0.32089743
KEGG;CALCIUM SIGNALING PATHWAY;;74;-1.253206;0.111265644;0.32091022
KEGG;GNRH SIGNALING PATHWAY;;67;1.213882;0.12012987;0.32128382
KEGG;PRION DISEASES;;21;-1.2562065;0.1767516;0.32141542
GO BP;POSITIVE REGULATION OF CYTOKINESIS;GO:0032467;25;-1.1947349;0.22015505;0.32201463
GO BP;RIBONUCLEOSIDE METABOLIC PROCESS;#N/A;52;-1.1945305;0.20895523;0.32218593
GO BP;MITOTIC RECOMBINATION;GO:0006312;20;-1.194326;0.23300971;0.3223367
GO BP;REGULATION OF SYNAPTIC VESICLE RECYCLING;#N/A;18;-1.1939188;0.24212272;0.32289353
GO BP;REGULATION OF LIPID TRANSPORT;#N/A;64;-1.1932986;0.18834081;0.32372463
GO BP;NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING;GO:0006297;22;1.3075298;0.12039312;0.32374448
GO BP;NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS;GO:0060761;38;-1.192813;0.19776714;0.32434556
GO BP;CARBOHYDRATE METABOLIC PROCESS;GO:0005975;441;-1.1921681;0.0731982;0.32532826
GO BP;TRNA PROCESSING;GO:0008033;115;1.3052138;0.05;0.32581604
GO BP;POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT;GO:0046824;56;-1.1916156;0.18475074;0.32612568
GO BP;CELLULAR RESPONSE TO DRUG;GO:0035690;257;-1.1911381;0.1104513;0.32661167
GO BP;RESPONSE TO ANTIBIOTIC;GO:0046677;216;-1.1911485;0.13693467;0.3268012
GO BP;REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC;GO:0032228;15;-1.1906143;0.24489796;0.3271726
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS;#N/A;484;-1.1907207;0.06808036;0.32718897
GO BP;REGULATION OF VASOCONSTRICTION;GO:0019229;22;-1.1901442;0.23809524;0.32774872
GO BP;REGULATION OF ANION TRANSMEMBRANE TRANSPORT;#N/A;18;-1.1900183;0.23887974;0.32775646
GO BP;ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS;#N/A;184;-1.1895608;0.1357868;0.32837024
GO BP;ANION HOMEOSTASIS;#N/A;39;-1.1893035;0.21692307;0.32858327
GO BP;COPII COATED VESICLE BUDDING;GO:0090114;61;1.2999022;0.0755287;0.32886854
GO BP;INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY;#N/A;79;1.3021592;0.06271777;0.32903105
GO BP;REGULATION OF TRANSLATIONAL ELONGATION;GO:0006448;17;1.3009161;0.15850815;0.32913643
GO BP;LIPID STORAGE;GO:0019915;50;-1.188183;0.19515885;0.3292017
GO BP;REGULATION OF NEURON PROJECTION REGENERATION;GO:0070570;22;-1.1880046;0.23139158;0.3293365
GO BP;MEIOTIC CELL CYCLE;GO:0051321;182;-1.1881841;0.12787724;0.32939968
GO BP;SPHINLIPID METABOLIC PROCESS;#N/A;121;-1.1885775;0.17514125;0.3295006
GO BP;CATION TRANSMEMBRANE TRANSPORT;GO:0098655;471;-1.1882098;0.085460596;0.3295576
GO BP;NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050849;18;-1.1886246;0.22537562;0.32960793
GO BP;POSITIVE REGULATION OF NUCLEAR DIVISION;#N/A;44;-1.1882359;0.20447761;0.3297127
GO BP;ENDOCHONDRAL BONE MORPHOGENESIS;GO:0060350;47;-1.1876532;0.2021773;0.32973635
GO BP;POSTSYNAPTIC SIGNAL TRANSDUCTION;#N/A;21;-1.1882768;0.22347267;0.32984078
GO BP;RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS;GO:0046390;152;-1.186914;0.13743456;0.3306836
GO BP;ORGANIC ACID TRANSPORT;#N/A;200;-1.1869407;0.12879708;0.3308357
GO BP;CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER;#N/A;23;-1.1866353;0.23275863;0.33099085
GO BP;GLAND MORPHOGENESIS;GO:0022612;73;-1.1859528;0.18715084;0.3320107
GO BP;REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III;GO:0006359;18;-1.1856049;0.23754153;0.33243123
GO BP;REGULATION OF PEPTIDE SECRETION;#N/A;275;-1.1846905;0.11497006;0.33388013
GO BP;GLYCOSPHINLIPID METABOLIC PROCESS;#N/A;51;-1.1836219;0.20933735;0.33539405
GO BP;REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS;GO:0099072;46;-1.1837016;0.21014492;0.33545953
GO BP;LGI TO PLASMA MEMBRANE PROTEIN TRANSPORT;#N/A;38;-1.1824362;0.24042879;0.33736297
GO BP;PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;17;-1.1820607;0.23817292;0.3378581
GO BP;PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;157;-1.1818976;0.16993465;0.33795443
GO BP;NEGATIVE REGULATION OF TRANSPORT;GO:0051051;277;-1.1809405;0.12731768;0.3389133
GO BP;REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL;GO:0051279;40;-1.1809806;0.21865444;0.33904287
GO BP;MESONEPHROS DEVELOPMENT;GO:0001823;55;-1.1810209;0.20147058;0.33917424
GO BP;AMMONIUM TRANSPORT;GO:0015696;46;-1.1811254;0.20787401;0.3391823
GO BP;NUCLEAR EXPORT;GO:0051168;184;-1.1803974;0.14249037;0.33931875
GO BP;REGULATION OF CARTILAGE DEVELOPMENT;GO:0061035;40;-1.1804236;0.24116744;0.3394701
GO BP;REGULATION OF ACTIN CYTOSKELETON REORGANIZATION;GO:2000249;28;-1.1805047;0.22748815;0.33951133
GO BP;PHOSPHOLIPID METABOLIC PROCESS;GO:0006644;330;-1.1798384;0.12139423;0.33997145
GO BP;POSITIVE REGULATION OF PROTEIN ACETYLATION;GO:1901985;33;-1.1791166;0.23394495;0.34003803
GO BP;ONE CARBON METABOLIC PROCESS;GO:0006730;21;-1.1792214;0.22875817;0.34006536
GO BP;NUCLEOSIDE CATABOLIC PROCESS;#N/A;19;-1.1798515;0.24418604;0.3401494
GO BP;ORGANELLE FISSION;GO:0048285;367;-1.1792842;0.1;0.34015626
GO BP;POSITIVE REGULATION OF POTASSIUM ION TRANSPORT;GO:0043268;18;-1.1789172;0.26484752;0.3401949
GO BP;NEGATIVE REGULATION OF LIPID LOCALIZATION;#N/A;30;-1.1787839;0.23831776;0.3402065
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION;GO:0030857;26;-1.1794603;0.23615634;0.34027848
GO BP;SUBSTRATE ADHESION DEPENDENT CELL SPREADING;GO:0034446;81;-1.1792939;0.18181819;0.34034052
GO BP;REGULATION OF VIRAL LIFE CYCLE;#N/A;101;-1.1795186;0.17793104;0.34038216
GO BP;POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION;GO:0032735;18;-1.17819;0.2545757;0.34093106
GO BP;RECEPTOR RECYCLING;GO:0001881;28;-1.1782917;0.23444976;0.34096345
GO BP;ADHERENS JUNCTION ORGANIZATION;GO:0034332;44;-1.1775432;0.22590837;0.34191424
GO BP;VENTRICULAR SYSTEM DEVELOPMENT;GO:0021591;21;-1.1771463;0.22061191;0.34205246
GO BP;FERTILIZATION;GO:0009566;86;-1.1773247;0.19945355;0.34213015
GO BP;DRUG CATABOLIC PROCESS;GO:0042737;74;-1.1771898;0.18644068;0.34218785
GO BP;REGULATION OF PROTEIN BINDING;GO:0043393;161;-1.1765157;0.17128463;0.34281197
GO BP;TRANSCRIPTION BY RNA POLYMERASE I;GO:0006360;58;-1.1765909;0.2096531;0.3428739
GO BP;AORTIC VALVE DEVELOPMENT;GO:0003176;22;-1.1760999;0.24794745;0.34334493
GO BP;POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;GO:2000108;16;-1.1751771;0.24161074;0.34486762
GO BP;CARBOHYDRATE DERIVATIVE TRANSPORT;#N/A;60;-1.175028;0.20028819;0.34493494
GO BP;VISUAL BEHAVIOR;GO:0007632;29;-1.174897;0.22380953;0.34497446
GO BP;SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS;#N/A;50;-1.1745896;0.22238806;0.34536767
GO BP;REGULATION OF CELLULAR RESPONSE TO DRUG;GO:2001038;22;-1.1741678;0.23909532;0.34598958
GO BP;INTERFERON ALPHA PRODUCTION;GO:0032607;19;-1.1738237;0.25;0.34643814
GO BP;MAMMARY GLAND MORPHOGENESIS;GO:0060443;27;-1.1735511;0.25040388;0.34676632
GO BP;POSITIVE REGULATION OF SPROUTING ANGIOGENESIS;GO:1903672;24;-1.173386;0.2711039;0.3468983
GO BP;REGULATION OF CARDIAC CONDUCTION;GO:1903779;38;-1.1728207;0.24104235;0.3477191
GO BP;RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;41;-1.1716214;0.23622048;0.34824595
GO BP;NUCLEAR TRANSPORT;GO:0051169;296;-1.1716608;0.14553991;0.34838182
GO BP;REGULATION OF SYNAPTIC VESICLE CYCLE;GO:0098693;64;-1.1716934;0.2062147;0.34853777
GO BP;TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY;GO:0007179;131;-1.1717784;0.15558511;0.34860778
GO BP;REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0042176;314;-1.171841;0.1216686;0.34869996
GO BP;ANGIOGENESIS INVOLVED IN WOUND HEALING;GO:0060055;15;-1.1718817;0.24418604;0.3488342
GO BP;REGULATION OF PHOSPHOLIPASE ACTIVITY;#N/A;36;-1.1719315;0.23311897;0.34895304
GO BP;BLASTOCYST GROWTH;GO:0001832;17;-1.1720144;0.267423;0.34899333
KEGG;T CELL RECEPTOR SIGNALING PATHWAY;;73;-1.2301786;0.14516129;0.35019892
GO BP;RECEPTOR INTERNALIZATION;GO:0031623;63;-1.170021;0.2137834;0.35102558
GO BP;REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0090199;39;1.2854422;0.11388889;0.35221636
GO BP;MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY;GO:0060135;42;-1.1692771;0.21677215;0.3522546
GO BP;RESPONSE TO IRON ION;GO:0010039;25;-1.1691686;0.25157234;0.35226142
GO BP;POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING;#N/A;24;-1.168249;0.23739837;0.3538085
GO BP;ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT;#N/A;26;1.2857201;0.11077844;0.35391605
GO BP;REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION;GO:0060390;19;-1.1680206;0.2731872;0.35405475
GO BP;POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION;GO:0032755;41;-1.1671278;0.24193548;0.35552642
GO BP;FIBROBLAST PROLIFERATION;#N/A;59;-1.1668649;0.22123894;0.35581774
GO BP;ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS;#N/A;39;-1.1657257;0.24772036;0.35779092
GO BP;MONOSACCHARIDE BIOSYNTHETIC PROCESS;#N/A;73;-1.1652875;0.22254336;0.35821736
GO BP;REGULATION OF VESICLE MEDIATED TRANSPORT;GO:0060627;369;-1.165363;0.115606934;0.3582918
GO BP;REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;#N/A;51;-1.1640813;0.23053892;0.36030513
GO BP;NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045638;54;-1.1630384;0.22720478;0.3610617
GO BP;LGI ORGANIZATION;#N/A;113;-1.1630657;0.18543956;0.36122426
GO BP;POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:1904951;299;-1.163482;0.13507108;0.36123925
GO BP;GENITALIA DEVELOPMENT;GO:0048806;30;-1.1631033;0.25407165;0.36136875
GO BP;REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904356;57;-1.1632012;0.22734027;0.361372
GO BP;PHOSPHATIDYLGLYCEROL METABOLIC PROCESS;GO:0046471;22;1.2797091;0.15447155;0.36138755
GO BP;REGULATION OF TISSUE REMODELING;GO:0034103;40;-1.1632217;0.23867069;0.3615463
GO BP;LENS MORPHOGENESIS IN CAMERA TYPE EYE;GO:0002089;17;-1.1624832;0.25042018;0.36188048
GO BP;POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;GO:1904031;28;-1.1623136;0.2504013;0.36200142
GO BP;REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035304;109;-1.1618577;0.20930232;0.36219662
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME;GO:0034502;81;-1.1619936;0.20113315;0.3623559
GO BP;LONG TERM SYNAPTIC DEPRESSION;GO:0060292;16;-1.1615607;0.28478965;0.36235598
GO BP;RNA LOCALIZATION;GO:0006403;211;-1.1618799;0.15589353;0.36236206
GO BP;RESPONSE TO GROWTH HORMONE;GO:0060416;23;-1.161639;0.26949152;0.36241096
GO BP;SIGNAL TRANSDUCTION INVOLVED IN CELLULAR RESPONSE TO AMMONIUM ION;#N/A;30;-1.161275;0.25;0.3627157
GO BP;NEGATIVE REGULATION OF EXOCYTOSIS;GO:0045920;18;-1.1607611;0.2909968;0.36322987
GO BP;NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS;GO:0010656;28;-1.1605852;0.2539432;0.36332443
GO BP;POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0045880;28;-1.1607935;0.25496182;0.363389
GO BP;INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS;GO:0035773;46;-1.1603556;0.23802613;0.36353853
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I;GO:0002474;73;1.2773087;0.088815786;0.363778
GO BP;SMALL MOLECULE CATABOLIC PROCESS;#N/A;329;-1.1600144;0.11812866;0.3639741
GO BP;NEGATIVE REGULATION OF CHEMOTAXIS;GO:0050922;34;1.27585;0.12672177;0.3644953
GO BP;REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002718;47;-1.1594343;0.23573573;0.36464733
GO BP;CELLULAR RESPONSE TO MECHANICAL STIMULUS;GO:0071260;58;-1.1592151;0.21947674;0.36466354
GO BP;CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS;GO:0003413;20;-1.1592938;0.26461038;0.36471146
GO BP;POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY;GO:0120034;81;-1.1594478;0.21059972;0.36482263
GO BP;REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;88;-1.1583245;0.21614227;0.36613414
GO BP;RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0001836;47;1.273321;0.09855072;0.36729324
GO BP;NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS;#N/A;219;-1.1574285;0.15900621;0.36763045
GO BP;REGULATION OF NEUROTRANSMITTER SECRETION;GO:0046928;59;-1.1567243;0.24042879;0.36856392
GO BP;NEGATIVE REGULATION OF CELL CELL ADHESION;GO:0022408;103;-1.15677;0.18838526;0.36870933
GO BP;ECTODERM DEVELOPMENT;GO:0007398;15;-1.1559379;0.2880259;0.3696433
GO BP;MULTI ORGANISM CELLULAR PROCESS;#N/A;32;-1.156039;0.23832528;0.3696542
GO BP;TRNA METHYLATION;GO:0030488;32;1.2685851;0.13043478;0.3701196
GO BP;CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS;GO:0071322;100;-1.1554062;0.20485175;0.37022293
GO BP;APOPTOTIC MITOCHONDRIAL CHANGES;GO:0008637;95;1.2707473;0.068100356;0.37023935
GO BP;REGULATION OF CHOLESTEROL METABOLIC PROCESS;GO:0090181;51;-1.155474;0.25386998;0.37030444
GO BP;NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903427;22;-1.154952;0.26751593;0.37063515
GO BP;TYPE I INTERFERON PRODUCTION;GO:0032606;101;-1.1550287;0.19669876;0.37069973
GO BP;INTERLEUKIN 6 PRODUCTION;GO:0032635;68;-1.1545067;0.23479491;0.37127817
GO BP;MITOCHONDRIAL TRANSCRIPTION;GO:0006390;15;1.2690754;0.17232376;0.37136605
GO BP;SENSORY PERCEPTION OF MECHANICAL STIMULUS;GO:0050954;85;-1.1538743;0.20641562;0.3720396
GO BP;MUCOPOLYSACCHARIDE METABOLIC PROCESS;#N/A;67;-1.1539587;0.20989506;0.3720883
GO BP;EXTRACELLULAR VESICLE BIOGENESIS;GO:0140112;19;1.2662977;0.16101696;0.37253705
GO BP;GENE SILENCING BY RNA;GO:0031047;157;-1.1534338;0.19473684;0.37266046
GO BP;BICARBONATE TRANSPORT;GO:0015701;25;-1.1531287;0.27941176;0.37282386
GO BP;FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY;GO:0002431;66;-1.1531932;0.23733719;0.3729245
GO BP;NEGATIVE REGULATION OF IMMUNE RESPONSE;GO:0050777;73;-1.1526357;0.24220963;0.37329274
GO BP;SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND;#N/A;45;-1.1527112;0.24667652;0.37336773
GO BP;REGULATION OF CHEMOTAXIS;GO:0050920;111;-1.1523935;0.23188406;0.37354216
GO BP;POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA;GO:0090200;26;1.2632428;0.15803815;0.37421724
GO BP;NEUROEPITHELIAL CELL DIFFERENTIATION;GO:0060563;35;-1.1515858;0.25846153;0.37467256
GO BP;INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION;GO:0060122;17;-1.1516604;0.26968175;0.37473306
GO BP;ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY;#N/A;37;-1.1513746;0.25581396;0.37489212
GO BP;PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA;#N/A;46;-1.1509253;0.25308642;0.37532037
GO BP;REGULATION OF COLLAGEN METABOLIC PROCESS;#N/A;26;-1.1510086;0.2576;0.37536296
GO BP;MALE MEIOTIC NUCLEAR DIVISION;GO:0007140;33;-1.1503662;0.27272728;0.3762078
GO BP;VIRAL BUDDING VIA HOST ESCRT COMPLEX;GO:0039702;20;1.2634184;0.1609756;0.37621078
GO BP;KERATINIZATION;GO:0031424;44;-1.1497314;0.25036818;0.37700406
GO BP;OUTFLOW TRACT SEPTUM MORPHOGENESIS;GO:0003148;18;-1.1498053;0.26994908;0.3770881
KEGG;CHEMOKINE SIGNALING PATHWAY;;101;-1.2121615;0.14973262;0.37742102
KEGG;NEUROTROPHIN SIGNALING PATHWAY;;100;-1.1910028;0.15086782;0.37793005
GO BP;GLYCOSYLCERAMIDE METABOLIC PROCESS;GO:0006677;15;-1.1491171;0.25880283;0.37797588
GO BP;PROTEIN PEPTIDYL PROLYL ISOMERIZATION;GO:0000413;33;1.260353;0.15957446;0.37809893
GO BP;SYNAPTONEMAL COMPLEX ORGANIZATION;GO:0070193;18;-1.148572;0.25827813;0.37834573
GO BP;RESPONSE TO MISFOLDED PROTEIN;GO:0051788;24;-1.1487983;0.25801283;0.37836325
GO BP;POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;41;-1.1485882;0.24770643;0.37853113
GO BP;MATURATION OF 5 8S RRNA;#N/A;26;1.2578706;0.1603261;0.37872243
GO BP;MONOSACCHARIDE METABOLIC PROCESS;GO:0005996;214;-1.1481805;0.18514007;0.37890688
GO BP;POSITIVE REGULATION OF CELL CYCLE PROCESS;GO:0090068;228;-1.147822;0.16242424;0.37940723
KEGG;DORSO VENTRAL AXIS FORMATION;;18;-1.1930673;0.2428115;0.38013354
GO BP;REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY;GO:0031664;17;1.2578765;0.155;0.38097867
GO BP;NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE;GO:0045824;27;-1.1468725;0.26272577;0.3810102
KEGG;MAPK SIGNALING PATHWAY;;181;-1.206549;0.11435832;0.38140976
KEGG;FC GAMMA R MEDIATED PHACYTOSIS;;73;-1.2028341;0.16738817;0.38165328
GO BP;REGULATION OF METALLOPEPTIDASE ACTIVITY;GO:1905048;16;-1.1462208;0.27243066;0.38187006
GO BP;POSITIVE REGULATION OF WOUND HEALING;GO:0090303;36;-1.1463143;0.25867507;0.3818935
GO BP;POSITIVE REGULATION OF SECRETION;GO:0051047;228;-1.1457273;0.1724138;0.38258076
GO BP;PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;GO:0002221;130;-1.1455266;0.1859558;0.38276294
KEGG;BASAL TRANSCRIPTION FACTORS;;28;1.1698587;0.22337662;0.38341066
GO BP;REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:1903076;73;-1.1447638;0.2300885;0.38401085
GO BP;CANONICAL WNT SIGNALING PATHWAY;GO:0060070;237;-1.1444551;0.19676214;0.38441
GO BP;NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY;#N/A;19;-1.1442354;0.2764613;0.38442212
GO BP;SMOOTH MUSCLE CELL DIFFERENTIATION;GO:0051145;35;-1.1443236;0.2539185;0.38443792
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001242;134;-1.1439952;0.21296297;0.3846597
KEGG;PROGESTERONE MEDIATED OOCYTE MATURATION;;69;-1.1939156;0.16964285;0.38502097
GO BP;POSITIVE REGULATION OF AUTOPHAGY;GO:0010508;102;-1.143277;0.2197183;0.38558418
GO BP;NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION;GO:2000515;15;-1.1433165;0.28114477;0.3857286
GO BP;NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;GO:0010801;16;-1.1430324;0.29373997;0.38584828
GO BP;ESTROGEN METABOLIC PROCESS;GO:0008210;16;-1.1427906;0.27090302;0.38609475
GO BP;INTESTINAL EPITHELIAL CELL DIFFERENTIATION;GO:0060575;15;-1.1425189;0.30375427;0.3862224
GO BP;ANATOMICAL STRUCTURE HOMEOSTASIS;#N/A;297;-1.1426109;0.15592028;0.38625333
GO BP;PROTEIN K11 LINKED UBIQUITINATION;GO:0070979;26;1.2530758;0.16372795;0.386438
GO BP;POLYSACCHARIDE METABOLIC PROCESS;#N/A;78;-1.1419902;0.23651452;0.3870625
KEGG;CYTOKINE CYTOKINE RECEPTOR INTERACTION;;75;-1.1960548;0.18103448;0.3877168
GO BP;RESPONSE TO STARVATION;GO:0042594;145;-1.1414157;0.2148541;0.38802764
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:0097193;237;-1.1413006;0.16463415;0.38804653
GO BP;CELLULAR GLUCOSE HOMEOSTASIS;GO:0001678;104;-1.1405072;0.21258742;0.38942212
GO BP;NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY;GO:2001234;174;-1.1402093;0.20833333;0.38962078
GO BP;TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:0010833;74;-1.1402211;0.2637681;0.3898107
GO BP;MICROTUBULE ORGANIZING CENTER LOCALIZATION;#N/A;28;-1.13965;0.28794992;0.3905324
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE;#N/A;15;-1.1395264;0.29222974;0.390578
GO BP;POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION;GO:2000144;20;-1.1392993;0.29666665;0.39079717
GO BP;GLYCEROLIPID BIOSYNTHETIC PROCESS;#N/A;201;-1.1386077;0.18988903;0.39153457
GO BP;RESPONSE TO ETHANOL;GO:0045471;76;-1.1386282;0.24752475;0.39171317
GO BP;ANDROGEN METABOLIC PROCESS;GO:0008209;16;-1.1386569;0.29593495;0.39188352
GO BP;REGULATION OF GLUCONEOGENESIS;GO:0006111;35;-1.1382924;0.26350245;0.3919177
GO BP;NEGATIVE REGULATION OF LIPID TRANSPORT;GO:0032369;20;-1.1378379;0.28145695;0.3919381
GO BP;REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055024;49;-1.138149;0.26745912;0.39198607
GO BP;POSITIVE REGULATION OF PROTEIN BINDING;GO:0032092;75;-1.1378417;0.24011299;0.39214888
GO BP;ACTIVATION OF PROTEIN KINASE ACTIVITY;GO:0032147;240;-1.1376035;0.19924812;0.3921928
GO BP;GRANULOCYTE DIFFERENTIATION;GO:0030851;19;-1.1378865;0.29725364;0.39227477
GO BP;REGULATION OF HEART MORPHOGENESIS;GO:2000826;25;-1.1366765;0.28384992;0.39359307
GO BP;AMINOGLYCAN BIOSYNTHETIC PROCESS;#N/A;69;-1.1367596;0.25591716;0.393655
GO BP;CATECHOLAMINE SECRETION;GO:0050432;21;-1.1363608;0.2840136;0.39379954
GO BP;INOSITOL PHOSPHATE CATABOLIC PROCESS;#N/A;15;-1.1364456;0.29516128;0.39385113
GO BP;POSITIVE REGULATION OF RNA SPLICING;GO:0033120;28;-1.1358342;0.2776886;0.39394394
GO BP;REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050848;58;-1.1358473;0.25947523;0.39413974
GO BP;REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;GO:1905475;138;-1.1355832;0.21773142;0.3942537
GO BP;REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY;GO:0032878;23;-1.135889;0.2909699;0.39428204
GO BP;ACIDIC AMINO ACID TRANSPORT;#N/A;37;-1.1359017;0.2690583;0.3944719
GO BP;POSITIVE REGULATION OF BINDING;GO:0051099;139;-1.1347218;0.21628839;0.3950106
GO BP;MONOCARBOXYLIC ACID TRANSPORT;GO:0015718;97;-1.1348095;0.23568575;0.39507696
GO BP;POSITIVE REGULATION OF FILOPODIUM ASSEMBLY;GO:0051491;23;-1.1349466;0.2848392;0.39525244
GO BP;NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT;GO:1901862;32;-1.1348174;0.28209192;0.3952825
GO BP;NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0042177;105;-1.1342305;0.24313186;0.39579403
GO BP;POSITIVE REGULATION OF TRANSLATION;GO:0045727;104;1.2473882;0.05498282;0.39631268
GO BP;RESPONSE TO UV;GO:0009411;116;-1.1337435;0.21825397;0.39653766
GO BP;KERATAN SULFATE METABOLIC PROCESS;GO:0042339;22;1.2461181;0.16377172;0.3968484
GO BP;POSITIVE REGULATION OF BMP SIGNALING PATHWAY;GO:0030513;25;-1.133299;0.27272728;0.3971778
GO BP;CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0060317;20;-1.133088;0.29356357;0.39736888
GO BP;REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051438;45;1.2446618;0.14195584;0.39773092
GO BP;CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS;GO:0031668;192;-1.1326586;0.21254802;0.39802995
GO BP;INTERACTION WITH SYMBIONT;GO:0051702;52;-1.1320196;0.27105665;0.39909697
GO BP;CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;458;-1.1311408;0.15401785;0.3993141
GO BP;MRNA TRANSPORT;GO:0051028;136;-1.1318007;0.22297297;0.39933386
GO BP;POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001244;47;1.2418609;0.15697674;0.39941627
GO BP;PROTEIN REFOLDING;GO:0042026;30;-1.1311704;0.2980456;0.3994751
GO BP;NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS;GO:2001021;69;-1.1312438;0.23376623;0.39955127
GO BP;B CELL HOMEOSTASIS;GO:0001782;20;-1.1314243;0.2879046;0.399649
GO BP;POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;#N/A;19;-1.1312879;0.2676282;0.39968336
GO BP;CELL CYCLE CHECKPOINT;#N/A;198;-1.1314987;0.20454545;0.3997357
GO BP;REGULATION OF SPHINLIPID BIOSYNTHETIC PROCESS;#N/A;16;-1.1305053;0.3003472;0.4003447
GO BP;NEGATIVE REGULATION OF MUSCLE HYPERTROPHY;#N/A;21;-1.1301798;0.31260505;0.40077302
GO BP;ACTIN NUCLEATION;GO:0045010;37;1.2419472;0.13445379;0.40153685
GO BP;REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE;#N/A;21;-1.1295738;0.30318257;0.40177444
GO BP;PROTEIN LOCALIZATION TO CELL SURFACE;GO:0034394;46;-1.1293296;0.2647504;0.402036
GO BP;NEGATIVE REGULATION OF ENDOCYTOSIS;GO:0045806;29;-1.129102;0.29153606;0.4022656
GO BP;REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002819;80;-1.1286116;0.25245443;0.40301642
GO BP;NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS;#N/A;213;-1.1283394;0.2113924;0.4033125
GO BP;NEUROTRANSMITTER METABOLIC PROCESS;GO:0042133;81;-1.1280084;0.25249642;0.4035287
GO BP;NEGATIVE REGULATION OF MUSCLE CONTRACTION;GO:0045932;15;-1.1280842;0.30173776;0.40360788
GO BP;LEFT RIGHT PATTERN FORMATION;GO:0060972;17;-1.1271021;0.29525483;0.4048954
GO BP;POSITIVE REGULATION OF SODIUM ION TRANSPORT;GO:0010765;27;-1.1271499;0.2919937;0.40500793
GO BP;CELLULAR RESPONSE TO UV;GO:0034644;66;-1.1260035;0.24786325;0.40691775
GO BP;CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS;GO:0002042;39;-1.1254067;0.28658536;0.4079225
GO BP;POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901798;20;1.2359579;0.18108109;0.4079945
GO BP;PEPTIDYL ARGININE MODIFICATION;#N/A;20;1.2364312;0.20844327;0.40925494
GO BP;REGULATION OF CALCIUM ION IMPORT;GO:0090279;17;-1.1245304;0.3115016;0.4094824
GO BP;NUCLEOTIDE EXCISION REPAIR DNA INCISION;GO:0033683;38;1.2339423;0.12957746;0.41008338
GO BP;ER NUCLEUS SIGNALING PATHWAY;GO:0006984;39;-1.1236212;0.27727273;0.411153
GO BP;PROSTATE GLAND DEVELOPMENT;GO:0030850;33;-1.123316;0.26507938;0.41132364
GO BP;TETRAHYDROFOLATE METABOLIC PROCESS;GO:0046653;15;-1.1233628;0.3061889;0.41145858
GO BP;REGULATION OF LIPID STORAGE;GO:0010883;33;-1.1230717;0.28895614;0.41160047
GO BP;REGULATION OF RECEPTOR INTERNALIZATION;GO:0002090;33;-1.1229055;0.30421218;0.4117256
GO BP;MESODERM DEVELOPMENT;GO:0007498;77;-1.1226807;0.28323698;0.411744
GO BP;REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;82;-1.1227667;0.25108224;0.41177243
GO BP;CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS;GO:0042219;17;-1.1221942;0.2961165;0.41185677
GO BP;RESPONSE TO OXYGEN LEVELS;#N/A;283;-1.1222377;0.20944309;0.4119954
GO BP;HOMOLOUS RECOMBINATION;#N/A;43;-1.1218487;0.2800609;0.4120909
GO BP;PHOSPHOLIPID TRANSPORT;GO:0015914;61;-1.1222726;0.28892216;0.41214728
GO BP;REGULATION OF PROTEIN OLIMERIZATION;#N/A;22;-1.1218793;0.30114567;0.4122539
GO BP;RESPONSE TO ANGIOTENSIN;GO:1990776;16;-1.1222882;0.31085527;0.4123322
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME;#N/A;27;-1.1216204;0.29249617;0.41234463
GO BP;TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER;GO:0006362;28;1.231754;0.16442049;0.41244915
GO BP;REGULATION OF MACROAUTOPHAGY;GO:0016241;151;-1.121127;0.24320827;0.41309142
GO BP;REGULATION OF PROTEIN TARGETING;#N/A;64;-1.1209786;0.28360415;0.4131756
GO BP;PHOSPHATIDYLCHOLINE METABOLIC PROCESS;GO:0046470;61;-1.1202263;0.27351665;0.41450104
GO BP;NEGATIVE REGULATION OF AUTOPHAGY;GO:0010507;62;-1.1199925;0.27462685;0.41478398
GO BP;ATP DEPENDENT CHROMATIN REMODELING;GO:0043044;75;-1.119828;0.2753825;0.41487634
GO BP;LGI VESICLE TRANSPORT;#N/A;313;-1.1194541;0.225;0.41541553
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904357;25;-1.1191853;0.30322582;0.4155389
GO BP;BETA CATENIN TCF COMPLEX ASSEMBLY;#N/A;27;-1.1192675;0.29983792;0.4155919
GO BP;CHLORIDE TRANSPORT;GO:0006821;54;-1.1184409;0.2877493;0.41682038
GO BP;RETINOL METABOLIC PROCESS;GO:0042572;16;1.2269735;0.184;0.41833013
GO BP;POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY;GO:1904874;15;1.2269839;0.21065989;0.4206352
GO BP;PROTEIN LOCALIZATION TO MICROTUBULE;GO:0035372;17;-1.1163726;0.33444816;0.42081317
GO BP;ENDOPLASMIC RETICULUM MANNOSE TRIMMING;#N/A;16;-1.1159623;0.31260794;0.42123732
GO BP;MESONEPHRIC TUBULE MORPHOGENESIS;#N/A;34;-1.1160245;0.30528054;0.4213208
GO BP;TYPE B PANCREATIC CELL PROLIFERATION;GO:0044342;16;-1.115581;0.30526316;0.42158365
GO BP;RESPONSE TO CORTICOSTEROID;GO:0031960;98;-1.1156197;0.24410541;0.4217316
GO BP;SERINE FAMILY AMINO ACID METABOLIC PROCESS;GO:0009069;31;-1.1151341;0.31350482;0.4222399
GO BP;RNA SPLICING VIA TRANSESTERIFICATION REACTIONS;GO:0000375;308;1.2235497;0.029069768;0.42387167
GO BP;REGULATION OF ORGAN GROWTH;GO:0046620;60;-1.1133496;0.28223497;0.42556304
GO BP;NEUROTRANSMITTER UPTAKE;GO:0001504;23;-1.1130868;0.32580644;0.42585564
GO BP;LYMPHOCYTE MEDIATED IMMUNITY;#N/A;120;-1.1128144;0.26234132;0.4259803
GO BP;DRUG METABOLIC PROCESS;GO:0017144;374;-1.1125801;0.19764706;0.4260149
GO BP;INACTIVATION OF MAPK ACTIVITY;GO:0000188;20;-1.1128706;0.32166666;0.4260954
GO BP;MULTI ORGANISM LOCALIZATION;#N/A;53;-1.1123793;0.28994083;0.4261818
GO BP;REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900076;50;-1.1126062;0.2927215;0.4261856
GO BP;NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010823;45;-1.1115947;0.29510704;0.42760286
GO BP;NEGATIVE REGULATION OF T CELL DIFFERENTIATION;GO:0045581;26;-1.1110722;0.30555555;0.42798698
GO BP;REGULATION OF DEFENSE RESPONSE;#N/A;439;-1.1112912;0.19887641;0.4280126
GO BP;POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000060;78;-1.1111282;0.26923078;0.42810905
GO BP;NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY;GO:0071901;105;-1.1106782;0.27875507;0.42834353
GO BP;REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045637;162;-1.1106869;0.25839794;0.4285512
GO BP;REGULATION OF TOR SIGNALING;GO:0032006;80;-1.1103182;0.28820962;0.42887402
GO BP;MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION;#N/A;79;-1.1098826;0.27058825;0.42958924
GO BP;STRESS GRANULE ASSEMBLY;GO:0034063;19;-1.1084499;0.3376206;0.4298079
GO BP;REGULATION OF T CELL APOPTOTIC PROCESS;#N/A;19;-1.1096096;0.3267974;0.42994407
GO BP;AGING;GO:0007568;228;-1.1084821;0.21644498;0.4299702
GO BP;MYELOID CELL DEVELOPMENT;GO:0061515;49;-1.1094462;0.30664653;0.43004206
GO BP;RESPONSE TO VIRUS;GO:0009615;199;-1.1082184;0.2257653;0.43007013
GO BP;SENSORY PERCEPTION OF CHEMICAL STIMULUS;GO:0007606;35;-1.1092021;0.30577224;0.43008026
GO BP;NEUROTROPHIN SIGNALING PATHWAY;GO:0038179;27;-1.108534;0.30983606;0.4300891
GO BP;REGULATION OF BINDING;GO:0051098;276;-1.1092597;0.21437126;0.4302029
GO BP;INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY;GO:0030518;101;-1.10891;0.2729805;0.43021402
GO BP;GLYCOGEN BIOSYNTHETIC PROCESS;GO:0005978;36;-1.10856;0.30952382;0.43026662
GO BP;LONG CHAIN FATTY ACID TRANSPORT;GO:0015909;47;-1.1079819;0.30555555;0.43032902
GO BP;REGULATION OF PLATELET ACTIVATION;GO:0010543;19;-1.1089504;0.31423897;0.43037105
GO BP;NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:1903170;15;-1.1085967;0.31064573;0.4304166
GO BP;REGULATION OF POTASSIUM ION TRANSPORT;GO:0043266;41;-1.1086282;0.3113497;0.43058142
GO BP;FOREBRAIN NEURON DIFFERENTIATION;GO:0021879;23;-1.107745;0.30373833;0.43061045
GO BP;AMINE TRANSPORT;GO:0015837;36;-1.1073408;0.31810766;0.43098024
GO BP;DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0030330;97;-1.1073802;0.26002768;0.43112302
GO BP;REGULATION OF CHONDROCYTE DIFFERENTIATION;GO:0032330;27;-1.1068983;0.30988276;0.43170056
GO BP;CELLULAR LIPID CATABOLIC PROCESS;GO:0044242;160;-1.1065677;0.2622739;0.43217596
GO BP;MESODERM MORPHOGENESIS;GO:0048332;44;-1.1058873;0.29037267;0.4333281
GO BP;CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION;GO:0086065;34;-1.1054865;0.29233226;0.43369123
GO BP;RESPONSE TO REACTIVE OXYGEN SPECIES;GO:0000302;160;-1.1055899;0.2545692;0.43371007
KEGG;DRUG METABOLISM CYTOCHROME P450;;19;-1.1500776;0.2701812;0.43399298
GO BP;POSITIVE REGULATION OF MAP KINASE ACTIVITY;GO:0043406;183;-1.1050451;0.24071702;0.43435112
KEGG;GLYCOLYSIS GLUCONEOGENESIS;;40;-1.1562848;0.2433281;0.43461612
KEGG;TOLL LIKE RECEPTOR SIGNALING PATHWAY;;62;-1.1592665;0.21921922;0.43490756
GO BP;RESPONSE TO LIGHT STIMULUS;GO:0009416;209;-1.1043344;0.24375;0.43559265
GO BP;I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0007249;194;-1.1038953;0.21534653;0.4360685
GO BP;REGULATION OF CENTROSOME DUPLICATION;GO:0010824;40;-1.1037518;0.30284858;0.43613958
GO BP;POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION;GO:0032481;64;-1.1039102;0.28820962;0.43626857
GO BP;POSITIVE REGULATION OF BIOMINERALIZATION;GO:0110151;26;-1.1032633;0.3116883;0.43694526
GO BP;POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS;GO:0046827;20;-1.1025947;0.31340873;0.43722615
GO BP;POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY;GO:0051092;101;-1.1030158;0.2867036;0.43726805
GO BP;REGULATION OF CELLULAR RESPIRATION;GO:0043457;25;-1.1027933;0.3231511;0.43729955
GO BP;CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS;#N/A;37;-1.102893;0.32213742;0.43730828
GO BP;GLYCEROPHOSPHOLIPID METABOLIC PROCESS;GO:0006650;251;-1.1026162;0.25030228;0.4374118
GO BP;RESPONSE TO AMINO ACID STARVATION;#N/A;43;-1.1023775;0.30495358;0.43745422
GO BP;GLYCOPROTEIN METABOLIC PROCESS;GO:0009100;284;-1.1020436;0.23507462;0.43792957
GO BP;PHOTORECEPTOR CELL MAINTENANCE;GO:0045494;25;-1.1017795;0.30963665;0.43800715
GO BP;NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS;GO:0002683;255;-1.1018511;0.23884198;0.43809545
GO BP;POSITIVE REGULATION OF LIPASE ACTIVITY;#N/A;35;-1.1010395;0.32919255;0.4393128
KEGG;CYSTEINE AND METHIONINE METABOLISM;;26;-1.1504343;0.27813506;0.4400227
GO BP;PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING;GO:0036151;16;1.2155296;0.22166246;0.44023383
GO BP;POSITIVE REGULATION OF VIRAL GENOME REPLICATION;GO:0045070;31;-1.1004956;0.33543307;0.44023463
GO BP;REGULATION OF APOPTOTIC SIGNALING PATHWAY;#N/A;309;-1.1002;0.24242425;0.44039991
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS;GO:0034656;32;-1.1002237;0.31490016;0.4405793
GO BP;SINGLE FERTILIZATION;GO:0007338;64;-1.0999944;0.27062228;0.4406121
GO BP;ORGANELLE DISASSEMBLY;GO:1903008;85;-1.0996984;0.29737207;0.44103327
GO BP;CELLULAR RESPONSE TO CHEMICAL STRESS;#N/A;255;-1.0993357;0.2199271;0.44109976
GO BP;POSITIVE REGULATION OF T CELL MIGRATION;GO:2000406;19;-1.099378;0.33278957;0.4412391
GO BP;RESPONSE TO TOXIC SUBSTANCE;GO:0009636;327;-1.0993804;0.23481308;0.4414625
GO BP;TOR SIGNALING;GO:0031929;98;-1.0987906;0.27832168;0.44179407
GO BP;REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;341;-1.0988649;0.24434389;0.44188237
GO BP;NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION;GO:2000104;18;-1.098144;0.34049585;0.44288605
GO BP;CHEMOKINE PRODUCTION;GO:0032602;44;-1.0980451;0.31104198;0.4428873
GO BP;ACUTE INFLAMMATORY RESPONSE;GO:0002526;43;-1.0969056;0.30837005;0.44457322
GO BP;POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903364;119;-1.0969807;0.28741723;0.44465256
GO BP;NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902236;16;-1.0970279;0.32993197;0.4447842
GO BP;PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;29;-1.0965614;0.29936305;0.44483536
GO BP;POSITIVE REGULATION OF PROTEOLYSIS;GO:0045862;263;-1.096611;0.26460072;0.44495827
GO BP;POSITIVE REGULATION OF CHEMOTAXIS;GO:0050921;66;-1.0963814;0.3020528;0.44498366
GO BP;POSITIVE REGULATION OF DNA RECOMBINATION;GO:0045911;27;-1.0960526;0.34201956;0.4454265
GO BP;DRUG TRANSPORT;#N/A;96;-1.095387;0.2897959;0.44659296
GO BP;ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS;#N/A;17;-1.095091;0.325;0.44701675
GO BP;SENSORY PERCEPTION OF SMELL;GO:0007608;20;-1.0949028;0.35064936;0.44717592
GO BP;ASYMMETRIC CELL DIVISION;GO:0008356;15;-1.0947226;0.3338983;0.44730598
GO BP;INNATE IMMUNE RESPONSE;GO:0045087;499;-1.0945276;0.20399113;0.44748747
GO BP;BLOOD VESSEL REMODELING;GO:0001974;20;-1.0943202;0.3289256;0.44771194
GO BP;POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY;GO:0043243;25;-1.0939534;0.3392;0.44800675
GO BP;REGULATION OF PROTON TRANSPORT;GO:0010155;17;-1.094023;0.3168;0.44810545
GO BP;CELLULAR KETONE METABOLIC PROCESS;GO:0042180;173;-1.0933546;0.2707254;0.44904932
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION;GO:2000142;27;-1.0931224;0.31622517;0.44933048
GO BP;REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT;GO:2000641;18;1.2103863;0.19602978;0.44995692
GO BP;T CELL DIFFERENTIATION IN THYMUS;GO:0033077;42;-1.0920782;0.33435583;0.4513069
GO BP;REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS;#N/A;15;-1.0917494;0.34948096;0.45131236
GO BP;REGULATION OF PROTEIN AUTOPHOSPHORYLATION;GO:0031952;32;-1.0919615;0.35932723;0.45132506
GO BP;CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE;GO:0002534;22;-1.091771;0.3344538;0.4514997
GO BP;MITOTIC DNA INTEGRITY CHECKPOINT;GO:0044774;96;-1.0911467;0.33286119;0.45238057
GO BP;NEGATIVE REGULATION OF KINASE ACTIVITY;GO:0033673;190;-1.0904435;0.27616647;0.45359248
GO BP;DOPAMINE METABOLIC PROCESS;GO:0042417;17;1.2077992;0.1941032;0.45366627
GO BP;NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS;GO:0036475;19;-1.0896846;0.3250825;0.45475903
GO BP;MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS;GO:0006509;31;-1.0897037;0.3184;0.4549471
GO BP;REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2000116;162;-1.0893172;0.2903646;0.45530537
KEGG;TYPE II DIABETES MELLITUS;;29;-1.1338192;0.2897351;0.45562384
GO BP;DEPHOSPHORYLATION;GO:0016311;368;-1.088444;0.25284737;0.45694113
KEGG;ANTIGEN PROCESSING AND PRESENTATION;;37;-1.135801;0.2681388;0.45773265
GO BP;REGULATION OF SISTER CHROMATID SEGREGATION;GO:0033045;74;-1.0876971;0.31073445;0.45830706
GO BP;TERPENOID METABOLIC PROCESS;#N/A;59;-1.0875198;0.32568148;0.45843482
GO BP;ESTABLISHMENT OF LOCALIZATION IN CELL;GO:0051649;389;-1.0873753;0.24384525;0.45847252
GO BP;MATING;#N/A;17;-1.0871742;0.35451505;0.45864022
GO BP;RESPONSE TO MOLECULE OF BACTERIAL ORIGIN;GO:0002237;188;-1.0864375;0.278402;0.45971388
GO BP;REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;63;-1.0864872;0.33870968;0.45983702
GO BP;REGULATION OF SIGNALING RECEPTOR ACTIVITY;GO:0010469;88;-1.0862298;0.32303372;0.45993173
GO BP;CHROMATIN REMODELING AT CENTROMERE;#N/A;41;1.2038239;0.18285714;0.46099815
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;GO:1905477;91;-1.0852263;0.3060921;0.46111995
GO BP;SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT;GO:0072395;66;-1.0855398;0.30329043;0.4611437
GO BP;ASSOCIATIVE LEARNING;GO:0008306;40;-1.0852376;0.33690658;0.46133083
GO BP;REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000058;126;-1.0853146;0.30298913;0.46140593
GO BP;ERROR PRONE TRANSLESION SYNTHESIS;GO:0042276;19;1.2025441;0.23684211;0.4615965
GO BP;COFACTOR BIOSYNTHETIC PROCESS;#N/A;192;-1.0846928;0.2841191;0.46201825
KEGG;PORPHYRIN AND CHLOROPHYLL METABOLISM;;21;-1.1273727;0.3047776;0.46227875
GO BP;NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS;#N/A;15;1.1998266;0.19849247;0.46333182
GO BP;MAMMARY GLAND EPITHELIAL CELL PROLIFERATION;GO:0033598;23;-1.083685;0.3379205;0.46392792
GO BP;PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS;GO:0046337;17;1.1984795;0.20485175;0.46427232
GO BP;RNA SPLICING;GO:0008380;386;1.2003298;0.016393442;0.46447092
GO BP;EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0007173;96;-1.0832921;0.31380752;0.46452594
KEGG;VEGF SIGNALING PATHWAY;;54;-1.1162324;0.29500756;0.46473613
KEGG;MELANOGENESIS;;58;-1.1124307;0.2817518;0.46522662
GO BP;ANTERIOR POSTERIOR AXIS SPECIFICATION;GO:0009948;32;-1.0825253;0.33385336;0.46592295
GO BP;CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT;GO:0021954;47;-1.0822661;0.32884902;0.46623346
GO BP;ANTEROGRADE AXONAL TRANSPORT;GO:0008089;39;-1.0821388;0.33440515;0.46628866
KEGG;GAP JUNCTION;;59;-1.1184754;0.2755102;0.46688432
GO BP;HISTONE EXCHANGE;GO:0043486;48;1.1964117;0.17109145;0.46694145
GO BP;REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;GO:1901016;25;-1.081194;0.3273906;0.46809512
GO BP;DOPAMINE RECEPTOR SIGNALING PATHWAY;GO:0007212;20;-1.0810465;0.35031846;0.4681665
KEGG;ALDOSTERONE REGULATED SODIUM REABSORPTION;;31;-1.121138;0.2874618;0.46832013
GO BP;POSITIVE REGULATION OF PEPTIDE SECRETION;#N/A;150;-1.0805279;0.30354795;0.46878654
GO BP;MONOVALENT INORGANIC ANION HOMEOSTASIS;#N/A;16;-1.0805343;0.36650082;0.46901047
GO BP;NEGATIVE REGULATION OF NEURON DEATH;GO:1901215;135;-1.0802759;0.3030303;0.46906656
GO BP;MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE;#N/A;34;-1.0797589;0.33226323;0.4699014
GO BP;POSITIVE REGULATION OF PROTEIN IMPORT;GO:1904591;33;-1.0795089;0.3379845;0.4701808
GO BP;HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN;GO:0002455;22;1.1939689;0.20413436;0.4704891
GO BP;MITOTIC G2 DNA DAMAGE CHECKPOINT;GO:0007095;18;-1.0791333;0.34775373;0.47049347
GO BP;DIGESTIVE TRACT MORPHOGENESIS;GO:0048546;28;-1.0792309;0.3484603;0.47052705
GO BP;NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:2001237;71;-1.078797;0.32647058;0.47098354
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS;#N/A;99;-1.0785753;0.34472933;0.4710113
GO BP;MEMBRANE INVAGINATION;GO:0010324;44;-1.0786009;0.33579883;0.47118336
GO BP;MISMATCH REPAIR;GO:0006298;30;-1.0782453;0.36050156;0.4715072
GO BP;POSITIVE REGULATION OF PEPTIDASE ACTIVITY;GO:0010952;132;-1.0779451;0.30933332;0.47189543
GO BP;POSITIVE REGULATION OF LIPID STORAGE;GO:0010884;15;-1.0776596;0.38330495;0.47227436
GO BP;MOTOR NEURON AXON GUIDANCE;GO:0008045;20;-1.0772691;0.36451614;0.47285774
GO BP;ESTABLISHMENT OF ORGANELLE LOCALIZATION;GO:0051656;335;-1.0770247;0.2880562;0.47311997
GO BP;BRANCHED CHAIN AMINO ACID METABOLIC PROCESS;GO:0009081;20;-1.0765561;0.3590164;0.47320053
GO BP;CELLULAR RESPONSE TO NUTRIENT;GO:0031670;43;-1.0765576;0.35458788;0.47343343
GO BP;OLFACTORY LOBE DEVELOPMENT;GO:0021988;19;-1.0767206;0.36626917;0.4735348
GO BP;POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION;GO:0045639;56;-1.0765982;0.34074074;0.47359365
GO BP;REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;#N/A;63;-1.0751731;0.33333334;0.4759858
GO BP;GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS;#N/A;32;1.1828817;0.2238806;0.47612265
GO BP;LIPOPROTEIN BIOSYNTHETIC PROCESS;GO:0042158;83;1.183841;0.14715719;0.47613
GO BP;NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING;#N/A;21;1.1887375;0.21090047;0.47621018
GO BP;POSITIVE REGULATION OF ATP METABOLIC PROCESS;GO:1903580;30;-1.0749435;0.33387887;0.4762527
GO BP;POSITIVE REGULATION OF PHACYTOSIS;#N/A;35;1.1894318;0.20833333;0.47683525
GO BP;NEUROTRANSMITTER TRANSPORT;GO:0006836;143;-1.0745454;0.31508678;0.47689617
GO BP;PORE COMPLEX ASSEMBLY;GO:0046931;17;-1.0743036;0.38045377;0.47717324
GO BP;MIDBODY ABSCISSION;GO:0061952;17;1.1842004;0.25187033;0.477678
GO BP;AMINO ACID ACTIVATION;#N/A;43;1.1896981;0.21052632;0.47873306
GO BP;ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION;GO:0034314;28;1.1761355;0.20572917;0.47889417
GO BP;POSITIVE CHEMOTAXIS;GO:0050918;24;1.176923;0.2371134;0.4792753
GO BP;POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS;GO:1900182;63;-1.0729926;0.3338214;0.47956204
GO BP;LUNG ALVEOLUS DEVELOPMENT;GO:0048286;27;-1.0729932;0.35147744;0.4797999
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY;#N/A;19;1.1843034;0.24691358;0.47983345
GO BP;OLIDENDROCYTE DIFFERENTIATION;#N/A;53;-1.0727369;0.34650457;0.47986248
GO BP;DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0006354;101;1.1775744;0.14126395;0.4799362
GO BP;TERMINATION OF RNA POLYMERASE I TRANSCRIPTION;GO:0006363;30;1.1783326;0.19794345;0.4803069
GO BP;NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035308;51;-1.0723284;0.3546945;0.48048976
GO BP;DETECTION OF STIMULUS;GO:0051606;118;1.184774;0.12156863;0.481116
GO BP;LABYRINTHINE LAYER DEVELOPMENT;GO:0060711;33;-1.0719043;0.32923076;0.48116586
GO BP;SPLICEOSOMAL COMPLEX ASSEMBLY;GO:0000245;51;1.1788234;0.18803419;0.48144016
GO BP;MACROPHAGE CHEMOTAXIS;GO:0048246;20;1.1713705;0.22084367;0.48161855
GO BP;DNA REPLICATION DEPENDENT NUCLEOSOME ORGANIZATION;#N/A;21;1.1739392;0.235012;0.4821578
GO BP;DETECTION OF LIGHT STIMULUS;GO:0009583;29;1.1852804;0.21750663;0.48224917
GO BP;REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;#N/A;16;-1.0712637;0.37664473;0.48229492
GO BP;REGULATION OF LAMELLIPODIUM ASSEMBLY;GO:0010591;23;-1.071124;0.36286202;0.48237494
GO BP;POSITIVE REGULATION OF TISSUE REMODELING;#N/A;18;-1.0709337;0.37641358;0.48253185
GO BP;VESICLE TARGETING;GO:0006903;80;1.1718884;0.16770187;0.4826326
GO BP;CELL REDOX HOMEOSTASIS;GO:0045454;60;1.1698565;0.15923567;0.48305148
GO BP;REGULATION OF MEIOTIC NUCLEAR DIVISION;GO:0040020;16;1.1791148;0.22391857;0.4831004
GO BP;HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION;GO:0002244;122;1.1724136;0.12903225;0.48361465
GO BP;POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY;GO:0090263;111;1.1675925;0.15444015;0.48414844
GO BP;SOMATIC STEM CELL POPULATION MAINTENANCE;GO:0035019;57;-1.0700178;0.35233918;0.4842218
GO BP;HEART FORMATION;GO:0060914;21;-1.0697306;0.3880597;0.48462898
GO BP;INTERLEUKIN 8 PRODUCTION;GO:0032637;40;-1.0694277;0.3395931;0.48503193
KEGG;RIG I LIKE RECEPTOR SIGNALING PATHWAY;;46;-1.0999001;0.2828125;0.48521313
GO BP;TRNA WOBBLE BASE MODIFICATION;#N/A;18;1.1678487;0.24009901;0.485739
GO BP;SYNAPTIC VESICLE EXOCYTOSIS;GO:0016079;69;-1.0689888;0.36627907;0.48576796
GO BP;CYTOPLASMIC MICROTUBULE ORGANIZATION;GO:0031122;45;-1.0684639;0.36801243;0.48668256
GO BP;POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010822;95;-1.0680048;0.32369146;0.4869505
GO BP;INTERLEUKIN 10 PRODUCTION;GO:0032613;24;-1.0678551;0.354067;0.48704615
GO BP;REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;#N/A;59;-1.0680457;0.33639145;0.48709464
GO BP;PYRIDINE NUCLEOTIDE METABOLIC PROCESS;#N/A;24;-1.0680912;0.36899224;0.4872281
GO BP;CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY;GO:0002753;48;-1.0674827;0.36060607;0.4873676
GO BP;NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS;GO:2000107;26;-1.0675056;0.38752052;0.48755866
GO BP;POSITIVE REGULATION OF PHOSPHATASE ACTIVITY;GO:0010922;22;-1.0670053;0.38580248;0.48795807
GO BP;VESICLE CAR LOADING;#N/A;19;-1.067092;0.36044657;0.48801336
GO BP;NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY;GO:0043433;109;-1.0662953;0.34428385;0.48920345
GO BP;NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS;GO:0043524;93;-1.0659275;0.36885247;0.4897369
GO BP;NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY;GO:2001258;18;-1.0652916;0.39173552;0.49084875
GO BP;INORGANIC ION TRANSMEMBRANE TRANSPORT;#N/A;462;-1.0649163;0.2897407;0.4914307
GO BP;ORGANOPHOSPHATE BIOSYNTHETIC PROCESS;#N/A;468;-1.0639706;0.29284903;0.4932766
GO BP;CHROMOSOME CONDENSATION;GO:0030261;36;-1.0634148;0.36320755;0.49418968
GO BP;ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY;#N/A;15;-1.0630103;0.38347107;0.49481434
GO BP;MITOTIC SISTER CHROMATID SEGREGATION;GO:0000070;140;-1.0627316;0.33163264;0.4951902
GO BP;PHOSPHATIDYLINOSITOL METABOLIC PROCESS;GO:0046488;138;-1.062151;0.33764553;0.49621907
GO BP;MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM;#N/A;90;-1.0618265;0.3572414;0.49667653
GO BP;RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY;GO:0051123;21;1.1579292;0.24489796;0.49687463
GO BP;SNRNA PROCESSING;GO:0016180;24;1.1584562;0.24054053;0.49790186
GO BP;REGULATION OF SPROUTING ANGIOGENESIS;GO:1903670;44;-1.061124;0.3771252;0.49796268
GO BP;REGULATION OF STEM CELL DIFFERENTIATION;GO:2000736;92;1.1599005;0.1533101;0.4988949
GO BP;PRIMARY ALCOHOL METABOLIC PROCESS;#N/A;41;1.1586245;0.23442137;0.49984464
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR;GO:1902165;16;1.1603683;0.25319692;0.5000051
GO BP;POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS;GO:0045732;178;-1.0600303;0.34738186;0.50016123
GO BP;RAC PROTEIN SIGNAL TRANSDUCTION;GO:0016601;28;-1.0597184;0.37913907;0.5006024
GO BP;OXIDOREDUCTION COENZYME METABOLIC PROCESS;#N/A;40;-1.0594133;0.3800623;0.50104356
GO BP;LAMELLIPODIUM ORGANIZATION;GO:0097581;58;-1.0592347;0.37337193;0.50119823
GO BP;REGULATION OF LEUKOCYTE PROLIFERATION;GO:0070663;117;-1.0588301;0.31266847;0.5016026
GO BP;MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS;GO:0051457;20;-1.0589213;0.3777403;0.50165194
GO BP;POSITIVE REGULATION OF INFLAMMATORY RESPONSE;GO:0050729;63;-1.0582626;0.34985423;0.5023811
GO BP;CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS;#N/A;39;-1.0583212;0.38153845;0.5024963
GO BP;HYPEROSMOTIC RESPONSE;GO:0006972;20;-1.0578785;0.40131578;0.5030053
GO BP;ENDOCYTIC RECYCLING;GO:0032456;41;-1.0576289;0.3625192;0.5033327
KEGG;TYROSINE METABOLISM;;21;1.1056147;0.2636816;0.5035521
GO BP;REGULATION OF CELLULAR KETONE METABOLIC PROCESS;GO:0010565;132;-1.0572505;0.34478202;0.5037296
GO BP;ERBB SIGNALING PATHWAY;GO:0038127;113;-1.0573447;0.33841887;0.5037586
GO BP;DNA REPAIR;GO:0006281;480;-1.0568026;0.30066815;0.50448525
GO BP;REGULATION OF NEUROTRANSMITTER LEVELS;GO:0001505;196;-1.0565866;0.33753148;0.50470746
GO BP;NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY;GO:0032232;15;-1.0562012;0.37563452;0.50528157
GO BP;REGULATION OF B CELL APOPTOTIC PROCESS;GO:0002902;15;-1.0555989;0.39790577;0.5061194
GO BP;NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION;GO:0033137;19;-1.0557094;0.3826955;0.5061232
KEGG;LONG TERM DEPRESSION;;44;-1.0838592;0.33587787;0.50675786
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION;GO:0010633;44;1.153119;0.21005917;0.50698596
KEGG;PATHOGENIC ESCHERICHIA COLI INFECTION;;44;-1.0678134;0.3375;0.5070721
GO BP;REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY;GO:0033146;32;-1.0548017;0.3707165;0.5076026
GO BP;SYNCYTIUM FORMATION;GO:0006949;28;-1.0541157;0.37520128;0.50763273
GO BP;IMMUNOGLOBULIN PRODUCTION;GO:0002377;66;-1.0544682;0.34542817;0.50763386
GO BP;SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE;GO:0042770;118;-1.054674;0.339498;0.50764537
GO BP;REGULATION OF HEMOPOIESIS;GO:1903706;299;-1.0545442;0.32160193;0.50769603
GO BP;REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;#N/A;34;-1.0541569;0.3840246;0.5077938
GO BP;ADULT LOCOMOTORY BEHAVIOR;GO:0008344;43;-1.054208;0.38102895;0.5079378
KEGG;PPAR SIGNALING PATHWAY;;50;-1.0861914;0.33482143;0.5084837
GO BP;MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA;#N/A;21;1.1507223;0.2580645;0.50849354
GO BP;GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS;#N/A;53;-1.0535271;0.37885463;0.50867957
GO BP;POSITIVE REGULATION OF CATION CHANNEL ACTIVITY;GO:2001259;25;-1.0532787;0.39240506;0.5089889
GO BP;CORNIFICATION;GO:0070268;38;-1.0530714;0.34756097;0.50917995
GO BP;NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY;GO:1901185;47;1.1512363;0.24260356;0.5095133
GO BP;RESPONSE TO RADIATION;GO:0009314;313;-1.0524644;0.34397164;0.5097737
GO BP;STEROID CATABOLIC PROCESS;GO:0006706;17;-1.0525204;0.39123377;0.5098899
GO BP;CELLULAR GLUCAN METABOLIC PROCESS;#N/A;58;-1.052158;0.39337176;0.5099588
GO BP;T CELL MEDIATED IMMUNITY;GO:0002456;46;-1.0522519;0.37405732;0.5100039
GO BP;NEGATIVE REGULATION OF CATABOLIC PROCESS;GO:0009895;230;-1.0525675;0.34409937;0.51003134
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:0070059;52;-1.0519378;0.37091988;0.51018864
GO BP;T CELL PROLIFERATION;GO:0042098;102;-1.0517907;0.37967914;0.5102654
KEGG;GLYCINE SERINE AND THREONINE METABOLISM;;21;-1.0689944;0.36805555;0.5113896
GO BP;ENDOMEMBRANE SYSTEM ORGANIZATION;GO:0010256;340;-1.050931;0.3375576;0.5119021
GO BP;NEGATIVE REGULATION OF LIPID METABOLIC PROCESS;GO:0045833;52;-1.0503329;0.36060607;0.5129498
GO BP;DNA DEPENDENT DNA REPLICATION;GO:0006261;136;-1.0499392;0.374502;0.51332486
GO BP;NEGATIVE REGULATION OF TORC1 SIGNALING;GO:1904262;15;-1.0500166;0.389948;0.51341075
GO BP;SECRETION BY TISSUE;#N/A;20;-1.0492752;0.39144215;0.51457536
GO BP;PHOSPHOLIPID BIOSYNTHETIC PROCESS;GO:0008654;218;-1.0484195;0.34438777;0.51572275
GO BP;TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY;GO:0070897;34;-1.0484498;0.39150944;0.5159032
GO BP;GERM CELL DEVELOPMENT;GO:0007281;154;-1.0485183;0.36204576;0.5159851
GO BP;RESPONSE TO DSRNA;GO:0043331;30;-1.0478814;0.3877551;0.5161542
GO BP;POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION;GO:0035025;17;-1.0480646;0.41252005;0.51623535
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION;GO:0050680;86;-1.0478927;0.37212643;0.5163729
KEGG;ENDOCYTOSIS;;143;-1.0695837;0.33643618;0.5166786
GO BP;POSITIVE REGULATION OF PROTEIN POLYMERIZATION;GO:0032273;96;-1.0474566;0.37399465;0.51681554
GO BP;GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;35;-1.047322;0.39263803;0.5168321
GO BP;STEM CELL DIFFERENTIATION;GO:0048863;171;-1.0471548;0.36828643;0.516936
GO BP;TISSUE HOMEOSTASIS;GO:0001894;127;-1.046431;0.36426592;0.51705045
GO BP;SPERM MOTILITY;#N/A;45;-1.0464842;0.38235295;0.5171816
GO BP;HOMOLOUS CHROMOSOME SEGREGATION;#N/A;41;-1.0469149;0.38449848;0.5172079
GO BP;SULFUR COMPOUND METABOLIC PROCESS;GO:0006790;270;-1.046563;0.36695018;0.5172525
GO BP;CELLULAR COMPONENT MAINTENANCE;GO:0043954;42;-1.0467372;0.36899224;0.5173508
GO BP;GLYCOSYL COMPOUND CATABOLIC PROCESS;#N/A;28;-1.0465672;0.38118023;0.51749
GO BP;CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY;#N/A;61;-1.0458311;0.37849778;0.5178
GO BP;REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0032434;104;-1.0458804;0.35752687;0.51794183
GO BP;REPLACEMENT OSSIFICATION;#N/A;18;-1.0448246;0.39303482;0.5190456
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS;GO:0043620;102;1.145832;0.1660079;0.5190909
GO BP;SPLEEN DEVELOPMENT;GO:0048536;23;-1.0448381;0.3847352;0.51926935
GO BP;STEROID HORMONE BIOSYNTHETIC PROCESS;#N/A;40;-1.0450257;0.39269406;0.5193298
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE;GO:0061951;55;-1.0445412;0.3868066;0.51942575
GO BP;MACROPHAGE DIFFERENTIATION;GO:0030225;27;-1.0448722;0.39157566;0.5194445
GO BP;CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS;#N/A;59;-1.0442415;0.3958641;0.51984906
GO BP;MAST CELL ACTIVATION;GO:0045576;36;-1.0432959;0.39370078;0.5207105
GO BP;METAPHASE PLATE CONGRESSION;GO:0051310;54;-1.0431297;0.38036808;0.5208374
GO BP;STRIATED MUSCLE CELL PROLIFERATION;#N/A;38;-1.0433097;0.38145897;0.52092737
GO BP;BONE CELL DEVELOPMENT;#N/A;23;-1.0428544;0.4012539;0.52096254
GO BP;CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS;GO:0006921;27;-1.0433954;0.4012841;0.5209928
GO BP;SPERMATID DIFFERENTIATION;GO:0048515;90;-1.042903;0.37122303;0.5211057
GO BP;POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING;GO:2000679;16;-1.0434448;0.41491085;0.5211412
GO BP;NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT;GO:0090317;32;-1.0435481;0.3789308;0.5211522
GO BP;MEMORY;GO:0007613;63;-1.042622;0.4118497;0.52125144
KEGG;B CELL RECEPTOR SIGNALING PATHWAY;;59;-1.0703459;0.34620887;0.52157915
GO BP;NEGATIVE REGULATION OF BMP SIGNALING PATHWAY;GO:0030514;29;-1.0421714;0.38485804;0.52200586
GO BP;APOPTOTIC SIGNALING PATHWAY;GO:0097190;457;-1.0411288;0.3773585;0.52380407
GO BP;REGULATION OF MEMBRANE DEPOLARIZATION;GO:0003254;28;-1.0411623;0.392;0.523976
GO BP;REGULATION OF AUTOPHAGY;GO:0010506;265;-1.0408572;0.36431226;0.5241619
GO BP;REGULATION OF DNA REPLICATION;GO:0006275;90;-1.0404692;0.3915416;0.52481043
GO BP;POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY;GO:0045747;34;-1.0399886;0.39721793;0.5254006
GO BP;ENERGY RESERVE METABOLIC PROCESS;GO:0006112;61;-1.0400511;0.393586;0.52550673
KEGG;SPHINLIPID METABOLISM;;33;-1.0715163;0.34815952;0.5260044
GO BP;POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS;#N/A;360;-1.0388703;0.3832547;0.5275797
GO BP;LIPID CATABOLIC PROCESS;GO:0016042;223;-1.0386447;0.37294564;0.5278181
GO BP;GLUCOSE 6 PHOSPHATE METABOLIC PROCESS;GO:0051156;20;-1.0385023;0.41720778;0.5278815
GO BP;EMBRYO IMPLANTATION;GO:0007566;39;-1.0380697;0.396875;0.52860326
GO BP;RESPONSE TO OXYGEN RADICAL;#N/A;18;-1.0375214;0.38593483;0.5288114
GO BP;ISOPRENOID METABOLIC PROCESS;GO:0006720;75;-1.0376484;0.37555885;0.5290202
GO BP;MITOCHONDRION MORPHOGENESIS;GO:0070584;21;1.1412237;0.24619289;0.5290261
GO BP;NEGATIVE REGULATION OF STEROID METABOLIC PROCESS;#N/A;15;-1.0375258;0.4407583;0.5290476
GO BP;DETECTION OF ABIOTIC STIMULUS;#N/A;53;-1.0377389;0.4127907;0.52908075
GO BP;INTRA LGI VESICLE MEDIATED TRANSPORT;#N/A;28;1.1367792;0.24880382;0.52915233
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:0072332;65;1.1357118;0.21656051;0.5296215
GO BP;NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY;GO:0061099;19;1.1347908;0.27543426;0.52982193
GO BP;POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY;GO:0051443;26;1.1372194;0.26287264;0.5302505
GO BP;DNA TEMPLATED TRANSCRIPTION TERMINATION;GO:0006353;71;1.1398064;0.2020202;0.5303973
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC;GO:0090502;61;1.1379889;0.20189275;0.530533
GO BP;LEUKOCYTE HOMEOSTASIS;GO:0001776;52;-1.0363842;0.38653;0.53078103
GO BP;POSITIVE REGULATION OF EXOCYTOSIS;GO:0045921;64;-1.0364618;0.39595374;0.5308561
GO BP;REGULATION OF VIRAL ENTRY INTO HOST CELL;GO:0046596;19;1.1386743;0.2773893;0.5309739
GO BP;AMYLOID BETA CLEARANCE;GO:0097242;24;-1.0356714;0.4079365;0.5320938
GO BP;POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION;GO:0045669;41;-1.0352974;0.40334857;0.5326863
GO BP;NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION;GO:0032480;31;-1.0351585;0.39813375;0.5327345
GO BP;ORGANIC ACID CATABOLIC PROCESS;#N/A;213;-1.0349008;0.3816121;0.53307694
GO BP;CALCIUM ION REGULATED EXOCYTOSIS;GO:0017156;42;-1.033779;0.4006024;0.535312
GO BP;REACTIVE NITROGEN SPECIES METABOLIC PROCESS;#N/A;43;-1.0335176;0.4107425;0.5353788
GO BP;LIPID TRANSLOCATION;GO:0034204;27;-1.0333067;0.4006116;0.53559154
GO BP;MITOTIC G2 M TRANSITION CHECKPOINT;GO:0044818;27;-1.0335314;0.39821693;0.5355995
GO BP;RESPONSE TO MANGANESE ION;GO:0010042;15;-1.033159;0.42062193;0.53569406
GO BP;CELLULAR RESPONSE TO TOXIC SUBSTANCE;GO:0097237;154;-1.0329802;0.38735178;0.53580195
GO BP;CYCLIC NUCLEOTIDE MEDIATED SIGNALING;#N/A;82;-1.031716;0.4023845;0.5378696
GO BP;ESTABLISHMENT OF EPITHELIAL CELL POLARITY;GO:0090162;24;-1.0315608;0.43137255;0.5379538
GO BP;EXECUTION PHASE OF APOPTOSIS;GO:0097194;55;-1.0317329;0.39701492;0.53808385
GO BP;MRNA MODIFICATION;GO:0016556;20;-1.0317687;0.42087543;0.53825873
GO BP;CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES;GO:0034614;116;-1.0309539;0.39459458;0.5382709
GO BP;ANTIBIOTIC CATABOLIC PROCESS;#N/A;26;-1.0310526;0.40504202;0.53830963
GO BP;CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM;#N/A;212;-1.0310568;0.39775562;0.5385494
GO BP;NEGATIVE REGULATION OF RNA CATABOLIC PROCESS;GO:1902369;48;-1.0306423;0.40307692;0.5387313
GO BP;ORGANOPHOSPHATE ESTER TRANSPORT;#N/A;85;-1.0310614;0.394958;0.53879297
GO BP;REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS;GO:0045428;31;-1.0304514;0.4022082;0.5388912
GO BP;CELLULAR METABOLIC COMPOUND SALVAGE;#N/A;26;1.1304169;0.26756757;0.53926826
GO BP;PANCREAS DEVELOPMENT;GO:0031016;50;-1.0298468;0.41048035;0.53975743
GO BP;RESPONSE TO AMINE;#N/A;23;1.12941;0.273743;0.5397808
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;GO:1902230;26;-1.0299026;0.41455695;0.5398858
GO BP;MEIOTIC CELL CYCLE PROCESS;#N/A;138;-1.0287777;0.40770254;0.5418772
GO BP;POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION;GO:0031954;16;-1.027363;0.4302926;0.54460746
GO BP;T CELL HOMEOSTASIS;GO:0043029;24;-1.0273961;0.424196;0.5447789
GO BP;RESPONSE TO GLUCAN;#N/A;22;-1.0266224;0.43035993;0.5457519
GO BP;DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION;#N/A;48;-1.0266778;0.4082232;0.5458865
GO BP;VACUOLE ORGANIZATION;GO:0007033;142;-1.0264283;0.41655886;0.54588675
GO BP;CELLULAR BIOGENIC AMINE METABOLIC PROCESS;GO:0006576;31;1.125385;0.27272728;0.5460137
GO BP;REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY;GO:1901385;17;-1.0260412;0.43585527;0.5465196
GO BP;STRIATED MUSCLE ADAPTATION;#N/A;29;1.1257634;0.28645834;0.54739636
GO BP;RESPONSE TO PROGESTERONE;GO:0032570;29;1.1229106;0.26756757;0.5505105
GO BP;POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE;GO:0090314;23;-1.0236621;0.41626015;0.551003
GO BP;NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY;GO:0048011;21;-1.0237021;0.41558442;0.5511792
GO BP;NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS;GO:0010664;18;-1.0237906;0.42276424;0.55121815
GO BP;POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903052;100;-1.0230738;0.4167813;0.55204993
GO BP;MUSCLE CELL CELLULAR HOMEOSTASIS;GO:0046716;16;-1.0229465;0.42762062;0.5521016
GO BP;ORGANOPHOSPHATE CATABOLIC PROCESS;GO:0046434;105;-1.0224057;0.42503437;0.5530707
GO BP;RESPONSE TO MITOCHONDRIAL DEPOLARISATION;GO:0098780;19;-1.0218661;0.3987034;0.5539991
GO BP;AUTOPHASOME ORGANIZATION;#N/A;83;-1.021104;0.41493776;0.55516475
GO BP;NEURAL TUBE PATTERNING;GO:0021532;29;-1.0212146;0.4296636;0.5551768
GO BP;BONE REMODELING;GO:0046849;53;-1.0204568;0.4003021;0.55559176
GO BP;CYTOKINE SECRETION;GO:0050663;110;-1.0207474;0.4200542;0.55572194
GO BP;KILLING OF CELLS OF OTHER ORGANISM;GO:0031640;17;-1.0204755;0.44136807;0.5558097
GO BP;POSITIVE REGULATION OF DNA BINDING;GO:0043388;42;-1.0205058;0.42;0.556003
GO BP;MEMBRANE DEPOLARIZATION;GO:0051899;48;-1.0186077;0.4331307;0.5594909
GO BP;SNRNA METABOLIC PROCESS;GO:0016073;33;1.1187224;0.26420453;0.55983055
GO BP;GLYCOLIPID BIOSYNTHETIC PROCESS;GO:0009247;51;1.1178668;0.24925816;0.5598318
GO BP;NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS;GO:0042036;16;-1.0181847;0.45317724;0.56017
GO BP;UBIQUINONE METABOLIC PROCESS;GO:0006743;16;-1.0177536;0.43414634;0.56060827
GO BP;POSITIVE REGULATION OF IMMUNE RESPONSE;GO:0050778;454;-1.0177916;0.4185268;0.5607764
KEGG;RETINOL METABOLISM;;15;1.0533398;0.3887468;0.56238866
GO BP;DICARBOXYLIC ACID TRANSPORT;GO:0006835;58;-1.0163338;0.42651296;0.5627888
GO BP;TORC1 SIGNALING;GO:0038202;37;-1.0165608;0.44580153;0.56301665
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II;GO:0002504;82;-1.0163447;0.43357664;0.563027
GO BP;COFACTOR METABOLIC PROCESS;#N/A;332;-1.0164508;0.42756185;0.5630342
GO BP;PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS;#N/A;17;1.1157296;0.3342318;0.56336635
GO BP;IMMUNE RESPONSE REGULATING SIGNALING PATHWAY;GO:0002764;353;-1.0154058;0.42774567;0.5646851
GO BP;REGULATION OF HEART RATE;GO:0002027;43;-1.0152807;0.42589703;0.5647026
GO BP;MITOCHONDRIAL FUSION;GO:0008053;20;-1.0147864;0.41582492;0.5655646
GO BP;POSITIVE REGULATION OF SYNAPSE ASSEMBLY;GO:0051965;24;-1.0141912;0.42651758;0.5664243
GO BP;PROTEIN DESTABILIZATION;GO:0031648;43;-1.0141958;0.42638037;0.5666728
GO BP;NEGATIVE REGULATION OF CYTOKINE PRODUCTION;GO:0001818;149;-1.0136706;0.41229194;0.56709474
GO BP;RESPONSE TO CHEMOKINE;#N/A;24;-1.0137849;0.4473684;0.56709665
KEGG;VASCULAR SMOOTH MUSCLE CONTRACTION;;64;-1.036336;0.3953824;0.5672349
GO BP;TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;GO:0006367;149;-1.0133156;0.43214756;0.5676436
GO BP;HORMONE BIOSYNTHETIC PROCESS;GO:0042446;49;-1.011454;0.4363354;0.5715865
GO BP;NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048025;20;1.1118941;0.31234866;0.5719992
GO BP;CELLULAR RESPONSE TO ABIOTIC STIMULUS;#N/A;227;-1.0107809;0.44638404;0.5722872
GO BP;RELAXATION OF MUSCLE;GO:0090075;17;-1.0105655;0.43432575;0.5725276
GO BP;REGULATION OF GLYCOPROTEIN METABOLIC PROCESS;#N/A;30;-1.0107876;0.44516128;0.5725335
GO BP;POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS;GO:1904407;20;-1.0104067;0.45498392;0.57263654
GO BP;RESPONSE TO INTERLEUKIN 7;#N/A;29;-1.0108534;0.40923077;0.57265526
KEGG;O GLYCAN BIOSYNTHESIS;;16;1.0678943;0.37435898;0.5739388
GO BP;OVULATION CYCLE PROCESS;GO:0022602;26;1.1103258;0.29396325;0.57409555
GO BP;MYELOID LEUKOCYTE ACTIVATION;#N/A;415;-1.0093799;0.46292135;0.57466334
KEGG;RNA DEGRADATION;;54;1.0570093;0.33438486;0.5768826
GO BP;RNA DEPENDENT DNA BIOSYNTHETIC PROCESS;GO:0006278;67;-1.0078061;0.44524497;0.5780036
GO BP;MITOTIC CHROMOSOME CONDENSATION;GO:0007076;16;-1.0074134;0.45049506;0.5786403
GO BP;CILIUM MOVEMENT;GO:0003341;40;1.107834;0.2967359;0.5788588
GO BP;VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION;#N/A;17;-1.0068349;0.42880794;0.579694
GO BP;TUMOR NECROSIS FACTOR SECRETION;GO:1990774;16;-1.0059758;0.44821733;0.5806003
GO BP;IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE;GO:0036498;60;-1.0060916;0.4300752;0.58060294
GO BP;GLANDULAR EPITHELIAL CELL DIFFERENTIATION;GO:0002067;30;-1.0062916;0.4399376;0.5806625
GO BP;POSITIVE REGULATION OF CHEMOKINE PRODUCTION;GO:0032722;31;-1.0061513;0.4386503;0.580734
GO BP;REGULATION OF MULTI ORGANISM PROCESS;#N/A;493;-1.005692;0.45495495;0.58096695
GO BP;NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS;GO:1902883;34;-1.0055556;0.4570552;0.581015
GO BP;NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION;GO:1903828;86;-1.005174;0.43615496;0.5816173
GO BP;CELLULAR RESPONSE TO ANTIBIOTIC;GO:0071236;100;-1.0047717;0.4501385;0.5822183
GO BP;REGULATION OF CELL CYCLE PHASE TRANSITION;GO:1901987;388;-1.0040767;0.44341803;0.583262
GO BP;NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION;GO:0046639;15;-1.0041854;0.46103895;0.5832694
GO BP;PROTEIN DEGLYCOSYLATION;GO:0006517;26;-1.0036023;0.45901638;0.5840765
GO BP;CELLULAR RESPONSE TO XENOBIOTIC STIMULUS;GO:0071466;99;-1.0034232;0.46311477;0.58420676
GO BP;ANTIBACTERIAL HUMORAL RESPONSE;GO:0019731;20;1.1051341;0.3004926;0.58428353
GO BP;REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL;GO:0051881;56;1.1041319;0.25949368;0.58469665
GO BP;REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902749;193;-1.00232;0.4653846;0.5864386
GO BP;RESPONSE TO ARSENIC CONTAINING SUBSTANCE;GO:0046685;31;-1.002042;0.452454;0.5868175
GO BP;NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION;GO:0046636;21;-1.001297;0.46915585;0.5882835
GO BP;SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS;GO:0016447;36;-1.000935;0.46214512;0.5888463
GO BP;CELLULAR COMPONENT DISASSEMBLY;#N/A;435;1.1018513;0.0990991;0.5889731
GO BP;REGULATION OF MAST CELL ACTIVATION;GO:0033003;24;-1.0002502;0.47217807;0.5901281
GO BP;CELLULAR RESPONSE TO DSRNA;GO:0071359;17;-1.0001041;0.46324787;0.5901796
GO BP;NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION;GO:0051154;23;-0.9996559;0.4517685;0.59070176
GO BP;ANOIKIS;GO:0043276;24;-0.999658;0.454844;0.59096384
GO BP;FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS;GO:0006760;23;-0.99939984;0.48058254;0.5909984
GO BP;ACTIVATION OF JUN KINASE ACTIVITY;GO:0007257;32;-0.9988329;0.45800316;0.59206676
GO BP;REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0032784;45;-0.998607;0.46686748;0.59232295
GO BP;CELL CYCLE ARREST;GO:0007050;185;-0.9973835;0.4699248;0.5948279
GO BP;ANTIBIOTIC METABOLIC PROCESS;GO:0016999;66;-0.99713767;0.4594203;0.5951293
GO BP;ALDITOL METABOLIC PROCESS;#N/A;16;-0.9969742;0.45286196;0.5952276
GO BP;ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD;GO:0043153;19;-0.9963377;0.43922204;0.59636843
GO BP;NEURON MATURATION;GO:0042551;27;-0.9959637;0.46464646;0.5969431
GO BP;POSITIVE REGULATION OF LIPID LOCALIZATION;#N/A;48;-0.9954647;0.47161573;0.5975488
GO BP;MYOBLAST DIFFERENTIATION;GO:0045445;54;-0.99547297;0.47007298;0.59780204
GO BP;POSITIVE REGULATION OF T CELL PROLIFERATION;GO:0042102;43;-0.9951281;0.46326837;0.5980515
GO BP;MODULATION BY HOST OF VIRAL PROCESS;GO:0044788;20;-0.9947963;0.4457429;0.59852874
GO BP;LAMELLIPODIUM ASSEMBLY;GO:0030032;42;-0.99454206;0.44149765;0.59885925
GO BP;PROTEIN DEMANNOSYLATION;#N/A;18;-0.9939828;0.47595358;0.5995652
GO BP;DNA REPLICATION INITIATION;GO:0006270;34;-0.99407315;0.46666667;0.5996219
GO BP;PROTEIN KINASE C SIGNALING;GO:0070528;17;-0.9931519;0.47019866;0.60034436
GO BP;RESPONSE TO X RAY;GO:0010165;28;-0.99322087;0.46325877;0.60045195
GO BP;RNA POLYADENYLATION;GO:0043631;44;-0.99298126;0.47384617;0.6004924
GO BP;NEURAL CREST CELL DIFFERENTIATION;GO:0014033;54;-0.9932474;0.46546546;0.6006686
GO BP;PLACENTA BLOOD VESSEL DEVELOPMENT;GO:0060674;24;-0.99332494;0.46518987;0.60075426
GO BP;REGULATION OF WATER LOSS VIA SKIN;GO:0033561;18;-0.9922289;0.4772344;0.6018967
GO BP;RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:0034976;242;-0.99207586;0.50060904;0.6019586
GO BP;WATER HOMEOSTASIS;GO:0030104;45;-0.99169344;0.46507937;0.60258025
GO BP;POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;55;-0.9911627;0.49177876;0.6035398
GO BP;INOSITOL TRISPHOSPHATE METABOLIC PROCESS;GO:0032957;19;1.095073;0.32289156;0.6040251
GO BP;VITAMIN METABOLIC PROCESS;GO:0006766;91;-0.99062467;0.47832167;0.6044481
GO BP;POSITIVE REGULATION OF WNT SIGNALING PATHWAY;GO:0030177;140;1.0957258;0.20242915;0.6044834
GO BP;NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS;#N/A;58;-0.98964244;0.4882698;0.60610205
GO BP;ACTIVATION OF IMMUNE RESPONSE;GO:0002253;369;-0.98965156;0.4925544;0.60635096
GO BP;INTERLEUKIN 6 SECRETION;#N/A;21;-0.9894148;0.48553056;0.6063552
GO BP;REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND;GO:2001239;24;-0.98911095;0.47191012;0.6068053
GO BP;NUCLEOSIDE METABOLIC PROCESS;GO:0009116;81;-0.98860586;0.49425286;0.6074415
GO BP;NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS;GO:1904036;29;-0.9886325;0.47289157;0.60765207
GO BP;RESPONSE TO HYDROGEN PEROXIDE;GO:0042542;103;-0.98805207;0.47659576;0.60845304
GO BP;FOREBRAIN GENERATION OF NEURONS;GO:0021872;32;-0.98737454;0.47916666;0.6096903
GO BP;INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY;GO:0030520;42;-0.98715144;0.4827044;0.6099208
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS;GO:0090501;121;1.0923198;0.27099237;0.61002016
GO BP;RESPONSE TO MURAMYL DIPEPTIDE;GO:0032495;15;-0.9863836;0.4695946;0.61134994
GO BP;POSITIVE REGULATION OF DEFENSE RESPONSE;#N/A;295;-0.9861064;0.50174624;0.6117035
GO BP;POLYOL BIOSYNTHETIC PROCESS;#N/A;51;-0.9855074;0.4833837;0.6128127
GO BP;POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048026;16;-0.98475736;0.48844886;0.61431533
GO BP;POSITIVE REGULATION OF B CELL ACTIVATION;GO:0050871;47;-0.9842772;0.49848944;0.6150868
GO BP;NEGATIVE REGULATION OF WNT SIGNALING PATHWAY;GO:0030178;151;-0.98385257;0.50132626;0.6157725
GO BP;NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION;GO:0000715;22;1.0895518;0.34236452;0.6159924
GO BP;MEMBRANE LIPID BIOSYNTHETIC PROCESS;#N/A;116;-0.983177;0.49166667;0.61707985
GO BP;REGULATION OF ORGANIC ACID TRANSPORT;#N/A;28;-0.9827027;0.48885587;0.61784214
GO BP;PHOTOPERIODISM;#N/A;20;-0.9824712;0.48455286;0.6180854
GO BP;CELL AGING;GO:0007569;85;1.0878679;0.24548736;0.6186121
GO BP;MULTICELLULAR ORGANISMAL RESPONSE TO STRESS;GO:0033555;32;-0.9818321;0.5;0.61927223
GO BP;VESICLE DOCKING;GO:0048278;55;-0.98163754;0.49244714;0.6194297
GO BP;REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903426;52;-0.9810229;0.49846154;0.6203035
GO BP;CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS;GO:1901137;483;-0.98104966;0.5297419;0.62051916
GO BP;PROTEIN LOCALIZATION TO VACUOLE;GO:0072665;56;-0.9806772;0.5086705;0.6205366
GO BP;NEGATIVE REGULATION OF TRANSFERASE ACTIVITY;#N/A;216;-0.9807127;0.5276753;0.6207246
GO BP;POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY;GO:0010592;16;-0.9804168;0.48076922;0.6208624
GO BP;FEAR RESPONSE;GO:0042596;18;-0.98027694;0.4719472;0.62089294
GO BP;N TERMINAL PROTEIN AMINO ACID ACETYLATION;GO:0006474;15;-0.980072;0.4645799;0.6210811
GO BP;POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION;GO:0035307;32;-0.97979337;0.4868217;0.62118345
GO BP;REGULATION OF THE FORCE OF HEART CONTRACTION;GO:0002026;15;-0.97990566;0.47974068;0.6211969
GO BP;REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE;#N/A;34;-0.97958994;0.48963317;0.62138355
GO BP;REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE;GO:1900101;23;-0.97942483;0.5032051;0.62147194
GO BP;CEREBRAL CORTEX CELL MIGRATION;GO:0021795;30;-0.979189;0.4752791;0.62172115
KEGG;LYSOSOME;;108;-1.0070442;0.44060773;0.6256174
GO BP;T CELL SELECTION;GO:0045058;22;-0.97727036;0.5;0.62574023
GO BP;ZINC ION TRANSMEMBRANE TRANSPORT;GO:0071577;17;-0.97666204;0.48675495;0.62631065
GO BP;POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE;GO:0002720;31;-0.97651356;0.48902822;0.6263707
GO BP;MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS;GO:0031293;17;-0.9766887;0.50084317;0.6265297
GO BP;LEUKOCYTE MEDIATED IMMUNITY;GO:0002443;478;-0.9767874;0.5558061;0.62659127
GO BP;PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE;GO:0002532;36;-0.97520614;0.4976526;0.6290543
GO BP;NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;54;-0.97506064;0.5030211;0.629097
KEGG;BETA ALANINE METABOLISM;;19;1.0183375;0.42385787;0.62985575
GO BP;NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY;GO:0090101;74;-0.974566;0.53835225;0.62994695
GO BP;INTERFERON GAMMA PRODUCTION;GO:0032609;40;-0.9739769;0.48470947;0.6310337
GO BP;REGULATION OF HUMORAL IMMUNE RESPONSE;#N/A;25;-0.97369874;0.49344262;0.6311316
GO BP;REGULATION OF DNA DAMAGE CHECKPOINT;GO:2000001;16;-0.97374374;0.47179487;0.63130105
GO BP;POSITIVE REGULATION OF TRANSLATIONAL INITIATION;GO:0045948;21;-0.97304374;0.5;0.63231176
GO BP;INTERLEUKIN 1 PRODUCTION;GO:0032612;42;-0.9726283;0.48698315;0.6329997
GO BP;SECRETORY GRANULE ORGANIZATION;GO:0033363;25;-0.9709954;0.49919486;0.6364825
GO BP;GTP METABOLIC PROCESS;GO:0046039;21;-0.9701502;0.50490195;0.63756
GO BP;REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE;GO:2000008;29;-0.97033775;0.4992224;0.6376783
GO BP;POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION;GO:0010862;25;-0.97016627;0.4935275;0.63779724
GO BP;ISOPRENOID BIOSYNTHETIC PROCESS;GO:0008299;19;-0.9698084;0.47317073;0.6380339
GO BP;POSITIVE REGULATION OF VIRAL LIFE CYCLE;GO:1903902;53;-0.9690114;0.51432884;0.63929933
GO BP;INTERLEUKIN 1 BETA PRODUCTION;GO:0032611;37;-0.96911514;0.50829566;0.63933235
GO BP;RETINA HOMEOSTASIS;GO:0001895;40;-0.9677754;0.5111465;0.6415048
GO BP;FOLIC ACID METABOLIC PROCESS;GO:0046655;16;-0.96763635;0.5089431;0.64152753
GO BP;CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS;GO:0021955;23;-0.9678596;0.53061223;0.6415998
GO BP;RNA EXPORT FROM NUCLEUS;GO:0006405;129;-0.9663413;0.5275482;0.64360136
GO BP;RESPONSE TO OXIDATIVE STRESS;GO:0006979;333;-0.9659416;0.5704142;0.64363784
GO BP;REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION;#N/A;18;-0.96575546;0.5058824;0.6437812
GO BP;LYSOSOME LOCALIZATION;GO:0032418;55;-0.9659727;0.53333336;0.6438554
GO BP;POSITIVE REGULATION OF LIPID KINASE ACTIVITY;GO:0090218;22;-0.9663516;0.5219512;0.6438644
GO BP;ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS;GO:0006919;57;-0.9664406;0.49562684;0.6439427
GO BP;INTEGRIN ACTIVATION;GO:0033622;16;-0.96604854;0.5149007;0.6439642
GO BP;REGULATION OF PROTEIN HOMODIMERIZATION ACTIVITY;#N/A;15;-0.9654239;0.5033784;0.6442295
GO BP;INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS;GO:0032958;27;-0.96469533;0.52006423;0.6456047
GO BP;T CELL RECEPTOR SIGNALING PATHWAY;GO:0050852;131;-0.9640821;0.54557467;0.64674634
GO BP;PHASOME ACIDIFICATION;#N/A;24;1.0705003;0.3575;0.64692855
GO BP;REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM;#N/A;163;-0.9638556;0.54161334;0.64698845
GO BP;COFACTOR TRANSPORT;#N/A;33;1.077503;0.33692724;0.6476004
GO BP;REGULATION OF MACROPHAGE CHEMOTAXIS;GO:0010758;15;1.0706613;0.35154393;0.6489572
GO BP;REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;319;-0.9627163;0.5642857;0.6493089
GO BP;PROTEIN EXIT FROM ENDOPLASMIC RETICULUM;GO:0032527;39;1.0711701;0.34421366;0.64986634
GO BP;B CELL MEDIATED IMMUNITY;GO:0019724;63;-0.9620215;0.53977275;0.65057766
GO BP;LGI VESICLE BUDDING;#N/A;69;1.0747336;0.2948718;0.65126735
GO BP;PIGMENT GRANULE ORGANIZATION;GO:0048753;21;1.0713501;0.33420366;0.65183085
GO BP;NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS;GO:0051055;34;-0.9612514;0.53488374;0.6520493
GO BP;RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE;GO:1990126;27;1.0750443;0.32446808;0.6529445
GO BP;REGULATION OF OXIDATIVE PHOSPHORYLATION;GO:0002082;26;1.0733702;0.36104512;0.6530622
GO BP;NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION;#N/A;42;-0.9605942;0.50940436;0.6532345
GO BP;CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION;GO:0086064;16;1.0717111;0.3587963;0.6532436
GO BP;TRNA WOBBLE URIDINE MODIFICATION;GO:0002098;15;1.0666536;0.35103926;0.6538254
GO BP;OLISACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS;#N/A;17;1.0674341;0.33990148;0.65392995
GO BP;REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS;GO:0097006;64;-0.9600094;0.5381166;0.6542768
GO BP;PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS;GO:0006661;100;-0.9595108;0.5360963;0.6548409
GO BP;NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0034122;23;-0.95954704;0.53061223;0.6550412
GO BP;NEGATIVE REGULATION OF RESPONSE TO DRUG;#N/A;16;-0.9591841;0.5042017;0.6552383
GO BP;CELLULAR RESPONSE TO OXYGEN RADICAL;#N/A;16;1.0718136;0.33417085;0.6554475
GO BP;SYNAPTIC VESICLE PRIMING;GO:0016082;18;-0.9588368;0.49177632;0.6556939
GO BP;PROTEIN TARGETING TO VACUOLE;GO:0006623;37;-0.9582529;0.5069552;0.6562082
GO BP;MEIOTIC CHROMOSOME SEGREGATION;GO:0045132;69;-0.95834494;0.526087;0.65627474
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION;GO:0051250;77;-0.95843333;0.5389049;0.6563658
GO BP;REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS;GO:0017158;27;-0.95676523;0.53697747;0.6590408
GO BP;MEMBRANE RAFT ORGANIZATION;GO:0031579;16;-0.9565658;0.51480263;0.6592
GO BP;NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY;GO:0045879;22;-0.9567934;0.53236246;0.6592633
GO BP;REGULATION OF MORPHOGENESIS OF AN EPITHELIUM;#N/A;128;-0.95596766;0.5483871;0.6602597
GO BP;RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM;GO:0007585;32;-0.9558336;0.5178849;0.66028565
GO BP;NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902807;88;-0.95567805;0.54366195;0.6603594
GO BP;DRUG TRANSMEMBRANE TRANSPORT;GO:0006855;46;-0.9552083;0.5198777;0.6611182
GO BP;CELLULAR RESPONSE TO GAMMA RADIATION;GO:0071480;29;1.0635325;0.35654595;0.6611715
GO BP;SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA GERMLINE RECOMBINATION WITHIN A SINGLE LOCUS;#N/A;42;-0.95491284;0.5275229;0.6612274
GO BP;CELLULAR HORMONE METABOLIC PROCESS;#N/A;65;-0.9549279;0.55423474;0.6614803
GO BP;GLYCOPROTEIN CATABOLIC PROCESS;GO:0006516;19;-0.95433605;0.5228013;0.66223216
GO BP;VESICLE DOCKING INVOLVED IN EXOCYTOSIS;GO:0006904;38;-0.95406276;0.53742516;0.66252744
GO BP;OVARIAN FOLLICLE DEVELOPMENT;GO:0001541;28;-0.95305854;0.5362319;0.66394526
GO BP;ANDROGEN RECEPTOR SIGNALING PATHWAY;GO:0030521;50;-0.95311093;0.5402985;0.66411346
GO BP;REGULATION OF VESICLE FUSION;GO:0031338;21;-0.95282805;0.52922076;0.66419333
GO BP;DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION;GO:0050906;33;-0.95317966;0.5248447;0.6642547
KEGG;NITROGEN METABOLISM;;15;-0.9865445;0.47213113;0.66634405
KEGG;VASOPRESSIN REGULATED WATER REABSORPTION;;35;-0.9824612;0.4773083;0.66636056
GO BP;BASE EXCISION REPAIR;GO:0006284;41;-0.9515076;0.52567977;0.6666712
GO BP;RAB PROTEIN SIGNAL TRANSDUCTION;GO:0032482;60;-0.9516243;0.5431548;0.6666868
GO BP;FATTY ACID BETA OXIDATION;GO:0006635;62;-0.950505;0.55167395;0.6686306
GO BP;NADPH REGENERATION;GO:0006740;15;-0.9495038;0.49578413;0.66940385
GO BP;EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS;GO:0060441;18;-0.94936556;0.5423453;0.6694415
GO BP;NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS;GO:1902042;27;-0.9496926;0.51480263;0.6695764
GO BP;PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY;GO:0035357;15;-0.94950455;0.53872633;0.66968966
GO BP;POSITIVE REGULATION OF MULTI ORGANISM PROCESS;#N/A;364;-0.94972646;0.6061644;0.6697891
GO BP;REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS;GO:0090049;27;-0.94983834;0.53858024;0.6698409
GO BP;FIBRINOLYSIS;GO:0042730;18;-0.9489431;0.52100843;0.67015207
GO BP;MEIOSIS I CELL CYCLE PROCESS;#N/A;88;-0.9483317;0.56534094;0.67100143
GO BP;POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION;#N/A;17;-0.9484523;0.5389948;0.67100215
GO BP;RESPONSE TO BACTERIUM;GO:0009617;308;-0.9478618;0.6287425;0.671213
GO BP;TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY;GO:0034138;16;-0.9480644;0.5354839;0.67131424
GO BP;ANIMAL ORGAN FORMATION;GO:0048645;40;-0.9478899;0.5381026;0.6714375
GO BP;PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;77;-0.94730026;0.5568345;0.6719006
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION;GO:0070198;29;-0.9469967;0.53246754;0.67199945
GO BP;LONG TERM MEMORY;GO:0007616;18;-0.9470934;0.53571427;0.6720809
GO BP;POSITIVE REGULATION OF CELL CYCLE ARREST;GO:0071158;66;-0.94730884;0.5603577;0.67216873
GO BP;LIVER MORPHOGENESIS;GO:0072576;16;-0.94515115;0.5540541;0.67588824
GO BP;NUCLEUS ORGANIZATION;GO:0006997;103;-0.94500923;0.58596975;0.6759313
GO BP;REGULATION OF IMMUNOGLOBULIN PRODUCTION;GO:0002637;37;-0.9448232;0.56727827;0.6760425
GO BP;CELL CELL RECOGNITION;#N/A;30;-0.94448763;0.5439137;0.6761928
GO BP;POSITIVE REGULATION OF DEPHOSPHORYLATION;GO:0035306;42;-0.9442937;0.5437788;0.67635214
GO BP;POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;GO:0060261;15;-0.9445351;0.5440932;0.67638004
GO BP;COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT;GO:0002066;37;-0.9439717;0.56240124;0.6767843
GO BP;POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002821;47;-0.943734;0.5474006;0.6770228
GO BP;BODY FLUID SECRETION;GO:0007589;58;-0.9434559;0.54933727;0.6770609
GO BP;HETEROTYPIC CELL CELL ADHESION;GO:0034113;39;-0.943504;0.5567823;0.67724496
GO BP;MYELOID LEUKOCYTE CYTOKINE PRODUCTION;#N/A;23;-0.94320863;0.53367;0.6773069
GO BP;REGULATION OF GRANULOCYTE CHEMOTAXIS;GO:0071622;21;1.0575879;0.35766423;0.6775329
GO BP;DETOXIFICATION;#N/A;78;-0.9428029;0.573508;0.67764616
GO BP;PHOSPHOLIPID CATABOLIC PROCESS;GO:0009395;30;-0.94288445;0.53267974;0.67774004
GO BP;POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE;GO:1900087;31;-0.941484;0.5520995;0.6800584
GO BP;MYELOID LEUKOCYTE MIGRATION;#N/A;90;-0.941215;0.5834464;0.6800828
GO BP;CYTOSOLIC TRANSPORT;GO:0016482;140;-0.94134367;0.6007905;0.6800888
GO BP;HISTONE DEUBIQUITINATION;GO:0016578;20;-0.9409079;0.5303266;0.6801962
GO BP;MITOTIC CELL CYCLE CHECKPOINT;GO:0007093;149;-0.9415181;0.5968992;0.68026984
GO BP;NEGATIVE REGULATION OF BLOOD PRESSURE;GO:0045776;17;-0.94094026;0.54710746;0.68040705
GO BP;POLYSACCHARIDE BIOSYNTHETIC PROCESS;GO:0000271;54;-0.9404632;0.5639881;0.6808931
GO BP;L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT;GO:1902475;32;-0.9403169;0.5378422;0.6809442
GO BP;RESPONSE TO MINERALOCORTICOID;#N/A;16;-0.9400917;0.5362319;0.6811764
GO BP;IRON ION TRANSPORT;GO:0006826;60;-0.93993646;0.5597015;0.68124676
GO BP;POSITIVE REGULATION OF CYTOKINE SECRETION;GO:0050715;56;-0.9397295;0.5510511;0.68142205
GO BP;POSITIVE REGULATION OF LYMPHOCYTE MIGRATION;GO:2000403;22;-0.9389706;0.5264;0.68194276
GO BP;NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY;#N/A;28;-0.9390335;0.54746836;0.68209416
GO BP;RIBONUCLEOTIDE CATABOLIC PROCESS;#N/A;26;-0.93928874;0.545156;0.68212694
GO BP;CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION;#N/A;18;-0.9390848;0.52579033;0.6822638
GO BP;REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902806;138;-0.9384723;0.5833333;0.6827688
GO BP;SNRNA TRANSCRIPTION;GO:0009301;68;1.0544466;0.3375796;0.6850222
GO BP;CELL CYCLE G1 S PHASE TRANSITION;GO:0044843;219;-0.9368389;0.6179067;0.6860526
GO BP;SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0072331;234;-0.93576384;0.65500605;0.6879543
GO BP;REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE;GO:0000083;24;-0.93458664;0.5598007;0.6880023
GO BP;REGULATION OF CELL CYCLE CHECKPOINT;#N/A;30;-0.9350776;0.54559505;0.6880671
GO BP;REGULATION OF CELL CYCLE ARREST;GO:0071156;82;-0.9353075;0.5877551;0.68811095
GO BP;SARCOMERE ORGANIZATION;GO:0045214;24;-0.9358018;0.5213946;0.68814754
GO BP;ACROSOME REACTION;GO:0007340;15;-0.9346304;0.5594059;0.6881939
GO BP;MRNA EXPORT FROM NUCLEUS;GO:0006406;104;-0.9351416;0.5842246;0.6882193
GO BP;ZINC ION TRANSPORT;GO:0006829;20;-0.93551254;0.5351882;0.688221
GO BP;PROTEIN PROCESSING;GO:0016485;152;-0.9348662;0.61328125;0.68824536
GO BP;REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902175;22;-0.93536144;0.55592656;0.6882818
GO BP;NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION;GO:1903038;63;-0.93468964;0.5832084;0.68835616
GO BP;MONOSACCHARIDE CATABOLIC PROCESS;#N/A;54;-0.93399733;0.5647059;0.6890607
GO BP;PROTEIN K48 LINKED UBIQUITINATION;GO:0070936;50;1.0515239;0.3488372;0.6891156
GO BP;ESTABLISHMENT OF MITOCHONDRION LOCALIZATION;GO:0051654;22;-0.93379265;0.5646688;0.68922865
GO BP;FATTY ACID DERIVATIVE TRANSPORT;#N/A;23;1.0507094;0.36553526;0.6892749
GO BP;CELL DEATH IN RESPONSE TO OXIDATIVE STRESS;GO:0036473;61;-0.9336039;0.5619469;0.68935245
GO BP;POSTREPLICATION REPAIR;GO:0006301;47;1.0521604;0.3323782;0.6896854
GO BP;POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION;GO:1902751;28;-0.9331097;0.55737704;0.6901783
GO BP;REGULATION OF MITOCHONDRION ORGANIZATION;GO:0010821;149;-0.93265307;0.61430395;0.6909097
GO BP;MYELOID LEUKOCYTE MEDIATED IMMUNITY;#N/A;376;-0.93157804;0.6514806;0.69272745
GO BP;IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY;GO:0002768;241;-0.9315811;0.64166665;0.6930101
GO BP;PROTEIN COMPLEX OLIMERIZATION;#N/A;339;-0.9295321;0.6678322;0.69635934
GO BP;APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT;GO:1902742;18;-0.92958546;0.5491803;0.69652355
GO BP;POSITIVE REGULATION OF LIPID TRANSPORT;GO:0032370;34;-0.92926544;0.54833597;0.69665515
GO BP;POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION;GO:1903055;15;-0.929608;0.5435898;0.6967695
GO BP;HUMORAL IMMUNE RESPONSE;GO:0006959;90;-0.9290412;0.5934844;0.6968627
GO BP;POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY;GO:2001056;99;-0.9286791;0.60991955;0.69735473
KEGG;OOCYTE MEIOSIS;;88;-0.9649255;0.5251397;0.6988298
GO BP;NUCLEOBASE BIOSYNTHETIC PROCESS;#N/A;17;-0.9278798;0.5559322;0.6988711
GO BP;POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION;#N/A;18;-0.9275973;0.57912457;0.69921577
GO BP;RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM;GO:1903514;16;-0.92732173;0.57621443;0.699535
GO BP;REGULATION OF MEMBRANE REPOLARIZATION;GO:0060306;16;-0.9265363;0.5652921;0.701027
GO BP;T CELL APOPTOTIC PROCESS;GO:0070231;31;-0.9259058;0.5968992;0.70208955
GO BP;REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;#N/A;210;-0.9243655;0.6438356;0.7051356
GO BP;RESPONSE TO HEPATOCYTE GROWTH FACTOR;#N/A;15;-0.92384887;0.5770548;0.70600605
GO BP;NADP METABOLIC PROCESS;GO:0006739;29;-0.9235783;0.5970874;0.7062894
GO BP;PEPTIDE CATABOLIC PROCESS;GO:0043171;17;-0.92336607;0.5518395;0.7064688
GO BP;REGULATION OF MITOCHONDRIAL FISSION;GO:0090140;20;-0.9230947;0.5707472;0.70677006
GO BP;POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT;GO:1901863;43;-0.9215943;0.58409786;0.7097963
GO BP;POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY;GO:0002711;19;-0.92140466;0.57211536;0.7099235
GO BP;PH REDUCTION;GO:0045851;42;1.042598;0.36494252;0.71034586
GO BP;POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE;GO:1990573;21;-0.92083085;0.5735294;0.71059114
GO BP;CALCIUM ION IMPORT;GO:0070509;37;-0.9209325;0.568;0.7106538
GO BP;CERAMIDE BIOSYNTHETIC PROCESS;GO:0046513;48;-0.9202345;0.5903427;0.7116108
GO BP;REGULATION OF DNA DEPENDENT DNA REPLICATION;GO:0090329;43;-0.9199466;0.58666664;0.7116582
GO BP;REGULATION OF MEMBRANE LIPID DISTRIBUTION;GO:0097035;32;-0.9199743;0.5769231;0.71189666
GO BP;VESICLE MEDIATED TRANSPORT IN SYNAPSE;GO:0099003;131;-0.91852444;0.6278755;0.71267754
GO BP;PEPTIDYL PROLINE MODIFICATION;GO:0018208;47;1.0426896;0.37643677;0.7127069
GO BP;IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE;GO:0002381;34;-0.91901946;0.59657323;0.71278805
GO BP;POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS;#N/A;249;-0.91909206;0.6618877;0.7129258
GO BP;THYMOCYTE APOPTOTIC PROCESS;GO:0070242;15;-0.91853166;0.5714286;0.71295536
GO BP;REGULATION OF ANIMAL ORGAN FORMATION;GO:0003156;19;-0.9187801;0.5787728;0.7129762
GO BP;REGULATION OF ATPASE ACTIVITY;GO:0043462;70;-0.9191668;0.6017316;0.7130632
GO BP;PROTEIN MATURATION;GO:0051604;214;-0.91818994;0.65989846;0.7131057
GO BP;POSITIVE REGULATION OF STEM CELL PROLIFERATION;GO:2000648;26;-0.91857296;0.58028615;0.7131515
GO BP;CELLULAR RESPONSE TO HYDROGEN PEROXIDE;GO:0070301;67;-0.9179788;0.6090652;0.71325946
GO BP;DNA UNWINDING INVOLVED IN DNA REPLICATION;GO:0006268;15;-0.9171849;0.5933333;0.7146288
GO BP;REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER;#N/A;20;-0.9167627;0.5729167;0.71523803
GO BP;QUINONE METABOLIC PROCESS;#N/A;19;-0.91633916;0.5942275;0.7155973
GO BP;TRANSITION METAL ION TRANSPORT;#N/A;93;-0.916464;0.61891514;0.7156286
GO BP;REGULATION OF TRANSLATIONAL FIDELITY;GO:0006450;17;1.0400505;0.3938619;0.7159858
GO BP;CELL KILLING;GO:0001906;63;-0.91472936;0.6231454;0.71883327
GO BP;PROTEIN O LINKED GLYCOSYLATION;GO:0006493;73;-0.9145145;0.6150568;0.71898454
GO BP;REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY;GO:0060338;29;-0.91396743;0.61066234;0.71992207
GO BP;MITOTIC METAPHASE PLATE CONGRESSION;GO:0007080;42;-0.9135367;0.60784316;0.7205869
GO BP;REGULATION OF ERAD PATHWAY;GO:1904292;25;1.0375568;0.38157895;0.7215422
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR;GO:0042771;39;-0.9125318;0.58914727;0.7221357
GO BP;REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING;GO:0010882;16;-0.91261;0.5675676;0.72226685
GO BP;MONONUCLEAR CELL MIGRATION;GO:0071674;35;1.0269438;0.38567492;0.7226578
GO BP;NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION;GO:0050732;33;1.0283014;0.4132948;0.7233402
GO BP;PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS;GO:0006213;22;1.027474;0.42751843;0.723506
GO BP;TETRAPYRROLE METABOLIC PROCESS;#N/A;46;1.0303593;0.3816156;0.72449076
GO BP;TETRAPYRROLE BIOSYNTHETIC PROCESS;GO:0033014;27;1.0295163;0.39370078;0.72463953
GO BP;PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;#N/A;16;1.0318216;0.41131106;0.7248239
GO BP;POSITIVE REGULATION OF BLOOD PRESSURE;GO:0045777;15;1.0309998;0.40359896;0.7249556
GO BP;CELLULAR RESPONSE TO GLUCOSE STARVATION;GO:0042149;35;-0.91090477;0.59370077;0.7253427
GO BP;TRANSCRIPTION BY RNA POLYMERASE III;GO:0006383;47;1.0283912;0.40597016;0.72561526
GO BP;PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION;GO:0071459;21;1.0322956;0.3856383;0.72580636
GO BP;POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY;GO:2001235;136;-0.9103543;0.6483957;0.72595024
GO BP;GLYCOSYL COMPOUND METABOLIC PROCESS;#N/A;94;-0.9104243;0.6315789;0.7261123
GO BP;NEGATIVE REGULATION OF REPRODUCTIVE PROCESS;#N/A;33;-0.9100579;0.63258785;0.7262908
GO BP;ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE;GO:0002251;19;1.0336641;0.40052357;0.72654235
GO BP;MICROTUBULE BUNDLE FORMATION;GO:0001578;62;1.0327339;0.3954984;0.7270141
GO BP;RENAL WATER HOMEOSTASIS;GO:0003091;19;-0.9091415;0.56796116;0.7279596
GO BP;CYTOKINE MEDIATED SIGNALING PATHWAY;GO:0019221;424;-0.9088167;0.7141243;0.72834253
GO BP;CELLULAR RESPONSE TO LIGHT STIMULUS;GO:0071482;84;-0.90850866;0.63762105;0.7287142
GO BP;RNA 3 END PROCESSING;#N/A;132;1.0336932;0.36466166;0.7290967
GO BP;CATECHOLAMINE METABOLIC PROCESS;GO:0006584;24;1.0341145;0.4044665;0.73038244
GO BP;CRANIAL NERVE DEVELOPMENT;GO:0021545;24;-0.9074586;0.6076555;0.73068213
GO BP;NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;17;-0.9070368;0.59870553;0.73127896
GO BP;REGULATION OF ANIMAL ORGAN MORPHOGENESIS;#N/A;162;-0.90640324;0.6701847;0.73233867
GO BP;ENDOSOMAL TRANSPORT;GO:0016197;200;-0.9056139;0.6662531;0.7337232
GO BP;LACTATION;GO:0007595;35;-0.90490323;0.5913978;0.7349523
GO BP;REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING;#N/A;97;-0.9044518;0.6657572;0.73559976
GO BP;NEGATIVE REGULATION OF AXON GUIDANCE;#N/A;21;1.0220549;0.44702843;0.7362372
GO BP;NATURAL KILLER CELL MEDIATED IMMUNITY;#N/A;22;-0.9036863;0.60819674;0.7369398
GO BP;REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:1901028;38;1.0210781;0.3888889;0.7369929
GO BP;PHACYTOSIS;#N/A;163;-0.9030493;0.6862745;0.7380346
GO BP;ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE;GO:0008608;30;-0.90254986;0.62238806;0.7387857
GO BP;PROTEIN HOMOOLIMERIZATION;#N/A;208;-0.90238696;0.69962454;0.73881227
GO BP;DNA CATABOLIC PROCESS;GO:0006308;32;-0.9020888;0.6332237;0.7391581
GO BP;REGULATION OF HORMONE METABOLIC PROCESS;GO:0032350;23;-0.8993432;0.5855263;0.74270743
GO BP;SECONDARY METABOLIC PROCESS;GO:0019748;31;-0.8996282;0.6165289;0.7427088
GO BP;LYMPHOCYTE HOMEOSTASIS;GO:0002260;40;-0.8997334;0.6131498;0.74276644
GO BP;REGULATION OF HEART GROWTH;GO:0060420;40;-0.8998249;0.6197183;0.74287665
GO BP;POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION;#N/A;20;-0.89939433;0.59076434;0.7429076
GO BP;TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002224;98;-0.90020466;0.6968877;0.74297
GO BP;POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY;#N/A;25;-0.8990653;0.6057692;0.74300116
GO BP;CELLULAR RESPONSE TO KETONE;#N/A;60;-0.8999104;0.6480118;0.74300283
GO BP;RESPONSE TO IONIZING RADIATION;GO:0010212;124;-0.8985584;0.68247694;0.74322647
GO BP;NEGATIVE REGULATION OF BLOOD CIRCULATION;GO:1903523;19;-0.8999311;0.614726;0.74326134
GO BP;PROSTATE GLAND MORPHOGENESIS;GO:0060512;15;-0.89863604;0.5795848;0.7433616
GO BP;XENOBIOTIC METABOLIC PROCESS;GO:0006805;57;-0.898764;0.6463768;0.7433699
GO BP;REGULATION OF LYASE ACTIVITY;#N/A;17;-0.8981933;0.6045381;0.7436956
GO BP;NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS;GO:1901292;59;-0.89768934;0.64893615;0.7444821
GO BP;INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY;#N/A;18;-0.8973582;0.6173045;0.7448795
GO BP;MALE MEIOSIS I;GO:0007141;16;-0.896111;0.59766275;0.74722785
GO BP;AMELOGENESIS;GO:0097186;15;-0.895733;0.5868167;0.7477128
GO BP;MEMBRANE LIPID METABOLIC PROCESS;GO:0006643;158;-0.8934367;0.7119078;0.7519317
GO BP;ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY;GO:0050851;156;1.0150114;0.42201835;0.7520292
GO BP;REGULATION OF NECROTIC CELL DEATH;GO:0010939;19;-0.89353013;0.6247906;0.75205857
KEGG;PURINE METABOLISM;;118;0.94585985;0.58113205;0.752362
GO BP;NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION;GO:2000737;19;-0.89293593;0.61904764;0.7527138
GO BP;INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION;GO:0042491;22;-0.8926008;0.61576355;0.7531454
GO BP;NUCLEOTIDE EXCISION REPAIR;GO:0006289;103;1.0150752;0.41366908;0.7544329
GO BP;POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION;GO:1901989;81;-0.89171135;0.6657184;0.75471646
GO BP;CERAMIDE METABOLIC PROCESS;GO:0006672;67;-0.89117384;0.6676301;0.7555162
GO BP;POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;109;-0.89021426;0.67302454;0.7572447
KEGG;AMINOACYL TRNA BIOSYNTHESIS;;37;0.9635198;0.5082418;0.75742346
GO BP;NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903051;60;1.0077928;0.4433657;0.7577845
GO BP;CENTROMERE COMPLEX ASSEMBLY;GO:0034508;49;-0.88975835;0.6513057;0.75787634
GO BP;REGULATION OF PROTEIN MATURATION;#N/A;47;-0.8895538;0.6458967;0.75799596
GO BP;NEGATIVE REGULATION OF TRANSLATIONAL INITIATION;GO:0045947;18;1.0085429;0.44415584;0.75799614
GO BP;REGULATION OF ESTABLISHMENT OF PLANAR POLARITY;GO:0090175;90;1.0122106;0.425;0.7587457
GO BP;LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE;GO:0034383;29;1.0089694;0.4534005;0.75914794
GO BP;REGULATION OF RNA SPLICING;GO:0043484;117;-0.88862425;0.6982409;0.75967044
GO BP;SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT;GO:0070296;19;-0.88782436;0.61726385;0.7610269
GO BP;NCRNA CATABOLIC PROCESS;#N/A;30;1.0090213;0.44262296;0.76154345
KEGG;METABOLISM OF XENOBIOTICS BY CYTOCHROME P450;;18;0.9316333;0.5611111;0.7622223
GO BP;RESPONSE TO BRONCHODILATOR;#N/A;25;1.0095505;0.40944883;0.76240605
GO BP;PROTEIN DEPHOSPHORYLATION;GO:0006470;245;-0.88693815;0.75603867;0.7625651
GO BP;TELOMERE ORGANIZATION;GO:0032200;153;-0.8864144;0.70887727;0.7627594
GO BP;PEROXISOME ORGANIZATION;GO:0007031;70;1.0054489;0.46078432;0.762906
GO BP;REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS;#N/A;53;-0.88658345;0.65884197;0.76300025
GO BP;G1 DNA DAMAGE CHECKPOINT;#N/A;59;-0.8864173;0.6661765;0.7630593
KEGG;EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION;;56;-0.9296504;0.6125356;0.7637681
GO BP;CHROMATIN SILENCING AT RDNA;#N/A;28;1.0098088;0.43349755;0.7641453
GO BP;MODULATION BY VIRUS OF HOST MORPHOLOGY OR PHYSIOLOGY;#N/A;26;-0.88502073;0.6352;0.76535654
GO BP;OLIDENDROCYTE DEVELOPMENT;#N/A;24;-0.8845983;0.6326861;0.7659341
KEGG;BIOSYNTHESIS OF UNSATURATED FATTY ACIDS;;18;-0.9325662;0.5576923;0.76599133
GO BP;PEPTIDYL TYROSINE DEPHOSPHORYLATION;GO:0035335;74;-0.8838611;0.70014346;0.76716304
KEGG;GLUTATHIONE METABOLISM;;38;0.9079464;0.61495847;0.7720435
GO BP;POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS;#N/A;30;-0.8812889;0.6236559;0.772272
GO BP;NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE;GO:0002820;21;-0.88110477;0.64364207;0.7723427
GO BP;TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER;GO:0006361;34;-0.8801724;0.6466877;0.77395695
GO BP;REGULATION OF MRNA PROCESSING;GO:0050684;121;-0.879864;0.71505374;0.7739788
GO BP;NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION;GO:0001937;21;-0.87998223;0.64715445;0.7740423
GO BP;CELL CYCLE G2 M PHASE TRANSITION;GO:0044839;243;-0.8792738;0.7527812;0.7749036
KEGG;MISMATCH REPAIR;;22;0.94754773;0.52020204;0.7749854
GO BP;MIDBRAIN DEVELOPMENT;GO:0030901;59;-0.8789825;0.69911504;0.77518517
GO BP;NEGATIVE REGULATION OF VIRAL TRANSCRIPTION;GO:0032897;20;-0.87879276;0.6328502;0.7752491
GO BP;REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING;GO:2000677;33;-0.8784347;0.6507177;0.77570736
GO BP;VACUOLAR ACIDIFICATION;GO:0007035;20;-0.87764853;0.63535035;0.77700806
GO BP;CELLULAR DETOXIFICATION;GO:1990748;68;-0.87720156;0.6942857;0.7770288
GO BP;PIGMENT METABOLIC PROCESS;#N/A;50;-0.87721694;0.6749634;0.77731097
GO BP;MONOVALENT INORGANIC CATION TRANSPORT;GO:0015672;281;-0.87729216;0.78114086;0.7774643
GO BP;HISTONE H2A ACETYLATION;GO:0043968;16;-0.8767721;0.6578073;0.7775781
GO BP;NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS;#N/A;64;-0.87653595;0.69014084;0.7777351
GO BP;G0 TO G1 TRANSITION;#N/A;42;-0.87560594;0.66358024;0.7793755
GO BP;NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE;GO:0070373;49;-0.8751735;0.69402987;0.7796582
GO BP;REGULATION OF ISOTYPE SWITCHING;GO:0045191;22;-0.8752306;0.6542373;0.77984107
GO BP;ARACHIDONIC ACID METABOLIC PROCESS;GO:0019369;23;-0.87480915;0.63826364;0.7801099
GO BP;ENTRY INTO HOST;#N/A;90;-0.8746106;0.6998617;0.7801901
GO BP;POSITIVE REGULATION OF TELOMERASE ACTIVITY;GO:0051973;32;-0.87375945;0.651446;0.78096324
GO BP;GLYCOPROTEIN BIOSYNTHETIC PROCESS;GO:0009101;228;-0.87354046;0.77459526;0.78108406
GO BP;PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY;GO:0007200;23;-0.87336266;0.665;0.7811644
GO BP;RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009156;26;-0.8739591;0.6507177;0.78116673
GO BP;GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS;#N/A;19;-0.8737701;0.6491525;0.7812503
KEGG;GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE;;15;-0.9138954;0.60232943;0.7818096
GO BP;REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901796;161;-0.8725842;0.73350585;0.7824457
GO BP;MODIFIED AMINO ACID TRANSPORT;#N/A;18;-0.87177384;0.6442006;0.78381974
KEGG;P53 SIGNALING PATHWAY;;60;-0.9167189;0.6147309;0.7845513
GO BP;CELLULAR PIGMENTATION;GO:0033059;41;0.99808985;0.4697802;0.7849646
GO BP;RESPONSE TO ELECTRICAL STIMULUS;GO:0051602;24;0.9956;0.4475;0.7855447
KEGG;CELL CYCLE;;115;0.9126492;0.7132867;0.7858963
GO BP;MRNA SPLICE SITE SELECTION;GO:0006376;27;0.9969312;0.45380434;0.78624827
GO BP;ATRIAL SEPTUM DEVELOPMENT;GO:0003283;15;-0.87020963;0.6276771;0.78643405
GO BP;REGULATION OF RECEPTOR RECYCLING;GO:0001919;20;-0.8702547;0.62876254;0.78663564
GO BP;GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR;#N/A;25;0.99586004;0.46614584;0.7873162
GO BP;DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS;GO:0009200;15;0.99391854;0.44871795;0.788483
GO BP;ACTIVATION OF INNATE IMMUNE RESPONSE;GO:0002218;211;-0.86891603;0.7770859;0.78877115
GO BP;NEGATIVE CHEMOTAXIS;GO:0050919;29;0.99253803;0.44352618;0.7903319
GO BP;OLISACCHARIDE METABOLIC PROCESS;#N/A;31;0.9915242;0.43967828;0.7911416
GO BP;OOGENESIS;GO:0048477;52;-0.86730313;0.6946565;0.7917571
GO BP;DOPAMINE TRANSPORT;GO:0015872;16;-0.8659445;0.6412478;0.7919853
GO BP;SULFUR COMPOUND TRANSPORT;#N/A;34;-0.86576825;0.68085104;0.79203933
GO BP;INTERACTION WITH HOST;#N/A;152;-0.86618143;0.7587131;0.7921533
GO BP;REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:0061136;154;-0.86600775;0.7558747;0.79217786
GO BP;POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;#N/A;35;-0.8662809;0.6697966;0.7922651
GO BP;REGULATION OF NEUTROPHIL MIGRATION;GO:1902622;16;-0.86670893;0.65986395;0.7923253
GO BP;REGULATION OF T CELL MEDIATED IMMUNITY;#N/A;29;-0.8664997;0.65189874;0.792437
GO BP;NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION;GO:1904950;108;-0.86677414;0.72153634;0.7925023
GO BP;POSITIVE REGULATION OF CHROMOSOME SEGREGATION;GO:0051984;27;-0.86629033;0.66925466;0.7925576
GO BP;NON CANONICAL WNT SIGNALING PATHWAY;GO:0035567;115;-0.8651097;0.72775567;0.793034
GO BP;TRABECULA FORMATION;#N/A;15;-0.86454684;0.630662;0.7935433
GO BP;NEGATIVE REGULATION OF PEPTIDE SECRETION;#N/A;68;-0.8638117;0.71387285;0.7937619
GO BP;ORGANELLE FUSION;GO:0048284;99;-0.8645839;0.7243319;0.7937818
GO BP;CELLULAR RESPONSE TO VITAMIN;#N/A;15;-0.8638511;0.6395349;0.7940086
GO BP;MEMBRANE REPOLARIZATION;GO:0086009;22;-0.8639948;0.65164644;0.7940358
GO BP;NEUROPEPTIDE SIGNALING PATHWAY;GO:0007218;25;-0.8640284;0.64659274;0.7942782
GO BP;REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY;GO:0010640;17;-0.863058;0.6617647;0.7949631
GO BP;PROTEIN O LINKED MANNOSYLATION;GO:0035269;18;-0.8625313;0.6438127;0.7956849
GO BP;NEGATIVE REGULATION OF MRNA METABOLIC PROCESS;#N/A;68;-0.8619756;0.7172312;0.79642797
GO BP;TRANSLESION SYNTHESIS;GO:0019985;37;0.9889211;0.47262248;0.79732525
GO BP;REGULATION OF MONOOXYGENASE ACTIVITY;#N/A;34;0.9880175;0.47058824;0.7978098
GO BP;FEMALE MEIOTIC NUCLEAR DIVISION;GO:0007143;24;-0.8607247;0.6687697;0.7982242
GO BP;ENTEROENDOCRINE CELL DIFFERENTIATION;GO:0035883;19;-0.8608019;0.66178864;0.7983954
GO BP;LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS;#N/A;20;-0.8604664;0.66174054;0.79843026
GO BP;MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION;#N/A;31;-0.86027354;0.6741573;0.7984929
GO BP;POSITIVE REGULATION OF COAGULATION;GO:0050820;19;-0.85930485;0.6666667;0.8000668
GO BP;REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902235;28;-0.85825074;0.6952224;0.80181897
GO BP;PLASMINOGEN ACTIVATION;GO:0031639;19;-0.8574572;0.6735341;0.80303085
GO BP;N TERMINAL PROTEIN AMINO ACID MODIFICATION;GO:0031365;25;0.98536354;0.46551725;0.8040404
GO BP;LIPOSACCHARIDE METABOLIC PROCESS;#N/A;87;-0.8564079;0.75774646;0.8048369
GO BP;POSITIVE REGULATION OF VIRAL TRANSCRIPTION;GO:0050434;39;0.9835062;0.48189417;0.8050017
GO BP;FC RECEPTOR SIGNALING PATHWAY;GO:0038093;142;0.98423725;0.4944238;0.8051389
GO BP;INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS;GO:0002437;24;-0.8557262;0.67255217;0.8058403
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST;GO:0050691;24;0.9820654;0.46153846;0.8071626
GO BP;SYNAPTIC VESICLE RECYCLING;GO:0036465;51;-0.8540166;0.7248521;0.8079087
GO BP;POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION;#N/A;66;-0.8544599;0.7346327;0.80798346
GO BP;ANIMAL ORGAN REGENERATION;GO:0031100;50;-0.854126;0.7066869;0.80801755
GO BP;GROWTH PLATE CARTILAGE DEVELOPMENT;GO:0003417;22;-0.85417235;0.68404424;0.8082437
GO BP;POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION;GO:0032732;17;-0.8532022;0.7181208;0.80915165
GO BP;CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS;GO:0006575;126;-0.85296166;0.7692308;0.8093179
GO BP;C21 STEROID HORMONE METABOLIC PROCESS;GO:0008207;24;-0.852685;0.705;0.8095072
GO BP;POST TRANSLATIONAL PROTEIN MODIFICATION;GO:0043687;283;0.9771953;0.57894737;0.8103029
GO BP;RESPONSE TO CADMIUM ION;GO:0046686;43;0.97638434;0.5217391;0.8104259
GO BP;NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS;GO:1903363;72;0.9778172;0.5118644;0.810931
GO BP;C4 DICARBOXYLATE TRANSPORT;#N/A;16;-0.85141045;0.65460527;0.81136215
GO BP;SYNAPTIC VESICLE TRANSPORT;GO:0048489;33;0.9784364;0.50277776;0.81150866
GO BP;PROTEIN FOLDING;GO:0006457;180;-0.8514839;0.7992228;0.8115363
GO BP;TRNA MODIFICATION;GO:0006400;75;0.97914594;0.49520767;0.81177765
GO BP;MITOCHONDRIAL FISSION;GO:0000266;31;-0.8499795;0.7065391;0.81254995
GO BP;ACTIVATION OF MAPK ACTIVITY;GO:0000187;108;-0.85007674;0.77531207;0.8126802
GO BP;MESODERMAL CELL DIFFERENTIATION;GO:0048333;17;-0.84973943;0.65112543;0.81269926
GO BP;RESPONSE TO GAMMA RADIATION;GO:0010332;50;-0.85016835;0.7216339;0.8128255
GO BP;POSITIVE REGULATION OF ORGAN GROWTH;GO:0046622;27;0.97959185;0.520436;0.8128343
GO BP;CELLULAR RESPONSE TO CADMIUM ION;GO:0071276;22;-0.8502301;0.6960133;0.8130203
GO BP;PROTEIN TRIMERIZATION;GO:0070206;30;-0.850235;0.6770671;0.81332266
GO BP;PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL;GO:0070646;241;-0.8486555;0.840796;0.8141247
GO BP;PURINE NUCLEOBASE METABOLIC PROCESS;GO:0006144;19;-0.84846646;0.68115944;0.8141865
GO BP;MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY;#N/A;33;-0.8487341;0.6969697;0.81429565
GO BP;LEUKOCYTE MEDIATED CYTOTOXICITY;GO:0001909;45;-0.847135;0.7112782;0.8154072
GO BP;REGULATION OF PROTEIN STABILITY;GO:0031647;242;-0.847307;0.8283671;0.8154079
GO BP;REGULATION OF PROTEIN SUMOYLATION;GO:0033233;17;-0.8473444;0.6956522;0.81566817
GO BP;POSITIVE REGULATION OF CARTILAGE DEVELOPMENT;GO:0061036;20;-0.84681666;0.69131833;0.815677
GO BP;POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING;GO:0050850;22;-0.84745604;0.6769481;0.8157727
GO BP;TERMINATION OF RNA POLYMERASE II TRANSCRIPTION;GO:0006369;33;0.9740216;0.49584487;0.81579787
GO BP;MONOVALENT INORGANIC CATION HOMEOSTASIS;#N/A;100;-0.8461481;0.7905983;0.81663
GO BP;PROTEIN POLYUBIQUITINATION;GO:0000209;260;-0.84556615;0.8574939;0.81744844
GO BP;POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION;GO:0002639;22;-0.84514207;0.69711536;0.81795233
GO BP;INORGANIC ANION TRANSPORT;GO:0015698;92;-0.84444344;0.7492997;0.8189534
GO BP;POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;#N/A;42;-0.8438523;0.71556884;0.81972957
GO BP;REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;#N/A;83;-0.8435968;0.76210827;0.8198841
GO BP;NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY;GO:1902176;15;-0.84274685;0.6914191;0.82115823
GO BP;GLANDULAR EPITHELIAL CELL DEVELOPMENT;GO:0002068;18;-0.8412045;0.692437;0.82382715
GO BP;POSITIVE REGULATION OF P38MAPK CASCADE;GO:1900745;21;-0.8400836;0.6919275;0.82553256
GO BP;POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;#N/A;22;-0.8395482;0.70274913;0.82592237
GO BP;HAIR CELL DIFFERENTIATION;GO:0035315;27;-0.8396339;0.7152209;0.82607734
GO BP;BONE GROWTH;GO:0098868;29;0.96982515;0.4871795;0.8271098
GO BP;LIPOPROTEIN METABOLIC PROCESS;GO:0042157;104;0.9686613;0.5218978;0.8285073
GO BP;POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY;GO:0051353;37;-0.83793545;0.735474;0.82855374
GO BP;CELLULAR RESPONSE TO OXYGEN LEVELS;GO:0071453;172;-0.8361625;0.8491049;0.83144516
GO BP;NEUROTRANSMITTER SECRETION;GO:0007269;96;-0.8353812;0.79448277;0.832554
GO BP;PIGMENT BIOSYNTHETIC PROCESS;#N/A;43;-0.8347439;0.73748106;0.833353
GO BP;WATER SOLUBLE VITAMIN METABOLIC PROCESS;#N/A;69;-0.83452183;0.7748918;0.8334095
GO BP;REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT;GO:0048641;30;-0.8340313;0.7299035;0.83399874
GO BP;NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS;#N/A;195;-0.8333949;0.850365;0.8348294
GO BP;CYCLIC NUCLEOTIDE METABOLIC PROCESS;#N/A;21;-0.83246386;0.6993243;0.836208
GO BP;NCRNA TRANSCRIPTION;GO:0098781;100;-0.8321017;0.7927677;0.8365524
GO BP;TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;#N/A;81;-0.83116144;0.80145985;0.8379048
GO BP;RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC;GO:0090503;39;0.9647978;0.5029762;0.83857834
GO BP;MULTICELLULAR ORGANISM AGING;GO:0010259;25;-0.8301702;0.70016474;0.83938646
GO BP;DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION;#N/A;17;-0.8298829;0.7004992;0.83956224
KEGG;VALINE LEUCINE AND ISOLEUCINE DEGRADATION;;38;-0.8846713;0.63297045;0.83978164
GO BP;CELLULAR TRANSITION METAL ION HOMEOSTASIS;#N/A;78;-0.82922095;0.7733142;0.83978194
GO BP;REGULATION OF MICROTUBULE BASED MOVEMENT;#N/A;18;-0.82932764;0.7031746;0.83991826
GO BP;POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING;GO:0043123;133;-0.8294378;0.8097754;0.8400328
GO BP;MEGAKARYOCYTE DIFFERENTIATION;GO:0030219;68;-0.8288036;0.7700146;0.8402171
GO BP;CHROMOSOME SEPARATION;GO:0051304;80;-0.8285043;0.76754385;0.8404094
GO BP;KINETOCHORE ASSEMBLY;GO:0051382;16;0.96321607;0.50130546;0.8409088
GO BP;RESPIRATORY BURST;GO:0045730;15;0.95996505;0.51842105;0.8411163
KEGG;DNA REPLICATION;;34;0.86781543;0.68604654;0.84113085
GO BP;RESPONSE TO VITAMIN D;GO:0033280;19;-0.82746077;0.71100163;0.8412799
GO BP;CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS;GO:0071549;26;-0.8274755;0.7324633;0.84157854
GO BP;POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS;GO:2000379;60;-0.8276052;0.7858177;0.8416745
KEGG;TRYPTOPHAN METABOLISM;;23;-0.8751652;0.65;0.842621
GO BP;TRANSITION METAL ION HOMEOSTASIS;#N/A;95;-0.8260086;0.7863248;0.8428643
GO BP;INTERLEUKIN 12 PRODUCTION;GO:0032615;28;0.96100456;0.5168539;0.8429419
GO BP;POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION;GO:0032786;30;-0.82576257;0.73364484;0.8429689
GO BP;REGULATION OF CYTOPLASMIC TRANSPORT;#N/A;22;-0.8261028;0.7284553;0.8430246
GO BP;REGULATION OF ANOIKIS;GO:2000209;15;-0.8261963;0.6973244;0.8431888
GO BP;NEGATIVE REGULATION OF PROTEIN MATURATION;#N/A;22;0.9601139;0.4744898;0.8432492
GO BP;REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;189;-0.825061;0.87048566;0.8435867
GO BP;RESPONSE TO DEXAMETHASONE;GO:0071548;31;-0.82515204;0.7278481;0.8437378
GO BP;OVULATION CYCLE;GO:0042698;37;0.96132857;0.48044693;0.8444932
GO BP;ACTIVATION OF PROTEIN KINASE B ACTIVITY;GO:0032148;23;-0.8240688;0.71428573;0.8450329
KEGG;STEROID HORMONE BIOSYNTHESIS;;16;-0.87756485;0.6275168;0.84643865
GO BP;PROTEIN MONOUBIQUITINATION;GO:0006513;65;-0.82296866;0.77588654;0.84664816
GO BP;TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION;GO:0032201;25;0.95178854;0.5371703;0.84719944
GO BP;BINDING OF SPERM TO ZONA PELLUCIDA;GO:0007339;16;0.9521668;0.50348026;0.848574
GO BP;MEMBRANE FUSION;GO:0061025;110;0.9525878;0.5595668;0.8497566
GO BP;POSITIVE REGULATION OF HEART GROWTH;GO:0060421;23;0.9542013;0.52956986;0.84975886
GO BP;DNA STRAND ELONGATION;GO:0022616;24;-0.82053787;0.73524153;0.8505153
GO BP;PERK MEDIATED UNFOLDED PROTEIN RESPONSE;GO:0036499;16;-0.8199628;0.6998395;0.85087734
GO BP;POSITIVE REGULATION OF ATPASE ACTIVITY;GO:0032781;51;-0.81974643;0.77963525;0.85093206
GO BP;MORPHOGENESIS OF A POLARIZED EPITHELIUM;GO:0001738;115;-0.8200487;0.82614744;0.851053
GO BP;CELLULAR ALDEHYDE METABOLIC PROCESS;GO:0006081;40;0.9545562;0.52409637;0.8512363
GO BP;ATRIOVENTRICULAR VALVE DEVELOPMENT;GO:0003171;19;-0.8192003;0.71138847;0.8512519
GO BP;NUCLEOBASE METABOLIC PROCESS;#N/A;31;-0.81931883;0.7466887;0.8513686
GO BP;PHASOME MATURATION;#N/A;34;0.9528242;0.5462185;0.8515867
GO BP;RESPONSE TO THYROID HORMONE;GO:0097066;18;0.95520836;0.54471546;0.8518168
GO BP;PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS;#N/A;18;0.94464564;0.54433495;0.8523908
GO BP;VESICLE BUDDING FROM MEMBRANE;GO:0006900;87;0.9477907;0.5531915;0.85243833
GO BP;PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:0010498;412;0.9438732;0.72794116;0.8524626
GO BP;REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA;#N/A;20;0.942986;0.5191257;0.85276365
GO BP;RESPONSE TO LITHIUM ION;#N/A;16;0.9556667;0.51073986;0.85287476
GO BP;NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND;#N/A;17;-0.81788874;0.7163695;0.8529007
GO BP;PEPTIDYL CYSTEINE MODIFICATION;#N/A;35;-0.8180125;0.7507837;0.853005
GO BP;POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST;GO:0002230;17;0.9467623;0.53723407;0.8531404
GO BP;REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:0043516;31;0.9491508;0.5329513;0.85318
GO BP;NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR;GO:1902254;18;0.939656;0.5135135;0.85320604
GO BP;SEMAPHORIN PLEXIN SIGNALING PATHWAY;GO:0071526;25;-0.817506;0.7487923;0.853222
GO BP;POSITIVE REGULATION OF REPRODUCTIVE PROCESS;#N/A;41;0.9451096;0.57300276;0.8535362
GO BP;LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY;GO:0031663;38;-0.81699294;0.7741433;0.8537671
GO BP;RESPONSE TO AMPHETAMINE;GO:0001975;15;0.94181067;0.5498721;0.8538791
GO BP;NEGATIVE REGULATION OF MRNA PROCESSING;#N/A;29;0.94810736;0.53387535;0.8539623
GO BP;REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY;GO:0007176;22;0.9456449;0.52896726;0.85425746
GO BP;NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:2000059;42;-0.8157574;0.7667683;0.85429096
GO BP;REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;#N/A;81;-0.81590825;0.81934565;0.8543518
GO BP;REGULATION OF TELOMERASE ACTIVITY;GO:0051972;42;-0.81596136;0.7901786;0.85457915
GO BP;RESPONSE TO DOPAMINE;#N/A;32;-0.8160977;0.7197452;0.85466194
GO BP;HYALURONAN METABOLIC PROCESS;GO:0030212;22;-0.8162473;0.738255;0.8547411
GO BP;SUPEROXIDE METABOLIC PROCESS;GO:0006801;43;-0.81516075;0.7534456;0.85498613
GO BP;MRNA CIS SPLICING VIA SPLICEOSOME;GO:0045292;29;0.9398287;0.5494506;0.855106
GO BP;PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS;GO:0006656;36;-0.81465036;0.752;0.8555268
GO BP;PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS;GO:0006778;31;0.9402147;0.564433;0.85647315
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS;GO:1903845;52;-0.8133766;0.79739505;0.8573931
GO BP;RETROGRADE TRANSPORT ENDOSOME TO LGI;#N/A;73;0.9374835;0.5980392;0.85740656
GO BP;NEGATIVE REGULATION OF CELL CYCLE PROCESS;#N/A;276;0.9350347;0.722973;0.8575047
GO BP;KINETOCHORE ORGANIZATION;GO:0051383;21;0.9355911;0.53968257;0.8583073
GO BP;DNA CATABOLIC PROCESS ENDONUCLEOLYTIC;GO:0000737;25;-0.8123403;0.7507837;0.85850143
GO BP;AROMATIC AMINO ACID FAMILY METABOLIC PROCESS;GO:0009072;28;-0.81249803;0.7424;0.85855705
GO BP;REGULATION OF RUFFLE ASSEMBLY;GO:1900027;24;-0.8120828;0.7574803;0.8586246
GO BP;PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS;GO:0042558;29;-0.8113267;0.75834656;0.8592379
GO BP;POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS;GO:0002690;44;-0.81139916;0.79160184;0.85943305
GO BP;PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;22;-0.8107058;0.7408638;0.85993415
GO BP;INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS;GO:0008631;36;-0.8104441;0.7777778;0.86003184
GO BP;NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY;GO:0032088;52;-0.81002116;0.8014925;0.860411
GO BP;CGMP MEDIATED SIGNALING;GO:0019934;18;0.93563116;0.55764705;0.86066175
GO BP;ENTRAINMENT OF CIRCADIAN CLOCK;GO:0009649;23;0.93302405;0.56735754;0.8611722
GO BP;MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION;GO:0097345;45;0.93173635;0.57758623;0.8626894
GO BP;REGULATION OF MEGAKARYOCYTE DIFFERENTIATION;GO:0045652;58;-0.8076006;0.8005865;0.8641798
GO BP;NEGATIVE REGULATION OF HORMONE SECRETION;GO:0046888;30;-0.8063979;0.7436306;0.864492
GO BP;NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS;GO:2000279;30;-0.80680084;0.7424;0.8645029
GO BP;NEGATIVE REGULATION OF MITOTIC CELL CYCLE;GO:0045930;262;-0.80656284;0.9312039;0.8645577
GO BP;REGULATION OF PH;GO:0006885;73;-0.8068386;0.8343108;0.8647731
GO BP;ZYMOGEN ACTIVATION;GO:0031638;40;-0.80695224;0.7901431;0.8649055
GO BP;EXTRACELLULAR TRANSPORT;GO:0006858;20;-0.80593574;0.7455717;0.8649408
GO BP;POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY;GO:0010518;27;-0.8039023;0.76508975;0.86749077
GO BP;POTASSIUM ION HOMEOSTASIS;GO:0055075;17;-0.80393595;0.73801917;0.8677647
GO BP;PROTEIN STABILIZATION;GO:0050821;152;0.9271346;0.6781116;0.86935943
GO BP;PEPTIDE HORMONE PROCESSING;GO:0016486;19;0.92870724;0.54567903;0.8694836
GO BP;NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS;#N/A;85;0.92624336;0.64214045;0.8696002
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE;GO:0072666;42;-0.80157095;0.8154312;0.8708766
GO BP;REGULATION OF TRANSLATIONAL INITIATION;GO:0006446;67;0.92722875;0.6057692;0.8715241
GO BP;REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY;GO:2000050;18;-0.80091393;0.72920066;0.8715739
GO BP;PROTEIN MANNOSYLATION;GO:0035268;22;-0.8005342;0.7590759;0.87183404
GO BP;REGULATION OF ANION TRANSPORT;GO:0044070;51;-0.7999034;0.800905;0.8724817
GO BP;POSITIVE REGULATION OF PROTEIN MATURATION;GO:1903319;17;-0.79900056;0.76;0.87354803
GO BP;REGULATION OF HORMONE BIOSYNTHETIC PROCESS;GO:0046885;17;-0.7985238;0.73762375;0.87396085
KEGG;HISTIDINE METABOLISM;;19;0.8396029;0.70207256;0.87428397
GO BP;REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY;GO:2000479;16;-0.79761994;0.7384106;0.8746675
GO BP;RUFFLE ORGANIZATION;GO:0031529;41;-0.79762906;0.78431374;0.874981
GO BP;POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS;#N/A;51;-0.7960127;0.79848486;0.8758481
GO BP;PROCESS UTILIZING AUTOPHAGIC MECHANISM;#N/A;409;-0.79616666;0.96825397;0.8759527
GO BP;PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION;GO:0060389;38;-0.79637027;0.79576397;0.8759697
GO BP;AMMONIUM ION METABOLIC PROCESS;#N/A;132;-0.7964105;0.8787062;0.8762364
GO BP;O GLYCAN PROCESSING;GO:0016266;33;0.9173906;0.57908845;0.8765563
GO BP;APOPTOTIC CELL CLEARANCE;GO:0043277;26;0.91819334;0.61126006;0.87661093
GO BP;NUCLEAR ENVELOPE ORGANIZATION;GO:0006998;43;0.91872305;0.6103152;0.8774815
GO BP;RESPONSE TO TESTOSTERONE;GO:0033574;27;0.9227603;0.5547619;0.8775427
GO BP;NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION;#N/A;205;0.9215288;0.6894977;0.878908
GO BP;NUCLEOTIDE SUGAR METABOLIC PROCESS;GO:0009225;34;0.92071384;0.5880682;0.8789295
GO BP;MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002755;22;0.91900605;0.5959079;0.8790782
GO BP;POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:1901030;30;0.91974705;0.5880759;0.8792346
GO BP;NIK NF KAPPAB SIGNALING;GO:0038061;112;-0.7934293;0.86174494;0.8794751
GO BP;POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY;GO:1903307;34;-0.7927782;0.8076336;0.8801561
GO BP;NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:1903573;36;-0.79199857;0.80893683;0.88099986
GO BP;NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY;GO:0000288;67;-0.79125774;0.83730716;0.8817892
GO BP;NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL;#N/A;68;-0.7904507;0.8273273;0.88234943
GO BP;CARDIAC MUSCLE CELL PROLIFERATION;GO:0060038;29;-0.7905934;0.79159665;0.8824637
GO BP;GLYCOSYLATION;GO:0070085;187;0.91448104;0.73394495;0.88257253
GO BP;REGULATION OF MRNA SPLICING VIA SPLICEOSOME;GO:0048024;85;-0.7895854;0.85310733;0.88300174
GO BP;REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY;GO:0032925;17;-0.78967047;0.75085324;0.88321203
GO BP;CARBOHYDRATE BIOSYNTHETIC PROCESS;GO:0016051;142;-0.78899944;0.88859767;0.8835494
GO BP;MRNA PROCESSING;GO:0006397;446;0.9132862;0.8761905;0.8835526
GO BP;REGULATION OF DNA BINDING;GO:0051101;90;-0.78810626;0.87323946;0.88453776
KEGG;DRUG METABOLISM OTHER ENZYMES;;20;0.8200476;0.73350924;0.8855619
GO BP;REPRODUCTIVE BEHAVIOR;GO:0019098;16;-0.7867658;0.776509;0.8861903
GO BP;NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION;GO:0032692;16;-0.7863684;0.75605816;0.8864732
GO BP;NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION;GO:0048147;20;-0.78603274;0.78407353;0.8866292
GO BP;PEPTIDYL GLUTAMIC ACID MODIFICATION;#N/A;19;0.9100019;0.57894737;0.88820815
GO BP;MACROPHAGE MIGRATION;GO:1905517;27;0.9108314;0.5988372;0.88827467
GO BP;ACTIVIN RECEPTOR SIGNALING PATHWAY;GO:0032924;25;-0.7834985;0.769103;0.88837695
GO BP;NEUTROPHIL MIGRATION;GO:1990266;43;-0.7837312;0.80757576;0.88868856
GO BP;POSITIVE REGULATION OF VIRAL PROCESS;GO:0048524;96;-0.7835051;0.88963664;0.8886941
GO BP;REGULATION OF ACTIN NUCLEATION;GO:0051125;21;-0.7839226;0.78474575;0.8887337
GO BP;ENDOPLASMIC RETICULUM TO LGI VESICLE MEDIATED TRANSPORT;#N/A;168;-0.78432095;0.920882;0.888803
GO BP;REGULATION OF OXIDOREDUCTASE ACTIVITY;GO:0051341;63;-0.7840038;0.84110785;0.8889527
GO BP;CELLULAR RESPONSE TO ALKALOID;GO:0071312;21;-0.7828584;0.7708674;0.88899225
GO BP;BILE ACID BIOSYNTHETIC PROCESS;GO:0006699;27;-0.78171694;0.7949126;0.8899985
GO BP;NEGATIVE REGULATION OF DENDRITE DEVELOPMENT;GO:2000171;21;-0.7819325;0.7790507;0.8900133
GO BP;CYTOKINETIC PROCESS;GO:0032506;38;-0.78045076;0.8156682;0.8915035
GO BP;PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS;GO:0006220;52;-0.78015625;0.8376723;0.8915722
GO BP;PROTEIN TETRAMERIZATION;GO:0051262;108;0.90688264;0.7210884;0.89214504
GO BP;PEPTIDE CROSS LINKING;GO:0018149;16;-0.7791581;0.76221496;0.8926506
GO BP;NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS;GO:1901799;47;0.9055186;0.61538464;0.8935964
GO BP;ERYTHROCYTE DEVELOPMENT;GO:0048821;23;0.9070022;0.63395226;0.8942327
GO BP;ENDOTHELIAL CELL APOPTOTIC PROCESS;GO:0072577;30;-0.7768988;0.82961786;0.895095
GO BP;DEFENSE RESPONSE TO BACTERIUM;GO:0042742;89;-0.7769132;0.874818;0.89540577
GO BP;ICOSANOID METABOLIC PROCESS;GO:0006690;55;-0.77427936;0.840625;0.8983882
KEGG;HOMOLOUS RECOMBINATION;;26;-0.84488666;0.6879085;0.898451
GO BP;REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY;GO:0050999;29;0.90288657;0.6346667;0.8985454
KEGG;SELENOAMINO ACID METABOLISM;;18;-0.8353985;0.7180328;0.8985672
GO BP;ERBB2 SIGNALING PATHWAY;GO:0038128;25;-0.7736348;0.79744816;0.89856863
GO BP;SKELETAL MUSCLE CELL DIFFERENTIATION;GO:0035914;41;-0.77383554;0.8439394;0.8986364
GO BP;CELLULAR SENESCENCE;GO:0090398;52;0.8967988;0.6910299;0.89868623
GO BP;REGULATION OF BONE REMODELING;GO:0046850;26;-0.77292746;0.8101266;0.8992283
GO BP;REGULATION OF RESPONSE TO INTERFERON GAMMA;GO:0060330;16;-0.77181673;0.777193;0.8997603
GO BP;LYTIC VACUOLE ORGANIZATION;#N/A;54;-0.7719812;0.8693009;0.8998703
GO BP;ENDOPLASMIC RETICULUM ORGANIZATION;GO:0007029;48;-0.7722155;0.8454405;0.8998862
GO BP;GLUTATHIONE METABOLIC PROCESS;GO:0006749;35;0.8971246;0.64220184;0.90011257
GO BP;DORSAL VENTRAL NEURAL TUBE PATTERNING;GO:0021904;19;-0.77098376;0.78145695;0.9005752
GO BP;LEUKOCYTE CHEMOTAXIS;GO:0030595;99;-0.7707257;0.88;0.9005766
GO BP;LIPID OXIDATION;GO:0034440;83;-0.7704631;0.87333333;0.90059
GO BP;DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM;GO:0050830;34;0.9003376;0.6581197;0.9007237
GO BP;RESPONSE TO MUSCLE ACTIVITY;GO:0014850;16;0.90113205;0.5790698;0.900906
GO BP;VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS;#N/A;41;0.89739716;0.6706949;0.9017543
GO BP;TRANSCYTOSIS;GO:0045056;17;0.89909804;0.63366336;0.90181667
KEGG;FRUCTOSE AND MANNOSE METABOLISM;;29;-0.8383922;0.7189441;0.9021065
GO BP;NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS;GO:0032435;31;-0.7687927;0.81875;0.90214247
GO BP;REGULATION OF REPRODUCTIVE PROCESS;#N/A;89;-0.7688432;0.8912134;0.9024131
GO BP;DIOL METABOLIC PROCESS;#N/A;17;-0.7680212;0.79571664;0.9025311
GO BP;PIGMENTATION;GO:0043473;71;-0.76816535;0.8690141;0.90266573
GO BP;CELLULAR AMINO ACID METABOLIC PROCESS;GO:0006520;264;0.8975146;0.86021507;0.9038179
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS;GO:0050688;51;-0.7654143;0.83812404;0.9055882
GO BP;REGULATION OF SUPEROXIDE METABOLIC PROCESS;#N/A;23;-0.7643297;0.79242176;0.90662926
GO BP;TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY;GO:0033209;109;0.89294523;0.74113476;0.9067586
GO BP;CLATHRIN DEPENDENT ENDOCYTOSIS;GO:0072583;36;-0.7625611;0.831307;0.9086341
GO BP;TRANSFERRIN TRANSPORT;GO:0033572;32;-0.7608799;0.8112903;0.9100688
GO BP;PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING;GO:0036152;15;0.8871379;0.63131315;0.9101569
GO BP;VENTRICULAR SEPTUM MORPHOGENESIS;GO:0060412;29;-0.7610466;0.81789637;0.9101875
GO BP;PROTEIN K63 LINKED UBIQUITINATION;GO:0070534;38;-0.7597401;0.85540336;0.9111805
KEGG;HEMATOPOIETIC CELL LINEAGE;;33;0.77261865;0.816;0.9115986
GO BP;BONE RESORPTION;GO:0045453;39;-0.7586048;0.84307694;0.911919
GO BP;REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS;#N/A;66;-0.758739;0.86562943;0.9120878
GO BP;CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION;GO:0034629;20;0.88545537;0.6177215;0.91213936
GO BP;GRANULOCYTE MIGRATION;GO:0097530;55;0.887236;0.6689189;0.91228294
GO BP;NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS;GO:0048261;15;0.8880081;0.6313253;0.91260165
GO BP;REGULATION OF ACUTE INFLAMMATORY RESPONSE;GO:0002673;15;-0.75751853;0.80716723;0.91295874
GO BP;CELL CELL ADHESION MEDIATED BY CADHERIN;GO:0044331;23;-0.7562829;0.8034591;0.9134841
GO BP;NEGATIVE REGULATION OF PROTEIN ACETYLATION;GO:1901984;15;-0.756468;0.795;0.913587
GO BP;ACID SECRETION;GO:0046717;56;-0.756668;0.88390094;0.9136843
GO BP;POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION;GO:0010800;20;0.888275;0.59585494;0.91431373
GO BP;NEGATIVE REGULATION OF ANION TRANSPORT;#N/A;15;-0.75498027;0.797054;0.9147851
GO BP;VESICLE LOCALIZATION;GO:0051648;168;-0.75386494;0.9594241;0.91514784
GO BP;FOAM CELL DIFFERENTIATION;#N/A;24;-0.7535805;0.8109453;0.91516787
GO BP;NEGATIVE REGULATION OF CYTOKINE SECRETION;GO:0050710;29;-0.75437605;0.8298217;0.91521955
GO BP;POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0032968;17;-0.75396365;0.82284766;0.9153682
GO BP;DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION;GO:0006271;17;0.88859373;0.6165413;0.915845
GO BP;RESPONSE TO KETONE;#N/A;119;-0.75156224;0.93775374;0.9172865
GO BP;EXPORT ACROSS PLASMA MEMBRANE;GO:0140115;25;-0.75113434;0.8564437;0.9174578
GO BP;REGULATION OF PROTEIN TARGETING TO MITOCHONDRION;GO:1903214;36;-0.75012517;0.8368;0.9179921
GO BP;REGULATION OF MYOBLAST DIFFERENTIATION;GO:0045661;30;-0.7501315;0.8354232;0.9183228
KEGG;GLYCEROPHOSPHOLIPID METABOLISM;;61;-0.8153127;0.78591955;0.9194253
GO BP;REGULATION OF MRNA METABOLIC PROCESS;#N/A;272;-0.74784416;0.981774;0.91999114
GO BP;REGULATION OF HETEROTYPIC CELL CELL ADHESION;#N/A;17;-0.74804956;0.81208056;0.9201121
GO BP;DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS;GO:0046386;20;-0.74608797;0.839404;0.9216268
GO BP;NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY;GO:0090090;127;-0.7453165;0.94451964;0.92183596
GO BP;VESICLE ORGANIZATION;GO:0016050;265;-0.74537605;0.9840881;0.92209405
GO BP;DNA SYNTHESIS INVOLVED IN DNA REPAIR;GO:0000731;45;0.879551;0.69753087;0.92256045
GO BP;NEURAL NUCLEUS DEVELOPMENT;GO:0048857;36;-0.7438203;0.87402797;0.92257166
GO BP;ANTIMICROBIAL HUMORAL RESPONSE;GO:0019730;43;-0.74400127;0.8676259;0.9226889
GO BP;SPERM EGG RECOGNITION;GO:0035036;23;-0.7440136;0.8410915;0.92301387
KEGG;UBIQUITIN MEDIATED PROTEOLYSIS;;123;-0.8180922;0.8486842;0.9230797
GO BP;ORGANELLE MEMBRANE FUSION;#N/A;79;-0.7428365;0.90935254;0.92333513
GO BP;AXIS ELONGATION;GO:0003401;21;-0.74214673;0.8422764;0.92375547
GO BP;REGULATION OF VASCULAR PERMEABILITY;GO:0043114;19;0.8799863;0.62113404;0.9238567
GO BP;POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION;GO:1903955;26;-0.7415098;0.8330733;0.92412734
GO BP;REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS;GO:1902108;48;0.8780362;0.69908816;0.9242128
GO BP;GLIAL CELL PROLIFERATION;GO:0014009;29;-0.74091834;0.85987264;0.9244667
GO BP;ENDOCRINE PANCREAS DEVELOPMENT;GO:0031018;29;-0.7405364;0.84219;0.9245375
GO BP;TRANSFORMING GROWTH FACTOR BETA PRODUCTION;GO:0071604;22;-0.7401131;0.83219177;0.9246524
GO BP;NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS;GO:0090305;246;-0.7391783;0.9792176;0.92532295
GO BP;PROTEIN HETEROOLIMERIZATION;#N/A;75;-0.73841375;0.90711176;0.9254699
GO BP;NUCLEOTIDE TRANSPORT;GO:0006862;18;-0.7387063;0.8139905;0.9254992
GO BP;APOPTOTIC DNA FRAGMENTATION;GO:0006309;19;-0.7373503;0.83254343;0.926275
KEGG;PROPANOATE METABOLISM;;28;0.7804147;0.8257143;0.9265281
GO BP;POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS;#N/A;39;0.87497896;0.7074468;0.9295828
GO BP;ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE;GO:0070200;18;-0.7337943;0.8330684;0.92966384
GO BP;NEGATIVE REGULATION OF CHROMOSOME SEGREGATION;#N/A;40;-0.7314157;0.88080496;0.931784
GO BP;NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR;GO:1901797;26;0.87149763;0.6461126;0.9335146
GO BP;PLATELET MORPHOGENESIS;GO:0036344;16;-0.7270688;0.85882354;0.9344835
GO BP;NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT;GO:1904893;15;-0.72729754;0.82857144;0.93460286
GO BP;MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS;#N/A;23;-0.7264763;0.8548644;0.9347124
GO BP;REGULATION OF MRNA CATABOLIC PROCESS;#N/A;165;-0.7274675;0.9681275;0.9347649
GO BP;POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION;GO:0030838;69;-0.72811633;0.93142855;0.9348388
GO BP;NEGATIVE REGULATION OF BINDING;#N/A;108;-0.7276606;0.9502618;0.93491524
GO BP;REGULATION OF CHROMOSOME SEPARATION;GO:1905818;56;-0.72581595;0.90697676;0.93502945
GO BP;PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS;#N/A;44;0.87167287;0.6978852;0.9354625
GO BP;POSITIVE REGULATION OF B CELL PROLIFERATION;GO:0030890;23;-0.72360665;0.85;0.9368352
GO BP;MITOCHONDRIAL DEPOLARIZATION;GO:0051882;16;0.8676766;0.6641414;0.9381015
GO BP;PLASMA MEMBRANE TUBULATION;GO:0097320;17;-0.72173196;0.8336;0.9383215
GO BP;RNA INTERFERENCE;GO:0016246;16;-0.7199017;0.8412162;0.9397107
GO BP;POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION;#N/A;47;0.8677716;0.74927956;0.94026756
GO BP;EXOCYTIC PROCESS;#N/A;62;-0.71772325;0.93088233;0.94138646
GO BP;REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS;GO:1905897;74;-0.71452683;0.93390805;0.9439842
GO BP;NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT;GO:0046426;15;-0.71307915;0.85596025;0.9449618
GO BP;LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT;GO:0060716;15;-0.7116247;0.8518519;0.94592625
KEGG;FC EPSILON RI SIGNALING PATHWAY;;54;-0.79533863;0.83128834;0.94637525
GO BP;MEIOTIC CHROMOSOME SEPARATION;GO:0051307;19;-0.7098942;0.86734694;0.94709724
GO BP;REGULATION OF MACROPHAGE MIGRATION;GO:1905521;21;-0.7080255;0.87070376;0.94769204
GO BP;POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT;GO:0055025;28;-0.70748484;0.88980263;0.9478156
GO BP;HISTONE PHOSPHORYLATION;GO:0016572;30;-0.7080806;0.88765824;0.94799
GO BP;AMINO SUGAR METABOLIC PROCESS;#N/A;26;-0.7064892;0.8816;0.94829524
GO BP;POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING;GO:1904358;34;-0.70811695;0.91463417;0.94830245
GO BP;POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS;#N/A;126;0.861157;0.8346457;0.9490772
GO BP;RESPONSE TO HYDROPEROXIDE;GO:0033194;16;-0.7045318;0.86906713;0.94957316
GO BP;EXOCRINE SYSTEM DEVELOPMENT;GO:0035272;29;-0.7040736;0.9029126;0.94961077
GO BP;INTERSTRAND CROSS LINK REPAIR;GO:0036297;50;0.8598304;0.72644377;0.9498981
GO BP;SUBSTANTIA NIGRA DEVELOPMENT;GO:0021762;33;-0.703058;0.89735615;0.9501271
GO BP;RRNA METHYLATION;GO:0031167;23;0.8613239;0.6760204;0.9510514
GO BP;FATTY ACID CATABOLIC PROCESS;GO:0009062;84;-0.699577;0.95494187;0.9525847
GO BP;VITAMIN BIOSYNTHETIC PROCESS;#N/A;15;-0.69812435;0.8737705;0.9533873
GO BP;NEGATIVE REGULATION OF LEUKOCYTE MIGRATION;GO:0002686;17;0.8512094;0.67268044;0.955372
GO BP;TYPE B PANCREATIC CELL DEVELOPMENT;GO:0003323;15;-0.6945902;0.8745981;0.9553753
GO BP;RESPONSE TO NERVE GROWTH FACTOR;#N/A;41;-0.694903;0.9250375;0.9554855
GO BP;PROTEIN LOCALIZATION TO NUCLEOLUS;GO:1902570;15;0.84795475;0.66410255;0.9555567
GO BP;HEME BIOSYNTHETIC PROCESS;GO:0006783;21;0.85206264;0.71022725;0.95587885
GO BP;KETONE BIOSYNTHETIC PROCESS;#N/A;32;-0.69251823;0.909375;0.9566166
GO BP;REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION;#N/A;59;0.8538093;0.77813506;0.95663494
GO BP;REGULATION OF INTERLEUKIN 1 SECRETION;#N/A;19;0.85267866;0.69077307;0.95682716
GO BP;CELL CYCLE DNA REPLICATION;#N/A;59;-0.6912274;0.9576023;0.9572229
GO BP;PHOSPHATIDYLSERINE METABOLIC PROCESS;GO:0006658;22;0.8555198;0.6953125;0.95748496
GO BP;CELLULAR RESPONSE TO RADIATION;GO:0071478;134;0.8480458;0.8651685;0.9577237
GO BP;SKELETAL MUSCLE ADAPTATION;#N/A;16;0.8490129;0.6831683;0.95794344
GO BP;NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY;GO:1904030;25;-0.6892162;0.9106858;0.95835406
GO BP;MONOCYTE CHEMOTAXIS;GO:0002548;20;0.8455532;0.68817204;0.9586184
GO BP;LIVER REGENERATION;GO:0097421;24;0.8539197;0.70308125;0.9587831
GO BP;SUBSTRATE DEPENDENT CELL MIGRATION;GO:0006929;18;-0.6874627;0.90453076;0.95931935
KEGG;PYRUVATE METABOLISM;;33;-0.77605635;0.81732285;0.95932066
GO BP;POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION;GO:1902808;39;-0.6867805;0.915873;0.9594605
GO BP;GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS;#N/A;15;-0.6846232;0.8689884;0.95991474
GO BP;REGULATION OF MRNA POLYADENYLATION;GO:1900363;17;-0.68470824;0.87034035;0.960185
GO BP;POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY;GO:0032770;16;-0.6850961;0.87459284;0.96025836
GO BP;PROTEIN KINASE A SIGNALING;GO:0010737;18;-0.6823193;0.8896211;0.9604452
GO BP;GLYCEROPHOSPHOLIPID CATABOLIC PROCESS;GO:0046475;17;-0.6824438;0.89813244;0.96071094
GO BP;RESPONSE TO COLD;GO:0009409;35;-0.68128896;0.9323899;0.9607783
GO BP;REGULATION OF TELOMERE CAPPING;#N/A;22;-0.6807025;0.9154705;0.96082103
GO BP;POSITIVE REGULATION OF ISOTYPE SWITCHING;GO:0045830;15;-0.682576;0.8894389;0.96096575
KEGG;PANTOTHENATE AND COA BIOSYNTHESIS;;15;0.6981319;0.87593055;0.96320623
GO BP;NUCLEAR ENVELOPE REASSEMBLY;GO:0031468;17;-0.6757787;0.91034484;0.96377057
GO BP;NUCLEOTIDE EXCISION REPAIR DNA INCISION 3 TO LESION;#N/A;21;0.84197915;0.73109245;0.9640016
GO BP;METAPHASE ANAPHASE TRANSITION OF CELL CYCLE;#N/A;52;-0.6748164;0.94925374;0.9640341
GO BP;PROTEIN PALMITOYLATION;GO:0018345;29;-0.67359954;0.9425466;0.9644753
KEGG;PEROXISOME;;70;-0.76014566;0.8869565;0.9645812
GO BP;ERAD PATHWAY;GO:0036503;88;-0.67201835;0.97115386;0.9651235
GO BP;MRNA CLEAVAGE;GO:0006379;20;-0.6706738;0.89649683;0.9655773
GO BP;REGULATION OF LEUKOCYTE CHEMOTAXIS;GO:0002688;56;-0.66933334;0.9495549;0.96571326
GO BP;PEROXISOMAL MEMBRANE TRANSPORT;#N/A;16;-0.6695664;0.88666666;0.96591187
GO BP;NEGATIVE REGULATION OF NUCLEAR DIVISION;#N/A;48;-0.66842425;0.9419355;0.96592546
GO BP;REGULATION OF GLUCAN BIOSYNTHETIC PROCESS;#N/A;22;-0.66774416;0.90819675;0.9659758
GO BP;NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION;GO:1903556;28;-0.66709805;0.9299363;0.96601015
GO BP;MONOCARBOXYLIC ACID CATABOLIC PROCESS;#N/A;100;-0.6659929;0.97899157;0.9663147
GO BP;REGULATION OF ERBB SIGNALING PATHWAY;GO:1901184;75;-0.6650472;0.9690141;0.9665047
GO BP;REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER;GO:0034243;27;-0.66424316;0.9109375;0.9666041
GO BP;NEURAL CREST CELL MIGRATION;GO:0001755;31;-0.66347045;0.93915755;0.9666872
GO BP;REGULATION OF CYTOPLASMIC TRANSLATION;GO:2000765;25;-0.6625144;0.91122276;0.96690184
KEGG;BUTANOATE METABOLISM;;24;-0.76491207;0.8097561;0.9673745
KEGG;ONE CARBON POOL BY FOLATE;;15;-0.7768095;0.7612688;0.9677542
GO BP;NEGATIVE REGULATION OF PROTEIN BINDING;GO:0032091;63;-0.6598622;0.9772404;0.9680846
GO BP;MODULATION BY VIRUS OF HOST CELLULAR PROCESS;#N/A;16;-0.6570314;0.9039451;0.96925604
GO BP;POSITIVE REGULATION OF DNA REPLICATION;GO:0045740;31;-0.65534884;0.9310345;0.9694687
GO BP;GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS;#N/A;15;-0.6555537;0.9298561;0.9697211
GO BP;FOREBRAIN NEURON DEVELOPMENT;GO:0021884;15;0.8381533;0.6791045;0.96987325
GO BP;HEME METABOLIC PROCESS;GO:0042168;27;0.8369192;0.74545455;0.97010577
GO BP;PROTEIN HOMOTETRAMERIZATION;GO:0051289;61;-0.651639;0.9740634;0.97106504
GO BP;RESPONSE TO TUMOR NECROSIS FACTOR;GO:0034612;188;-0.64580435;0.99746513;0.97146857
GO BP;IRON ION TRANSMEMBRANE TRANSPORT;GO:0034755;15;-0.6477456;0.9066214;0.9715605
GO BP;NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION;GO:0032715;15;-0.64476734;0.91219515;0.9716072
GO BP;NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY;#N/A;19;-0.6466668;0.94892913;0.9717256
GO BP;REGULATION OF CAMP MEDIATED SIGNALING;GO:0043949;22;-0.64595556;0.91404957;0.9717417
GO BP;REGULATION OF B CELL MEDIATED IMMUNITY;#N/A;27;-0.64806145;0.9389313;0.97175336
GO BP;CELLULAR RESPONSE TO IONIZING RADIATION;GO:0071479;59;0.83492225;0.7969231;0.971965
GO BP;SODIUM ION HOMEOSTASIS;GO:0055078;23;-0.6481952;0.91054314;0.9720369
GO BP;UBIQUITIN DEPENDENT ERAD PATHWAY;GO:0030433;69;-0.64874554;0.9729345;0.9721309
KEGG;NOD LIKE RECEPTOR SIGNALING PATHWAY;;36;-0.7478792;0.86195827;0.9723366
GO BP;NEGATIVE REGULATION OF T CELL PROLIFERATION;GO:0042130;32;-0.64116853;0.95015574;0.97257596
GO BP;BILE ACID METABOLIC PROCESS;GO:0008206;35;-0.64178175;0.96232337;0.97265255
GO BP;DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM;GO:0050829;22;0.82988924;0.74120605;0.9729711
GO BP;PHOSPHATE ION TRANSPORT;GO:0006817;17;0.82838273;0.71576226;0.9737466
GO BP;NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION;GO:0045662;17;-0.63661397;0.92845255;0.97424674
GO BP;POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY;#N/A;17;-0.63520324;0.9412674;0.9745046
GO BP;REGULATION OF VIRAL TRANSCRIPTION;GO:0046782;56;0.8302465;0.7936508;0.97459155
GO BP;REGULATION OF MONONUCLEAR CELL MIGRATION;#N/A;26;0.83125925;0.75418997;0.97485393
GO BP;MACROAUTOPHAGY;GO:0016236;259;0.8322926;0.97109824;0.9750835
GO BP;ENERGY HOMEOSTASIS;GO:0097009;23;0.82650596;0.73551637;0.9752247
GO BP;REGULATION OF GLYCOGEN METABOLIC PROCESS;GO:0070873;27;-0.6219785;0.9695024;0.97942847
GO BP;AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS;GO:0009074;22;-0.61998916;0.9532258;0.9797981
GO BP;PROSTANOID METABOLIC PROCESS;#N/A;26;-0.6152336;0.9584718;0.9811777
KEGG;OLFACTORY TRANSDUCTION;;17;-0.72538126;0.8188034;0.9816875
GO BP;LUNG EPITHELIUM DEVELOPMENT;GO:0060428;20;-0.6047194;0.94871795;0.9838592
GO BP;CERAMIDE CATABOLIC PROCESS;GO:0046514;16;-0.60503393;0.9445351;0.98411685
KEGG;VIBRIO CHOLERAE INFECTION;;44;-0.73077303;0.88921714;0.9844969
GO BP;NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE;#N/A;16;-0.59768546;0.9616027;0.9855428
GO BP;ICOSANOID BIOSYNTHETIC PROCESS;GO:0046456;28;-0.59476835;0.9808917;0.98601055
GO BP;COENZYME A METABOLIC PROCESS;GO:0015936;15;-0.5918708;0.9485904;0.98642
GO BP;SPINDLE LOCALIZATION;GO:0051653;42;-0.5879896;0.9880597;0.98702735
GO BP;DENDRITIC SPINE MAINTENANCE;GO:0097062;15;-0.5799244;0.9586919;0.9885844
KEGG;ARGININE AND PROLINE METABOLISM;;39;-0.7101817;0.9010495;0.98932284
KEGG;ALANINE ASPARTATE AND GLUTAMATE METABOLISM;;21;-0.67963773;0.90619767;0.9903892
KEGG;FATTY ACID METABOLISM;;31;0.56225437;0.9948454;0.99115455
GO BP;TOXIN METABOLIC PROCESS;GO:0009404;16;0.7832196;0.78809524;0.9914001
GO BP;PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS;GO:0006221;36;0.791193;0.85066664;0.9923546
GO BP;MANNOSYLATION;GO:0097502;31;0.81621885;0.77020204;0.99300665
GO BP;MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY;GO:0002756;24;0.792149;0.78426397;0.9932005
GO BP;PIGMENT CELL DIFFERENTIATION;#N/A;24;0.7832999;0.79746836;0.9935373
GO BP;C21 STEROID HORMONE BIOSYNTHETIC PROCESS;GO:0006700;19;-0.5516933;0.98504984;0.99367344
GO BP;POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS;GO:1903428;25;0.7860451;0.80487806;0.993859
GO BP;NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE;#N/A;26;0.7844457;0.80748665;0.99404913
GO BP;POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION;GO:0032729;20;-0.54582614;0.985342;0.99420303
GO BP;ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION;GO:0040001;31;0.7970499;0.84573;0.9943052
GO BP;INTERLEUKIN 1 SECRETION;#N/A;24;0.7926764;0.7803618;0.99460995
GO BP;SYNAPTIC VESICLE LOCALIZATION;#N/A;40;0.78835654;0.84;0.9946583
GO BP;REGULATION OF MRNA 3 END PROCESSING;#N/A;28;-0.52853507;0.9952;0.99504846
GO BP;SULFUR AMINO ACID METABOLIC PROCESS;#N/A;30;0.79792535;0.77393615;0.9950964
GO BP;POSITIVE REGULATION OF MRNA PROCESSING;#N/A;26;-0.534803;0.98286605;0.99532896
GO BP;POSITIVE REGULATION OF TOR SIGNALING;GO:0032008;29;-0.5290508;0.98299843;0.9953386
GO BP;MRNA 3 END PROCESSING;#N/A;94;-0.53139246;1;0.9954095
GO BP;CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE;GO:0036474;19;0.7990043;0.7480315;0.99556875
GO BP;NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS;GO:2000352;18;0.7862201;0.78535354;0.99584174
GO BP;NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS;GO:1903671;18;0.7933104;0.75970876;0.99591404
KEGG;BASE EXCISION REPAIR;;32;-0.6836388;0.92604005;0.99626726
KEGG;CYTOSOLIC DNA SENSING PATHWAY;;32;-0.6578719;0.93841165;0.99637604
GO BP;EXIT FROM MITOSIS;GO:0010458;26;0.81319743;0.7432432;0.99639845
GO BP;POSITIVE REGULATION OF ANION TRANSPORT;#N/A;25;0.5070239;0.9973753;0.99664605
GO BP;AUTOPHASOME MATURATION;#N/A;30;-0.50159687;0.99251497;0.99711436
GO BP;NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION;GO:0043537;19;0.7938408;0.76984125;0.99731624
GO BP;COBALAMIN METABOLIC PROCESS;GO:0009235;15;0.79912966;0.7493858;0.9976844
GO BP;CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE;GO:0071243;18;-0.4836658;0.99335545;0.9978834
GO BP;PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS;#N/A;18;0.5106523;0.99469495;0.9983219
KEGG;STARCH AND SUCROSE METABOLISM;;22;-0.6914395;0.8894231;0.9983749
GO BP;POSITIVE REGULATION OF MEMBRANE PERMEABILITY;GO:1905710;50;0.8105745;0.85714287;0.9987584
GO BP;RNA METHYLATION;GO:0001510;70;0.7684481;0.9131833;0.99912804
GO BP;CELLULAR IRON ION HOMEOSTASIS;GO:0006879;50;0.7666645;0.9171779;0.9992332
GO BP;REGULATION OF MEIOTIC CELL CYCLE;GO:0051445;33;0.5396602;0.9971182;0.9992491
GO BP;PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY;GO:0001844;24;0.7731931;0.81632656;0.9993099
GO BP;NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS;GO:0009226;21;0.80748355;0.7607053;0.9995979
GO BP;NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE;#N/A;23;0.76466244;0.8333333;0.99973994
KEGG;GALACTOSE METABOLISM;;21;-0.40494737;0.9984351;0.9997852
GO BP;ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME;GO:0000380;65;0.79925305;0.8738462;0.9998159
GO BP;VITAMIN TRANSPORT;GO:0051180;26;-0.34182832;1;0.9999814
GO BP;MITOCHONDRIAL CALCIUM ION HOMEOSTASIS;GO:0051560;19;0.80834943;0.72440946;1
GO BP;PROTEIN LOCALIZATION TO KINETOCHORE;GO:0034501;17;0.8056411;0.7480315;1
GO BP;DNA LIGATION;GO:0006266;17;0.8039629;0.74390244;1
GO BP;POSITIVE REGULATION OF MEIOTIC CELL CYCLE;#N/A;15;0.80076236;0.74029124;1
GO BP;CELL COMMUNICATION BY ELECTRICAL COUPLING;GO:0010644;19;0.7998577;0.7654321;1
GO BP;REGULATION OF GLIAL CELL PROLIFERATION;#N/A;22;0.79973805;0.7860963;1
GO BP;ENDOSOME ORGANIZATION;GO:0007032;71;0.7753791;0.8899371;1
GO BP;NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING;GO:0051898;34;0.7738641;0.8543956;1
GO BP;PROSTANOID BIOSYNTHETIC PROCESS;#N/A;16;0.7700366;0.7627551;1
GO BP;PEROXISOMAL TRANSPORT;#N/A;61;0.7688112;0.9130435;1
GO BP;ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION;#N/A;19;0.76164603;0.82222223;1
GO BP;REGULATION OF MEMBRANE PERMEABILITY;GO:0090559;65;0.757473;0.9119718;1
GO BP;TRICARBOXYLIC ACID CYCLE;GO:0006099;33;0.75638;0.8659218;1
GO BP;NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS;GO:0050687;21;0.75126845;0.8244275;1
GO BP;THYMUS DEVELOPMENT;GO:0048538;31;0.75094086;0.88709676;1
GO BP;MITOTIC CYTOKINETIC PROCESS;GO:1902410;23;0.75030255;0.82469136;1
GO BP;RESPONSE TO INTERFERON BETA;GO:0035456;19;0.7498364;0.8235294;1
GO BP;REGULATION OF AXON GUIDANCE;GO:1902667;29;0.7453426;0.8725762;1
GO BP;REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY;GO:0050855;16;0.74463147;0.8328982;1
GO BP;PHENOL CONTAINING COMPOUND METABOLIC PROCESS;GO:0018958;44;0.736554;0.89117646;1
GO BP;PIGMENT GRANULE LOCALIZATION;GO:0051875;21;0.7347961;0.858156;1
GO BP;RNA MODIFICATION;GO:0009451;136;0.73377526;0.9919028;1
GO BP;REGULATION OF TRANSLATION IN RESPONSE TO STRESS;#N/A;15;0.7314438;0.83902436;1
GO BP;GLUTAMATE METABOLIC PROCESS;GO:0006536;25;0.7265982;0.8891892;1
GO BP;RUFFLE ASSEMBLY;GO:0097178;35;0.7243686;0.91032606;1
GO BP;ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN;GO:0048002;144;0.7220796;0.97863245;1
GO BP;POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS;GO:0010907;30;0.72154075;0.93351066;1
GO BP;B CELL RECEPTOR SIGNALING PATHWAY;GO:0050853;33;0.72054154;0.91256833;1
GO BP;ESTABLISHMENT OF SPINDLE ORIENTATION;GO:0051294;32;0.7187042;0.93333334;1
GO BP;TELOMERASE RNA LOCALIZATION;#N/A;19;0.71676946;0.8582474;1
GO BP;REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS;#N/A;24;0.7155185;0.89402175;1
GO BP;T CELL MEDIATED CYTOTOXICITY;GO:0001913;17;0.7151653;0.86893207;1
GO BP;ANTIGEN PROCESSING AND PRESENTATION;GO:0019882;165;0.71479654;1;1
GO BP;MEMBRANE LIPID CATABOLIC PROCESS;GO:0046466;26;0.71321297;0.89502764;1
GO BP;PROTEIN HOMOTRIMERIZATION;GO:0070207;20;0.708943;0.89081883;1
GO BP;NEGATIVE REGULATION OF DNA BINDING;GO:0043392;38;0.6968405;0.9470752;1
GO BP;CARBOHYDRATE PHOSPHORYLATION;GO:0046835;22;0.696029;0.9032258;1
GO BP;NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS;GO:0009124;35;0.6936852;0.9196676;1
GO BP;CELLULAR RESPONSE TO ESTRADIOL STIMULUS;GO:0071392;20;0.6891042;0.89736843;1
GO BP;NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE;GO:0032211;19;0.68636394;0.9081365;1
GO BP;SYNAPTIC VESICLE ENDOCYTOSIS;GO:0048488;40;0.6856347;0.9467456;1
GO BP;NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS;GO:1900077;23;0.6821855;0.9303483;1
GO BP;MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT;GO:0006851;19;0.68065107;0.92467535;1
GO BP;RRNA MODIFICATION;GO:0000154;33;0.68056;0.9369863;1
GO BP;FIBROBLAST APOPTOTIC PROCESS;GO:0044346;16;0.6805162;0.915601;1
GO BP;IRON ION HOMEOSTASIS;GO:0055072;63;0.67954123;0.97865856;1
GO BP;DICARBOXYLIC ACID METABOLIC PROCESS;#N/A;77;0.67875403;0.9724138;1
GO BP;2 OXOGLUTARATE METABOLIC PROCESS;GO:0006103;16;0.678008;0.9045346;1
GO BP;UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS;GO:0006047;15;0.6650025;0.89540815;1
GO BP;NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION;GO:0010719;17;0.66377723;0.8911917;1
GO BP;TELOMERE CAPPING;GO:0016233;45;0.65143645;0.9728097;1
GO BP;BROWN FAT CELL DIFFERENTIATION;GO:0050873;23;0.64933413;0.9342466;1
GO BP;CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS;#N/A;75;0.6475131;0.9966887;1
GO BP;PLASMA LIPOPROTEIN PARTICLE CLEARANCE;GO:0034381;42;0.6390203;0.9730539;1
GO BP;POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION;GO:0002763;31;0.6353589;0.94578314;1
GO BP;NEGATIVE REGULATION OF AXON EXTENSION;GO:0030517;28;0.63419646;0.9630682;1
GO BP;DNA REPLICATION CHECKPOINT;GO:0000076;15;0.628013;0.9404145;1
GO BP;MYELOID CELL APOPTOTIC PROCESS;GO:0033028;20;0.61396855;0.9493671;1
GO BP;PSEUDOURIDINE SYNTHESIS;GO:0001522;17;0.61213243;0.94;1
GO BP;MELANOCYTE DIFFERENTIATION;GO:0030318;16;0.60955465;0.94221103;1
GO BP;UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY;GO:0043162;20;0.60694534;0.9586777;1
GO BP;NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION;#N/A;25;0.6069038;0.9731183;1
GO BP;SALIVARY GLAND DEVELOPMENT;GO:0007431;21;0.5948201;0.9626667;1
GO BP;PEPTIDYL L CYSTEINE S PALMITOYLATION;GO:0018230;18;0.5785906;0.9848485;1
GO BP;NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS;GO:0045922;17;0.57592034;0.9677419;1
GO BP;NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE;#N/A;34;0.5738458;0.9884393;1
GO BP;NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY;#N/A;15;0.57084394;0.9722222;1
GO BP;DEVELOPMENTAL PIGMENTATION;GO:0048066;30;0.57020974;0.98930484;1
GO BP;REGULATION OF POLYSACCHARIDE METABOLIC PROCESS;#N/A;33;0.5643556;0.991404;1
GO BP;DEOXYRIBONUCLEOTIDE METABOLIC PROCESS;#N/A;31;0.55650663;0.98734176;1
GO BP;SUPEROXIDE ANION GENERATION;GO:0042554;21;0.5426428;0.98092645;1
GO BP;REGULATION OF SUPEROXIDE ANION GENERATION;GO:0032928;16;0.5136172;0.99255586;1
KEGG;LEISHMANIA INFECTION;;40;-0.6154065;0.9639344;1
KEGG;CITRATE CYCLE TCA CYCLE;;29;-0.591704;0.98580444;1
KEGG;ARACHIDONIC ACID METABOLISM;;28;-0.5232169;0.9933222;1
KEGG;AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM;;38;-0.43960366;1;1